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Abbreviations and Acronyms 
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Abstract 
 
The capsular polysaccharide (CPS), or capsule, is one of the main 
virulence factors of Streptococcus pneumoniae. This gram-positive 
bacterium can asymptomatically colonize the nasopharynx of healthy 
individuals, but it also has the capacity to spread to other parts of the 
host’s body and cause disease. The ability of pneumococcal bacteria to 
cause invasive disease is dependent upon the presence of the CPS, which 
surrounds the entire cell surface, protecting it from the host immune 
system. 
 There are more than 90 different types of capsule currently 
known. Importantly, in almost all serotypes the regulation of 
polymerization and cell wall attachment of the CPS seems to be 
dependent upon two proteins belonging to the Bacterial Tyrosine Kinase 
family. These proteins, Wzd and Wze, are proposed to function as main 
regulators of CPS synthesis in S. pneumoniae. In this work, the study of 
the dependence of CPS synthesis upon these two proteins was performed. 
Investigation of how capsule synthesis proceeds and its coordination with 
other essential cellular processes, such as cell division and cell wall 
synthesis, is described in this thesis. 
 Chapter II of this dissertation describes the construction and 
improvement of tools for S. pneumoniae cell biology studies. The 
developed tools allow the in vivo localization of proteins fused, either at 
the N- or C- terminus, to fluorescent proteins mCherry, Citrine, CFP and 
sfGFP. These new cell biology tools were subsequently used to study the 
cellular localization of Wzd and Wze. As described in chapter III, Wzd, a 
membrane protein, and Wze, a cytoplasmic protein, localized at the 
division septum when in the presence of each other. This process did not 
require any additional proteins encoded in the cps operon. Using a 
Abstract  
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Bacterial Two-Hybrid assay, Wzd and Wze were found to interact and the 
roles of the two conserved motifs of Wze, a Walker A ATP-binding motif 
and a C-terminal tyrosine cluster, in this interaction were determined. 
Mutation of conserved residues in the Wze Walker A ATP-binding motif, 
which prevents ATP binding to Wze, was shown to eliminate the 
interaction with Wzd, while substitution of the C-terminal tyrosines for 
phenylalanines had no effect. Moreover, Wze containing a mutated 
Walker A ATP-binding motif no longer localized to the septum of 
encapsulated S. pneumoniae cells, but became dispersed throughout the 
cytoplasm. In the absence of Wzd and Wze, capsular polysaccharide was 
produced and attached to the cell wall, but it was found to be absent from 
the division septum, the site of cell wall synthesis. These results suggest 
that Wzd and Wze are spatial regulators of capsule synthesis, ensuring 
that it occurs at the correct cellular localization. 
 In chapter IV the investigation of how Wzd and Wze spatially 
regulate capsule synthesis is described. Using a Bacterial Two-Hybrid 
assay, screens for interactions between Wzd and Wze, and other 
components of the CPS synthesis machinery, were performed. 
Interestingly, a positive interaction between Wzd and the CPS-cell wall 
ligase, Wzg, was detected. Fluorescent derivatives of Wzg were found to 
localize at the division septum of encapsulated bacteria in the presence of 
Wzd and Wze. This suggests that one role of the Wzd and Wze proteins 
may be to activate the attachment of the CPS to the cell wall at the 
division septum, ensuring that the whole surface is protected by the 
capsule.  
 The work described in this thesis has contributed to the 
elucidation of the mechanism of capsule synthesis in S. pneumoniae. A 
new role for the main regulators of this process, Wzd and Wze, was 
identified and interactions with other members of the CPS synthesis 
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machinery were found. The findings described here may have important 
implications in the design of new strategies against pneumococcal 
infection. 
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Resumo 
 
 O polissacárido capsular (CPS), ou cápsula, é um dos principais 
factores de virulência de Streptococcus pneumoniae. Esta bactéria Gram-
positiva pode colonizar assintomaticamente a nasofaringe de indivíduos 
saudáveis, possuindo também a capacidade de se espalhar para outras 
partes do corpo do hospedeiro e causar doença. A aptidão das bactérias 
pneumocócicas de causar doença invasiva é dependente da presença de 
CPS, que rodeia toda a superfície celular, protegendo-a do sistema 
imunitário do hospedeiro. 
 Existem mais de 90 tipos diferentes de cápsula actualmente 
conhecidos. No entano, em quase todos os serótipos, a regulação da 
polimerização e ligação da cápsula à parede celular parece ser dependente 
de duas proteínas que pertencem à família das Tirosinas Cinases 
Bacterianas. Estas proteínas, Wzd e Wze, são propostas funcionar como 
os principais reguladores da síntese de CPS em S. pneumoniae. Neste 
trabalho, estudou-se a dependência da síntese de CPS destas proteínas. A 
investigação de como decorre a síntese da cápsula e de como esta é 
coordenada com outros processos celulares essenciais, como a divisão 
celular e a síntese de parede celular, é descrita nesta tese. 
O capítulo II desta dissertação descreve a construção e 
optimização de ferramentas para estudos de biologia celular de S. 
pneumoniae. As ferramentas desenvolvidas permitem a localização in vivo 
de proteínas fundidas, quer no seu N- ou C-terminal, às proteínas 
fluorescentes mCherry, Citrine, CFP e sfGFP. Estas novas ferramentas de 
biologia celular foram subsequentemente utilizadas no estudo da 
localização celular do Wzd e do Wze. Como descrito no capítulo III, o 
Wzd, uma proteína de membrana, e o Wze, uma proteína citoplasmática, 
localizaram-se no septo de divisão, quando na presença uma da outra. Este 
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processo não requereu nenhuma proteína adicional codificada no operão 
cps. Usando um ensaio de Bacterial Two-Hybrid, demonstrou-se que o 
Wzd e o Wze interagem e determinou-se o papel dos dois motivos 
conservados do Wze, um motivo Walker A de ligação de ATP e um grupo 
de tirosinas no seu C-terminal, nesta interacção. A mutação dos resíduos 
conservados no motivo Walker A de ligação de ATP do Wze, impedindo 
a ligação de ATP, eliminou a interacção com o Wzd, enquanto que a 
substituição das tirosinas do C-terminal por fenilalaninas não teve 
qualquer efeito. Além disso, o Wze contendo um motivo Walker A de 
ligação de ATP mutado deixou de se localizar no septo de células 
encapsuladas de S. pneumoniae, encontrando-se disperso pelo citoplasma. 
Na ausência do Wzd ou do Wze, o polissacárido da cápsula era produzido 
e ligado à parede celular, mas encontrava-se ausente do septo de divisão, o 
local da síntese de parede. Estes resultados sugerem que o Wzd e o Wze 
são reguladores espaciais da síntese da cápsula, garantindo que esta ocorre 
na sua correcta localização celular. 
 No capítulo IV descreve-se a investigação de como o Wzd e o 
Wze regulam espacialmente a síntese de cápsula. Usando um ensaio de 
Bacterial Two-Hybrid, testaram-se interacções entre o Wzd e o Wze e 
outros componentes da maquinaria de síntese de CPS. Curiosamente, 
detectou-se uma interacção positiva entre o Wzd e o Wzg, a proteína que 
liga o CPS à parede celular. Derivados fluorescentes do Wzg localizaram-
se no septo de divisão de bactérias encapsuladas na presença do Wzd e do 
Wze. Isto sugere que um dos papéis das proteínas Wzd e Wze poderá ser a 
activação da ligação do CPS à parede celular no septo de divisão, 
assegurando que toda a superfície celular é protegida pela cápsula. 
 O trabalho descrito nesta tese contribuiu para a elucidação do 
mecanismo da síntese de cápsula em S. pneumoniae. Um novo papel para 
os principais reguladores deste processo, o Wzd e o Wze, foi identificado 
Resumo 
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e interacções com outros membros da maquinaria de síntese do CPS 
foram encontradas. As descobertas aqui descritas poderão ter importantes 
implicações no desenvolvimento de novas estratégias contra a infecção 
por pneumococos. 
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 When, in 1880, Pasteur described the isolation of Streptococcus 
pneumoniae, he noted: “Each of these little particles is surrounded at a 
certain focus with a sort of aureole which corresponds perhaps to a 
material substance.” [5]. This structure, observed by Pasteur more than a 
century ago, was in fact the capsule or capsular polysaccharide (CPS) that 
surrounds pneumococcal bacteria. Since then, the CPS of S. pneumoniae 
has been at the center of major scientific observations in the fields of 
genetics, immunology and pathogenesis. Its study elucidated the role of 
capsular polysaccharides in bacterial virulence [6] and in protective 
immunity observed in the infected host [56], but perhaps the more 
important contribution to biology was the discovery of the capsule 
transformation reaction [34], which ultimately led to the identification of 
DNA as the genetic material [7]. Today, the study of pneumococcal 
capsule remains an area of active research, particularly with the aim of 
developing strategies to fight S. pneumoniae infections. 
 
Structure of the S. pneumoniae capsular polysaccharide 
 
The capsular polysaccharide forms the outermost layer of all S. 
pneumoniae fresh clinical isolates. The CPS is approximately 200 – 400 
nm thick [96] and is usually found covalently attached to the outer surface 
of the cell wall peptidoglycan [95]. Currently, a total of 94 capsular 
serotypes have been reported in S. pneumoniae [14, 16, 82], and it is 
expected that additional serotypes will probably be identified in the future 
[114]. 
Capsular polysaccharides differ in their sugar composition and in 
the linkages between each of their components. They are complex 
structures containing different sugars, linkages and sometimes side chains 
(Figure I-1). Some capsular polysaccharides, like teichoic acids, contain 
ribitol or phosphorylcholine, such as types 6 and 15, while others possess 
Chapter I 
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a simpler structure, being composed of only one or two sugars, such as 
types 3 and 37 [112].  
 
 
Figure I-1: S. pneumoniae capsular polysaccharide repeating units. The 
capsule repeating units of specific S. pneumoniae serotypes are shown to 
demonstrate their diversity. Glc, glucose; Gal, galactose; GlcNAc, N-
acetylglucosamine; Rha, rhamnose; GlcUA, glucuronic acid; Rib, ribitol. Adapted 
from references [83, 112]. 
 
Role of the S. pneumoniae capsular polysaccharide 
 
 The essential role of the capsule in pneumococcal virulence was 
found by Avery and co-workers, when they discovered that enzymatic 
removal of the capsule protected mice from a pneumococcal infection [6]. 
Since then, the essential role of capsule in S. pneumoniae virulence has 
been demonstrated with unencapsulated mutants or with mutants that 
produce reduced amounts of capsule. These strains contained mutations in 
essential capsule genes, which render them avirulent in mice models [11-
12, 36, 66], or mutations that impaired the activity of cellular enzymes 
that are required for capsule synthesis [36]. Importantly, pneumococcal 
General Introduction 
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virulence requires not only the expression of capsule, but also its 
attachment to the cell wall [70]. 
 
Cell surface protection 
 
Although structurally diverse, capsules perform the same major 
role: to confer resistance to opsonophagocytosis by reducing access of 
phagocytic receptors to complement bound to the cell wall of S. 
pneumoniae. 
 
 
Figure I-2: Scheme of the S. pneumoniae cell surface. The membrane (light 
orange) is surrounded by the cell wall (dark orange). Teichoic acids and 
lipoteichoic acids (blue lines), choline (red circles) and Choline-binding proteins 
(green shapes) are shown. The capsule surrounds the entire surface of the cell 
(yellow). Modified from reference [81].  
 
The S. pneumoniae cell wall can activate the complement system. 
In the absence of capsule, antibodies and C3b molecules, bound to the 
surface of the cells, are easily recognized by specific receptors produced 
by the host’s phagocytes. In encapsulated bacteria, the CPS acts as a 
shield or mechanical barrier (Figure I-2) that prevents a successful 
interaction. This renders the pneumococcal cells resistant to phagocytosis 
[73, 106]. More recently, capsule was also shown to reduce the trapping 
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of S. pneumoniae by neutrophil extracellular traps (NETs), but not to be 
required for resistance to NET-mediated killing [103].  
 
Contribution to the colonization of the host  
 
Although a thick capsule prevents the exposure of surface 
molecules that might be important for the establishment of the 
colonization stage, the total absence of capsular polysaccharide is 
nevertheless deleterious for pneumococcal bacteria even at this stage. In 
fact, unencapsulated mutants are not able to colonize mouse models, 
requiring at least ~20% of the amount of capsular polysaccharide found in 
the parental encapsulated strains to be able to colonize at parental levels 
[58]. The reason for this might be the reduced clearance of the 
pneumococcus from the mucus, in the absence of CPS. Unencapsulated 
strains remain agglutinated in the luminal mucus and are less likely to 
migrate to the epithelial surface, where stable colonization occurs. The 
capsule inhibits mucus binding, in a process possibly mediated by 
electrostatic repulsion [74]. 
 
Importance of capsule type 
 
The capsular type that is expressed by a particular pneumococcal 
strain has a direct role in the virulence and in the accessibility of surface 
adhesins and antigens to antibodies, although CPS structure does not seem 
to be the only factor involved in these mechanisms [1, 44, 87]. Also, 
isolates of the serotypes more commonly found in invasive disease resist 
better to complement deposition [62]. 
Importantly, the occurrence of spontaneous capsular 
transformation events, i. e. the exchange of genes that determine capsule 
type, have been identified in vivo [75]. This might be a mechanism by 
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which S. pneumoniae avoids opsonophagocytosis by serotype-specific 
antibodies during infection. Most importantly, it can lead to the spreading 
of a multiresistant phenotype into new serotypes, and to the increase in 
blood virulence and invasive phenotype of multiresistant strains [75]. 
Despite the differences between capsular types, the virulence 
observed with different strains within the same serotype is correlated with 
the amount of capsular polysaccharide that is expressed at the surface of 
the cells [57].  
Why certain serotypes are more prevalent than others is a question 
that remains to be answered. It has been proposed that the serotypes 
producing a less metabolically costly CPS will be more heavily 
encapsulated, and hence be able to resist phagocytosis and persist in 
carriage. However, many serotypes with low metabolic cost remain rare, 
indicating that this is not sufficient for high prevalence [104]. 
 
Genetic organization of the S. pneumoniae capsular 
polysaccharide locus 
 
 In all the S. pneumoniae serotypes, with the exception of serotype 
37, the genes that encode the enzymes responsible for the capsular 
polysaccharide synthesis are located in the same chromosomal region, the 
cps operon, located between the dexB and aliA genes [13, 113]. Although 
some of the nucleotide diphospho-sugars necessary for CPS production 
that are common to other metabolic pathways may be obtained from 
cellular pools [37, 113], most of the enzymes required for capsule 
synthesis are encoded in this region. 
 The 5’ region of the cps operon is highly conserved between 
serotypes and comprises four genes: wzg, wzh, wzd and wze (also known 
has cpsABCD) (Figure I-3). The fifth gene of the operon is also conserved  
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and encodes the initiating glycosyltransferase. This is constituted by 
WchA (CpsE) in the 68 serotypes in which glucose (Glc) is the first sugar 
of the capsule repeat unit [13, 113]. The sequence of gene wzg is the most 
conserved. It falls into only one sequence cluster, whereas the sequences 
of wzh through wze or wchA can be divided into two different clusters [61, 
69, 101]. Interestingly, these two clusters have been associated with 
ancestral forms of the capsular regulatory genes or with sequences 
probably acquired by lateral gene transfer, which in turn correlated with a 
predominance of carriage serotypes or invasive serotypes, respectively 
[101]. 
The downstream region of the cps operon is considered to be 
serotype specific (Figure I-3). This sequence is not conserved as the 5’ 
region and it encodes the enzymes responsible for the assembly of the 
specific sugar repeating unit of each serotype [13, 48]. This includes 
genes encoding enzymes responsible for the synthesis of NDP-sugars that 
are unique to the CPS, glycosyltransferases and sugar modification 
enzymes. Also in this region is encoded the enzyme responsible for the 
transport of the repeat unit across the membrane, the Wzx flippase, as well 
as the enzyme required for its polymerization, the Wzy polymerase [13, 
113]. 
The cps locus of the S. pneumoniae serotype 3 is also located 
between genes dexB and aliA and it includes the common region 
described above. However, this is not transcribed and all the genes except 
wzd are mutated. The 3’ end of the type 3 locus is also constituted by 
truncated sequences and only two genes, ugd (cps3D) and wchE (cps3S) 
are required for serotype 3 capsular polysaccharide synthesis [4, 23, 113]. 
As mentioned above, serotype 37 is the only exception to this 
chromosomal location. Strains belonging to this serotype contain a cps 
locus correspondent to serotype 33, between the dexB and aliA genes, but 
Chapter I 
 
- 18 - 
this is mutated. A single gene, tts, located elsewhere in the pneumococcal 
genome, is responsible for the synthesis of the type 37 capsule [55]. 
 
S. pneumoniae capsular polysaccharide synthesis 
 
 The majority of the pneumococcal capsular polysaccharide types 
are synthesized through the Wzy-dependent mechanism [13]. In this mode 
of synthesis, which proceeds in a similar way as the synthesis of 
peptidoglycan, the repeating units of the polymer are assembled in the 
inner face of the cytoplasmic membrane, transported across it to the outer 
face by a Wzx flippase and then polymerized in a nonprocessive manner 
by a Wzy polymerase. The defining enzymes of this pathway are the Wzx 
flippase and the Wzy polymerase [113]. Only in serotypes 3 and 37 the 
CPS synthesis occurs by a different mechanism, the synthase-dependent 
mechanism [13]. In this case, a single enzyme is responsible for the 
initiation, polymerization and transport of the capsular polysaccharide 
polymer [113]. The polysaccharides synthesized through this mechanism 
are simpler than those synthesized by the Wzy-dependent manner, 
consisting of only one or two repeating sugars. Also, defined repeating 
units are not formed, instead single sugars are added directly to the 
growing chain while it is being synthesized and transported across the 
cytoplasmic membrane. 
 
Synthase dependent synthesis 
 
 Synthesis of the capsular type 3 is the paradigm for the synthase 
dependent capsule mode of synthesis in S. pneumoniae. It requires only 
one membrane associated enzyme, WchE (Cps3S), to transport and link 
the two sugar residues, from UDP-glucose (UDP-Glc) and UDP-
glucuronic acid (UDP-GlcUA), that are part of the type 3 CPS [19]. 
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Synthesis initiates with the addition of one of the sugar residues, the 
majority of the times from UDP-Glc, to phosphatidylglycerol [20]. 
Subsequently, alternating UDP-Glc and UDP-GlcUA units are used until 
the oligosaccharide reaches a critical length of ~8 monosaccharides [31]. 
This causes the oligosaccharylphosphatidylglycerol to become tightly 
associated with the synthase and shifts the enzyme to a highly processive 
phase, leading to the production of polymer of high molecular weight 
[31]. 
 The rate of capsule synthesis in serotype 3 is regulated by the 
concentration of the UDP-sugars. In the absence or presence of 
insufficient levels of one of the UDP-sugars, synthesis is stopped and the 
polysaccharide is ejected from the enzyme in an abortive translocation 
reaction [30]. The presence of the second UDP-sugar prevents the release 
of the polysaccharide and,  in a concentration-dependent manner, leads to 
the processive addition of sugars to the polymer [18]. Since cellular levels 
of UDP-Glc are usually sufficient to inhibit the ejection reaction, UDP-
GlcUA levels are the limiting factor in this process [31]. Because capsule 
production correlates with capsule chain length, the concentration of 
UDP-GlcUA also modulates this property [102]. 
 
Wzy-dependent synthesis 
 
 Synthesis of the S. pneumoniae capsule by the Wzy-dependent 
mechanism (Figure I-4) begins with reversible transfer of an activated 
sugar, the majority of the times glucose (Glc) [13], to the C55 
undecaprenyl-phosphate (Und-P) lipid carrier, leading to the formation of 
Und-PP-Glc [17]. This transfer was shown to be catalyzed by WchA, the 
first glycosyltransferase encoded in the cps locus, in serotypes 2, 8, 9V 
and 14 [17, 47, 84, 91], and it is assumed that it catalyzes this reaction in 
all the serotypes in which glucose is the first sugar of the repeating unit. 
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 Once the formation of the repeating unit is initiated, subsequent 
sugars are added by additional glycosyltransferases. These are usually 
identified by homology from the genes encoded in the cps locus, but for 
serotype 14 the activities of the putative enzymes have been confirmed 
[46, 49]. WchK is a -1, 4-galactosyltransferase that transfers galactose to 
lipid-linked glucose, the second step in the assembly of the type 14 
repeating unit. WchL is a -1, 3-N-acetylglucosaminyltransferase that 
adds the third sugar of the repeating unit, N-acetylglucosamine. Finally, 
WchM, a -1, 4-galactosyltransferase, adds the last sugar to the repeating 
unit (Figure I-4). 
 
 
Figure I-4: CPS Wzy-dependent synthesis pathway. The steps in CPS 
synthesis of serotype 14 are shown as example. Protein WchA adds the first 
glucose of the CPS14 repeating unit to the lipid carrier. Proteins WchK, WchL 
and WchM successively add the next sugars of the repeating unit, which is then 
transported across the membrane by the flippase Wzx. At the outer surface, 
repeating units are added by the Wzy polymerase and high-molecular weight 
capsular polysaccharide is formed. The final step in CPS synthesis is the covalent 
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linkage of the capsule to the cell wall peptidoglycan, a reaction catalyzed by 
protein Wzg. See text for more details. 
 
Following the assembly of the repeating unit in the inner face of 
the cytoplasmic membrane, the polymer is “flipped” to the external side 
by protein Wzx. At the outer face of the cytoplasmic membrane, repeating 
units are added and high molecular weight capsular polysaccharide is 
formed in a reaction catalyzed by the Wzy polymerase [113] (Figure I-4). 
The Wzy polymerases are generally predicted by their putative membrane 
topologies. Only for the Escherichia coli O-polysaccharide biosynthetic 
pathway (in an in vitro system) has unambiguous biochemical evidence 
that Wzy acts as a sugar polymerase been presented [107]. 
 The final step in capsular polysaccharide synthesis is the covalent 
linkage of the capsule to the cell wall peptidoglycan [95]. For a long time 
the enzyme responsible for this step has remained unknown. Recently, 
Kawai and colleagues [43] have identified the Wzg protein, the product of 
the first gene of the cps operon, as the long searched capsule-cell wall 
ligase. Wzg belongs to a family of proteins, named LCP (LytR – Cps2A – 
Psr), that carry out the transfer of anionic cell wall polymers, such has 
teichoic acids and acidic capsular polysaccharides, from their lipid-linked 
precursors to peptidoglycan. Crystallographic studies have demonstrated 
the phosphotransferase activity of the serotype 2 Wzg protein, supporting 
the proposed enzymatic function of the protein [25]. Importantly, the LCP 
proteins apparently do not recognize the repeating chain of the anionic 
polymer, recognizing instead the lipid and pyrophosphorylated part [25]. 
Therefore, these proteins are not specific and have somewhat redundant 
roles. The precise linkage of the CPS to peptidoglycan is not known. 
 In the last years, protein WchA has gained importance has a 
central player in the control of polymer assembly. Knockout mutants of 
serotype 2 wzx, wzy and ugd (encoding Ugd, a UDP-glucose 
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dehydrogenase necessary for side chain synthesis in this serotype) were 
only obtained in the presence of suppressor mutations [111]. In the 
majority of the cases, the suppressor mutations were mapped in wchA. It 
was proposed that the lethality of the wzx, wzy and ugd mutations was due 
to sequestration of Und-P in the capsule synthesis pathway, preventing its 
turnover for utilization in other essential cellular pathways, like 
peptidoglycan synthesis, or desestabilization of the membrane due to the 
accumulation of lipid-linked intermediates. The suppressors led to a 
reduction in the amount of capsule, presumably to a level that did not 
seriously affect the levels of available Und-P. The mutations in WchA 
occurred in the non-conserved extracytoplasmic and in the conserved 
cytoplasmic glyosyltransferase domains of the protein, indicating both 
have important roles [111]. It is possible that these mutations disrupt 
interactions with other proteins of the pathway, causing a reduction of its 
global activity. 
 Regulation of capsular polysaccharide synthesis in the Wzy-
dependent mode occurs through a complex phosphoregulatory system, 
which is discussed in the following section. 
 
Regulation of the S. pneumoniae capsular polysaccharide 
synthesis 
 
 The production of capsule and the length of the CPS chain in the 
Wzy-dependent synthesis are regulated by proteins from the Bacterial 
Tyrosine Kinase (BY-kinase) family. The members of this family are 
often involved in the regulation of the synthesis of polysaccharides, such 
as exopolysaccharides and capsular polysaccharides [33]. 
The BY-kinase regulatory systems consist of a membrane sensor 
domain, a catalytic cytoplasmic domain and a phosphatase that 
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dephosphorylates the latter. Two transmembrane domains and an 
extracytoplasmic loop between them, which is proposed to participate in 
the sensing of signals from the outside, constitute the membrane sensor 
domain. The catalytic cytoplasmic domain is the kinase part of the system. 
It possesses conserved Walker A and B ATP binding motifs and a tyrosine 
cluster at its C-terminal end. In Gram-negative bacteria and in 
Actinobacteria, these two domains are present in the same protein. On the 
other hand, in the firmicutes, such as S. pneumoniae, the two domains 
exist as two separate, interacting proteins [33] (Figure I-5). 
 
 
 
Figure I-5: Organization of Bacterial Tyrosine Kinases. BY-kinases are 
constituted by a transmembrane “sensory” domain (blue) and an intracellular 
catalytic domain (green). The cytoplasmic catalytic domain possesses conserved 
motifs: a Walker A ATP binding (WA) and a C-terminal tyrosine cluster (Y). In 
proteobacteria, the BY-kinases exist as a single protein, whereas in firmicutes 
they exist as two separate interacting polypeptides. The loop between the two 
transmembrane -helices is shorter in firmicutes than in proteobacteria. 
 
Protein Wzd is the sensor transmembrane domain in S. 
pneumoniae CPS synthesis. It belongs to the Polysaccharide Co-
Polymerase (PCP) family [72] and it was shown to be required for the 
autophosphorylation of Wze [12]. In the absence of Wzd, pneumococcal 
colonies exhibit a rough phenotype, indicating capsule is not produced 
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[71]. However, immunoblot analysis revealed the production of short-
chain CPS polymers in these mutants [11]. Also, immunofluorescence 
experiments detected the presence of low levels of CPS-related material at 
the cell poles of some of the cells [71]. 
 Protein Wze is the catalytic cytoplasmic domain part of the BY-
kinase system involved in S. pneumoniae CPS synthesis. As mentioned 
above for these types of proteins, it possesses the conserved motifs 
characteristic of the group: the Walker A and B ATP binding motif and 
the C-terminal tyrosine cluster [71]. Wze autophosphorylates at this 
cluster and this requires the binding of ATP and the presence of protein 
Wzd [12, 71]. Null mutants of wze produced the same phenotype as 
described above for wzd [11, 66, 71]. Interestingly, mutation of the two 
conserved motifs of Wze had different effects on capsule synthesis. 
Mutation of the Walker A ATP binding motif eliminated capsule 
production and prevented tyrosine phosphorylation, whereas mutation of 
the C-terminal tyrosines to phenylalanines still allowed capsule 
production [71]. However, deletion of the whole tyrosine cluster produces 
a phenotype indistinguishable from a wze null mutant and at least two 
functional tyrosine repeats are required for the normal function of the 
protein [67], indicating that this motif is involved in CPS production. 
 As mentioned above, the third member of the BY-kinase 
regulatory system is a phosphatase, responsible for dephosphorylating the 
cytoplasmic kinase. In S. pneumoniae CPS synthesis, the phosphatase is 
protein Wzh, a manganese-dependent phosphotyrosine-protein 
phosphatase that belongs to the Polymerase and Histidinol Phosphatase 
(PHP) family [68]. Wzh was shown to bind and dephosphorylate Wze, but 
also to inhibit its phosphorylation [12]. Pneumococcal wzh null mutant 
colonies have a rough phenotype, but immunobloting and 
immunofluorescence experiments have shown that, although at lower 
levels, capsule is produced and expressed all around the surface of the 
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cells [66, 71]. Also, the capsule produced has a normal chain size, as seen 
by the CPS ladder pattern observed in immunoblots, which is identical to 
the WT [11]. Point mutations in conserved aspartate and histidine residues 
of wzh, predicted to be involved in catalysis and metal binding, 
respectively, inactivate the protein. This leads to an increase in the levels 
of phosphorylated Wze and produces the same phenotype as a wzh null 
mutant [68]. 
 For a long time, the role of the tyrosine phosphorylation in 
capsular polysaccharide synthesis has been the subject of debate, since 
apparently conflicting results were obtained by different authors. Weiser 
et al. observed that changes in the availability of environmental oxygen 
had an effect in the amount of capsule produced by transparent (T 
variants, producing less CPS) and opaque (O variants, producing more 
CPS) pneumococci [105]. Oxygen had an inhibitory effect in capsule 
production and this correlated with a decrease in the levels of tyrosine 
phosphorylation of Wze. Therefore, it seemed that tyrosine 
phosphorylation positively regulated capsule synthesis. This was also 
observed by Bender and colleagues, who found that the amounts of 
capsule and tyrosine-phosphorylated Wze correlated directly [11]. 
However, Morona and colleagues observed the opposite trend: tyrosine 
phosphorylation appeared to reduce capsule synthesis [67, 71]. It was only 
when the distinction between capsule synthesized and capsule attached to 
the cell wall was made that this question was elucidated. Mutants in which 
capsule was synthesized at normal levels but was defectively attached to 
the cell wall expressed mutated Wzd proteins, whose specific point 
mutations allowed the protein to function independently of Wze tyrosine 
phosphorylation [70]. Also, wzh mutants produced less CPS than the WT 
strain, but the proportion of attached CPS versus total amount produced 
was higher in these strains [70]. These data indicated that high cellular 
levels of the phosphorylated form of protein Wze reduce the overall rate 
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of CPS biosynthesis and increase the rate of cell wall-CPS attachment 
[70]. 
Currently, the model for S. pneumoniae capsular polysaccharide 
synthesis regulation is the following [70] (Figure I-6): nonphosphorylated 
Wze interacts with Wzd, and ATP binds to the Walker A motif of Wze. 
This promotes the interaction with other proteins of the machinery such 
that CPS biosynthesis/polymerization proceeds at a maximal level (Figure 
I-6A). At some point, due to an as yet unknown signal, Wze becomes 
phosphorylated. This changes the interactions between the proteins in the 
assembly machinery, slowing down CPS polymerization and promoting 
instead the transfer of the polymer to the cell wall ligase and consequent 
linkage to peptidoglycan. When Wzh dephosphorylates Wze, the cycle 
can be repeated (Figure I-6B). 
Structural studies of the Wzd and Wze Staphylococcus aureus 
homologues, CapA and CapB, have provided a model for the molecular 
mechanism of polysaccharide synthesis regulation. Olivares-Illana et al. 
solved the structure of the S.aureus tyrosine kinase CapB fused at its N-
terminus with the carboxyl-terminal cytoplasmic part of its cognate 
transmembrane modulator, CapA [80]. The unphosphorylated form of the 
protein was found to associate in a ring-shaped octamer and this led to the 
proposal of a structural-mechanical cycling process. 
Phosphorylation/dephosphorylation of the tyrosine kinase would induce 
cyclic dissociation-association of the octamer. These conformational 
changes would probably be transmitted to the other members of the 
polysaccharide synthesis machinery, affecting their interactions, this way 
modulating the capsule synthesis process [80]. 
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Figure I-6: Current model for the regulation of S. pneumoniae CPS 
synthesis. A) Wzd and Wze interact allowing ATP to bind to the Walker A motif 
of Wze. At this stage, the interactions between the proteins of the CPS machinery 
occur in a way that promotes CPS polymerization by the Wzy polymerase and 
leads to the formation of high-molecular weight CPS. B) Wze autophosphorylates 
at its C-terminal tyrosine cluster, due to an as yet unknown signal. This changes 
the interaction with Wzd, and with the other proteins in the complex. CPS 
synthesis is slowed down and the transfer of the capsular polysaccharide to the 
Wzg ligase and subsequent cell wall ligation is promoted. When the Wzh 
phosphatase dephosphorylates Wze, the cycle can be repeated. 
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S. pneumoniae capsule synthesis as a potential drug target 
 
Importance of S. pneumoniae as a human pathogen 
 
 S. pneumoniae is the leading cause of otitis media, community-
acquired pneumonia and bacterial meningitis. The pneumococcus spreads 
from person-to-person by aerosols and nasopharynx colonization is 
generally asymptomatic, with carriage rates ranging from 5 – 10% of 
healthy adults to 20 – 40% of healthy children. When the bacteria present 
at the nasopharynx migrates to other parts of the human body, spreading 
into the inner ear, lungs, bloodstream or brain, invasive pneumococcal 
disease (IPD) develops. IPD risk groups include infants, the elderly and 
immunocompromised individuals [81]. 
Although the rates of colonized individuals which develop IPD 
are low, the morbidity associated with S. pneumoniae is very high, due to 
its high colonization levels. In 2005, it was estimated that pneumococcus 
was the cause of 1.6 million deaths annually, including 0.7 – 1 million 
deaths of children under the age of 5 [110]. The situation is of most 
concern in developing countries, in which the majority of the latter occur. 
In 2000, 19% of the deaths of children under the age of five, which were 
HIV negative, due to pneumococcal disease, occurred solely in India and 
more than half occurred in only six countries (India, Nigeria, Ethiopia, 
Democratic Republic of the Congo, Afghanistan and China) [108]. In 
Europe and the United States, S. pneumoniae is the most common cause 
of community-acquired bacterial pneumonia in adults. In these 
economically developed regions, IPD is also responsible for high 
mortality levels. The mortality rates average 10 – 20% for adults with 
pneumococcal pneumonia, reaching as much as 50% in high-risk groups 
[109]. Furthermore, pneumococcal disease is also responsible for a high 
economical burden. In 2004 in the United States, it was estimated that 
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direct medical costs reached as much as 3.5 billion US dollars [41]. When 
one considers the work loss and productivity, the value is even higher. 
Pneumococcal disease still remains a substantial cause of morbidity and 
mortality in developed countries nowadays. 
 
Current strategies to fight S. pneumoniae infections 
 
Given the figures presented above, it is clear that effective 
strategies against S. pneumoniae disease are required. In the search for 
strategies to fight pneumococcal infections, the capsule has been a subject 
of interest for a long time. 
Despite the existence of several S. pneumoniae serotypes, the 
majority of the disease is caused by only a small subset [8]. Therefore, 
polysaccharide vaccines (containing capsular polysaccharide) and 
conjugated vaccines (containing capsular polysaccharides conjugated with 
a highly immunogenic protein) against these CPS types have been 
developed [86]. Unfortunately, they only confer protection to the 
particular serotypes contained in their formulation. This has led to a 
phenomenon of replacement, in the population, of the vaccine serotypes 
by other non-vaccine serotypes [3, 38, 42]. New approaches, preferably 
directed at several serotypes simultaneously, are therefore required and 
would be a major breakthrough in the field. Vaccines against non-variable 
pneumococcal surface structures are being developed and will possibly be 
of great use in the future [59]. 
 
BY-kinases as novel drug targets 
 
Since proteins Wzd, Wze and Wzh, as seen above, are key 
enzymes involved in CPS regulation in all but two of the pneumococcal 
serotypes, they present themselves as natural candidates for new strategies 
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designed against pneumococcal infections. Moreover, the fact that they 
belong to the BY-kinase family is another important factor, since this 
family of proteins has been raising attention as novel drug targets. 
 Several features of BY-kinases meet the criteria for an 
antibacterial target [21]. These enzymes control the metabolism of 
polysaccharides that are present at the surface of the bacterial cells, but 
not of the host cells, and they are embedded in the membrane, allowing 
relatively easy access. Also, through the phosphorylation of other cellular 
targets, they are involved in a broad spectrum of essential metabolic 
pathways. Most importantly, the structures of two BY-kinases, Etk from 
the Gram-negative E. coli [54] and CapB from the Gram-positive S. 
aureus [80], have been solved and they revealed some important features. 
Besides the absence of sequence similarity with tyrosine kinases from 
eukaryotes, the fold of BY-kinases is also entirely different from their 
eukaryotic counterparts, as well as their mechanism of action [53]. 
 Not only BY-kinases serve as good candidates for drug 
development, their cognate phosphatases are also promising targets. The 
first structure of a tyrosine phosphatase from a Gram-positive, Wzh from 
S. pneumoniae serotype 4, was solved and shown to have a completely 
different structure from its E. coli functional homologue Wzb [35]. 
Recently, a screening for inhibitors of the phosphatase Wzh led to the 
finding of a metabolite produced by a marine sponge that inhibited the 
activity of the enzyme, causing a decrease in capsule synthesis [97]. 
Interestingly, despite their different structures, this metabolite also 
inhibited the phosphatase activity of the E. coli Wzb, demonstrating the 
value of these enzymes as drug development targets. 
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State-of-the-art of S. pneumoniae cell biology 
 
 In order to fully comprehend how important and essential 
mechanisms for the survival of bacteria occur and how they are regulated, 
it is mandatory to determine where the proteins involved in those 
mechanisms are localized in the cell and what factors control that 
localization. In S. pneumoniae, fundamental processes such as cell wall 
synthesis [64-65] and cell division [27, 32, 51, 78] have been studied 
through the use of immunofluorescence techniques. However, these types 
of techniques present several disadvantages. They require the fixation of 
the cells and their lysis in order to allow access of antibodies, therefore 
they are prone to the production of artifacts. Importantly, they also do not 
allow the visualization of live cells, making it impossible to follow the 
dynamics of a particular protein throughout the cell cycle of the bacteria 
[90]. 
 The discovery of the GFP protein and its application to the 
construction of protein fusions that allow their in vivo visualization has 
revolutionized the cell biology field. Several characteristics of GFP make 
it an attractive reporter, in particular the fact that no external co-factors 
are necessary for its fluorescence and its self-contained domain structure. 
This reduces the chance of perturbations of the fluorescence by the protein 
to which GFP is fused, while simultaneously allowing that protein to 
retain its function [60, 100]. However, GFP maturation requires post-
translational oxidation of the protein, which has hindered the application 
of this technology in microaerophiles such as S. pneumoniae [100]. 
 In 2000, Acebo and colleagues provided the first report on the 
expression of GFP in S. pneumoniae [2]. They were able to measure 
directly the fluorescence of GFP in cells expressing single or multiple 
copies of the gene, opening the way to the possibility of following the fate 
of the pneumococcal cells during colonization. Shortly after, other 
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strategies in the same direction and allowing tighter control of GFP 
expression followed [76-77]. 
 It was only in 2009 that the first study of protein localization 
through GFP fusions, in live pneumococcal cells, was reported [26]. 
Eberhardt and colleagues successfully localized proteins involved in 
choline decoration of teichoic acids, and since then several proteins 
involved in processes such as chromosome segregation [63], cell division 
[10, 29] or capsule synthesis [25] have been studied. 
 The use of GFP protein fusions in S. pneumoniae has no doubt 
been an important breakthrough in the cell biology of this important 
human pathogen, and the constant laboratory evolution and improvement 
of the GFP proteins [28, 94] is constantly increasing its range of 
applications [24]. Despite this, pneumococcal processes are still being 
studied through immunofluorescence techniques [9, 50, 92]. This 
indicates that the field of pneumococcal cell biology is still in need of 
more and better tools for the in vivo study of protein localization. 
 
S. pneumoniae cell division 
 
 S. pneumoniae cells have the shape of an elongated ellipsoid, 
similar to a rugby ball. Cocci bacteria which have this shape have been 
designated as ovococci, to distinguish from the truly spherical cocci such 
as Staphylococcus aureus. Pneumococcal cells can be visualized as 
isolated cells, as diplococcic or as small chains, a characteristic which is 
the result of their mode of division which proceeds in successive parallel 
planes, perpendicular to the long axis of the cells [115].  
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S. pneumoniae possesses two modes of cell wall synthesis 
 
 In rod-shaped cells, cell wall growth occurs in two phases, 
elongation and division. On the contrary, cocci do not possess a cell wall 
elongation machinery, so that all cell wall growth is associated with 
division. Ovococcal cells possess an annular outgrowth of peptidoglycan 
which encircles the cells at their middle [39, 98], termed the equatorial 
ring (Figure I-7A), and this is the only site where new cell wall material is 
incorporated [15, 99]. In these bacteria, peptidoglycan is synthesized in 
two ways: peripheral synthesis and septal synthesis [40]. 
In ovococci, division initiates with the appearance of an ingrowth 
below the equatorial ring (Figure I-7B). When the equatorial ring splits at 
its middle, peripheral cell wall synthesis takes place as new material is 
incorporated between the two separating equatorial rings (Figure I-7C). 
Septal cell wall synthesis begins when the ingrowth, which has remained 
equidistant from the two rings, starts to grow centripetally, leading to the 
formation of the cross-wall, perpendicular to the main axis of the cell 
(Figure I-7D-E) [40, 115]. It is important to note that both types of cell 
wall synthesis in ovococci are division specific, since peripheral synthesis 
is different from the elongation, or lateral wall synthesis, that occurs in 
rod-shaped bacteria. 
PBPs (Penicillin-binding proteins) are enzymes responsible for 
the last steps of peptidoglycan synthesis: the transglycosylation of 
disaccharide units that form the glycan strands; and the transpeptidation 
that cross-links the glycans through peptide bridges [89]. These proteins 
can be classified into high-molecular-weight (HMW) and low-molecular-
weight (LMW) PBPs. HMW PBPs can be further divided into class A, 
which includes bifunctional proteins with both transglycosylase and 
transpeptidase activities, and class B, which includes proteins only with 
transpeptidase activity. LMW PBPs are carboxypeptidases or 
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endopeptidases [89]. S. pneumoniae has 3 class A HMW PBPs (PBP1a, 
PBP1b and PBP2a), two class B HMW PBPs (PBP2b and PBP2x) and 
one LMW PBP (PBP3) [115]. 
 
 
Figure I-7: Schematic representation of the ovococci mode of division. 
Ovococci cells possess an outgrowth at their middle, termed the equatorial ring 
(A). Division starts with the appearance of an ingrowth below the equatorial ring 
(B). The equatorial ring is split and the two resulting rings spread from each other 
as new cell wall material is incorporated during peripheral cell wall synthesis (C). 
Septal cell wall synthesis occurs when the ingrowth, which has remained 
equidistant from the two departing rings, starts to grow centripetally (D). Division 
proceeds with the addition of cell wall material at midcell (E) until the septum is 
closed and the two daughter cells separated (F). Cell wall material of peripheral 
and septal synthesis origin is represented in dark and light gray, respectively. 
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 Initial immunofluorescence studies on the localization of the 
pneumococcal HMW PBPs led to the identification of two distinct 
localization patterns, septal and equatorial, which seemed to relate with 
the organization of the PBPs in two cell wall synthesis machineries, septal 
and peripheral [65]. Importantly, subsequent studies have shown that this 
patterns were an artifact and that all PBPs have the same localization at 
the middle of the cells [115]. However this does not rule out the existence 
of two cell wall synthesis machineries in ovococci, which is supported by 
recent data. 
 
 
Figure I-8: Model for the composition of the peripheral and septal 
peptidoglycan synthesis machineries in S. pneumoniae. Both septal and 
peripheral peptidoglycan synthesis machineries are dependent on the division 
protein FtsZ. In S. pneumoniae, PBP2x is proposed to be part of the septal 
machinery, whereas PBP2b is proposed to be part of the peripheral machinery. 
The peripheral machinery also includes proteins MreC and MreD, as well as 
PBP1a. Based on studies with B. subtilis, PBP1a is proposed to shuttle between 
the two peptidoglycan synthesis machineries. The location of the other 
pneumococcal HMW PBPs has not been yet determined. Adapted from reference 
[93].  
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First, Lactococcus lactis, an ovococcus, was found to have the 
ability to become rod-shaped. Studies on the mechanism that allows this 
morphological transition led to the identification of PBPs associated with 
septal growth (PBP2x) and peripheral growth (PBP2b), which function 
independently of each other. This allows elongation to occur during 
inhibition of division and vice versa [85]. Second, proteins MreC and 
MreD, which are required to maintain the shape of rod-shaped bacteria, 
were found to direct peripheral peptidoglycan synthesis in S. pneumoniae. 
MreCD achieved this through the control of PBP1a localization or activity 
[50]. Based on these results and on other studies from Bacillus subtilis, 
which showed that PBP1 shuttles between peripheral and septal 
peptidoglycan synthesis, a model for the composition of the septal and 
peripheral peptidoglycan synthesis machineries has been proposed (Figure 
I-8) [93]. 
 Interestingly, dual labeling of PBPs showed that different 
populations of PBPs are differentially localized within the same region of 
a cell. The observation that the activities of PBPs are not uniform in the 
midcell regions is in accordance with the model that two cell wall 
synthesis machineries, septal and peripheral, exist and operate at that site 
[45]. 
 
Coordination of cell wall synthesis with cell division 
 
 The first event in cell division is the recruitment of the tubulin-
like protein FtsZ to the division site, where it assembles into a ring 
structure at the inner face of the cytoplasmic membrane. Following the 
formation of the Z-ring other division proteins are recruited to the division 
site, including the PBPs [115]. These were initially thought to localize 
through protein-protein interactions, but increasing evidence has been 
accumulating that supports the idea that substrate recognition plays a part 
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in this process. The S. pneumoniae LMW PBP3, a carboxypeptidase that 
hydrolyses the D-Ala-D-Ala terminus of the peptidoglycan precursor, was 
found to localize all over the cell surface of the pneumococcal cells, but 
absent from the future division site. This implies that pentapetides are 
only available at the equator, making the localization of the HMW PBPs 
at that site dependent on the availability of their substrate. In the absence 
of PBP3, the HMW PBPs rings were no longer co-localized with the FtsZ 
ring [64]. Also, in L. lactis the substitution of the terminal D-Ala of the 
peptidoglycan precursors for D-Lac led to the production of spherical 
cells, instead of ovococcal, that remained attached in chains [22]. The 
changes in the structure of the peptidoglycan precursor were postulated to 
affect the activity of the carboxypeptidase peptidoglycan processing 
enzymes, which in turn affected the recruitment of other PBPs. 
 Other proteins seem to be important in S. pneumoniae cell 
division. DivIVA, a protein that in B. subtilis is involved in division site 
selection, localizes as a ring at the division septum and as dots at the poles 
of S. pneumoniae cells. In the absence of DivIVA, the percentage of cells 
with constricted FtsZ rings is reduced, indicating a possible role in Z-ring 
progression. Using a Bacterial Two-Hybrid assay, DivIVA was found to 
interact with itself and with FtsZ, as well as with several other division 
proteins [27]. Protein DivIB seems to have a role in the early and late 
stages of the division process, since in its absence cells form chains and a 
small fraction are enlarged and have defective septa [52]. DivIB forms a 
trimeric complex with proteins DivIC and FtsL, the function of which has 
been proposed to be related to septal peptidoglycan synthesis [78]. 
 Recently, protein StkP has emerged as a main regulator of 
pneumococcal cell division. StkP is the only eukaryotic-type Ser/Thr 
protein kinase in S. pneumoniae and it was shown to affect the 
transcription of several genes encoding proteins involved in several 
processes, including cell wall metabolism [88]. StkP mutant cells are 
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round or elongated and form chains, with non-functional septa and with 
delocalized sites of peptidoglycan synthesis [10, 29]. Importantly, the cell 
division defects observed in the absence of StkP are the result of the lack 
of phosphorylation of its targets [10], among which is DivIVA [79]. StkP 
localizes to the division site [10, 32], and this localization occurs through 
the sensing of uncross-linked peptidoglycan, since the protein is 
delocalized in the presence of antibiotics that target the late stages of 
peptidoglycan synthesis, as well as in cells that stopped dividing [10]. It 
seems that cell wall synthesis and uncross-linked peptidoglycan are 
sensed by StkP, leading to its recruitment to the cell division sites and to 
the stimulation of its autophosphorylation activity. StkP, trough the 
phosphorylation of key division substrates, would in this way regulate cell 
division and control the shift from peripheral to septal cell wall synthesis 
[10]. 
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Abstract 
 
 We have constructed a set of plasmids that allow efficient 
expression of both N- and C-terminal fusions of proteins of interest to 
fluorescent proteins mCherry, Citrine, CFP and sfGFP in the Gram-
positive pathogen Streptococcus pneumoniae. 
 In order to improve expression of the fluorescent fusions to levels 
that allow their detection by fluorescence microscopy, we have introduced 
a 10 amino acid tag at the N-terminal end of the fluorescent proteins. This 
caused increased expression due to improved translation efficiency. 
 The availability of the new plasmids described in this work should 
greatly facilitate studies of protein localization in an important clinical 
pathogen. 
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Introduction 
 
Studies on the sub-cellular localization of bacterial proteins have 
changed our view on the organization of bacterial cells. Initially, these 
studies were essentially restricted to the model organisms Escherichia coli 
and Bacillus subtilis. Despite their importance, these organisms do not 
eliminate the need for specific studies using different clinically important 
bacterial species, given the diversity in terms of morphology, physiology 
and metabolism among bacteria. Therefore, we have recently witnessed 
the development of new tools to allow cell biology studies in different 
pathogenic bacteria [6, 24].  
 Streptococcus pneumoniae is a major cause of morbidity and 
mortality worldwide. This Gram-positive bacterium is associated with a 
range of infections, which can vary from simple otitis media to more 
complicated ones, such as pneumonia or meningitis. Infection by this 
important human pathogen is of particular concern in developing 
countries, in which pneumococcal septicemia causes 25% of all 
preventable deaths in children under the age of five [11]. 
 In order to design new and more efficient strategies to fight 
pneumococcal infections it is essential to understand how these bacteria 
divide or perform specific tasks important for their survival inside the 
host, such as the synthesis of peptidoglycan, the target of -lactam 
antibiotics which are widely used against S. pneumoniae, or the synthesis 
of the capsular polysaccharide, the target of several successful anti-
pneumococcal vaccines. An important step to accomplish this goal is the 
study of the localization of proteins involved in these processes. However, 
for a long time, cell biology studies in S. pneumoniae were limited by the 
lack of appropriate tools. Localization of pneumococcal proteins involved 
in cell wall synthesis [20-21] and cell division [7, 16, 22] was initially 
Construction of tools for protein localization in S. pneumoniae 
 
 
- 57 - 
 
performed using immunofluorescence techniques, which require cell 
fixation and lysis to allow access of the antibodies to the target proteins. 
Therefore, immunofluorescence cannot be used with live cells and is 
prone to the generation of artifacts [25]. It was only recently that the first 
studies on the localization of proteins in live pneumococcal cells, using 
fluorescent protein fusions tagged to the Green Fluorescent Protein (GFP), 
was reported [6]. Since then, other proteins involved in processes such as 
cell division [3, 19], cell wall synthesis [18] and capsular polysaccharide 
synthesis [5, 10] have been localized in live pneumococcal cells. 
However, the variety of tools available for these studies is still limited. 
 In this chapter, we report the construction of new plasmids that 
expand the tools available for S. pneumoniae cell biology studies by 
allowing the expression of N- or C- terminal protein fusions to different 
fluorescent reporters, namely mCherry, Citrine, CFP and sfGFP. For this 
purpose, we have improved the expression of the various fluorescent 
proteins in S. pneumoniae, by introducing an upstream tag, named “i-tag”, 
which increases protein translation. The availability of these plasmids 
should greatly facilitate studies of protein localization in this important 
clinical pathogen. 
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Materials and Methods 
 
Bacterial strains and growth conditions 
Bacterial strains and plasmids used in this study are listed in 
Tables SII-1 and SII-2, respectively, in the Supplementary Information. S. 
pneumoniae was grown in C + Y liquid medium [14] at 37ºC, without 
aeration, or in tryptic soy agar (TSA, Difco) plates supplemented with 5% 
sheep blood (Probiologica). Tetracycline was added to the media at 1 
µg/ml final concentration.  
 
DNA manipulation procedures 
S. pneumoniae competent cells preparation and transformation 
was executed as previously described [17]. PCR products and plasmid 
DNA were purified with kits Wizard® SV Gel and PCR Clean-up System 
and Wizard® Plus SV Minipreps, respectively (Promega). PCR fragments 
were amplified with Phusion High-fidelity DNA polymerase (Finnzymes). 
Restriction enzymes were from New England Biolabs. Primers used in 
this study are listed in Table SII-3 in Supplementary Information. 
 
Construction of plasmids for protein expression in S. pneumoniae 
For expression of CFP and sfGFP, not fused to any protein, we 
constructed plasmids pBCSMH018 and pBCSMH020 by amplification of 
the CFP and sfGFP coding sequences from plasmids pMUTIN-CFP and 
pTrc99A-sfGFP, respectively, with primers 1/2 and primers 7/8, followed 
by restriction and ligation to the vector backbone obtained by 
amplification of pBCSMH001 with primers 3 and 4.  
For expression of Wze-CFP and Wze-sfGFP, the wze gene was 
amplified with primers 5 and 6 and cloned in pBCSMH018 and 
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pBCSMH020, upstream of the fluorescent protein gene, producing 
plasmids pBCSMH019 and pBCSMH021, respectively. 
Construction of the plasmids encoding truncated mCherry, in 
which successive parts of the N-terminus of the encoded protein were 
removed, was obtained by ligation of the PCR products resulting from the 
amplification of plasmid pBCSMH001 with primer 12 combined with 
primers 15 – 18. The plasmids obtained in this way were named 
pBCSMH024 – 027.  
In order to express different truncated forms of Wze-Citrine we 
constructed plasmids pBCSJC003, pBCSJC004 and pBCSJC005 that 
lacked the DNA encoding the N-terminus, central and C-terminus regions 
of Wze fused to Citrine, respectively. This was done by restriction and 
ligation of the PCR products resulting from amplification of plasmid 
pBCSMH004 using primer pairs 19/20, 21/22, and 23/9, respectively. 
Construction of the plasmids that allowed the expression of 
Citrine in fusion with the first 3, 5 and 7 aminoacids of Wze at its N-
terminus was carried out by ligation of the PCR products resulting from 
the amplification of plasmid pBCSMH004 with primer 20 combined with 
primers 28 – 30, respectively. The plasmids obtained in this way were 
named pBCSMJ008 – 010. Construction of the plasmid pBCSJC002, 
which allowed the expression of Citrine in fusion with the first 50 
aminoacids of Wze at its N-terminus, was carried out by ligation of the 
PCR products resulting from the amplification of plasmid pBCSMH004 
with primer 9 combined with primer 11. Construction of the plasmid 
pBCSJC007, which allowed the expression of Citrine in fusion, at its N-
terminus, with the peptide sequence that in Wze is located between 
positions 11 to 50 was carried out by ligation of the PCR product resulting 
from the amplification of plasmid pBCSJC002 with primer pair 20/33. 
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Construction of plasmids pBCSMH030, pBCSJC001, 
pBCSMH031 and pBCSMH032, in which the fluorescent proteins 
mCherry, Citrine, CFP and sfGFP, respectively, are expressed in fusion 
with the first 10 aa of Wze, the “i-tag”, at their N-terminus, was carried 
out by amplification of plasmids pBCSMH003, pBCSMH004, 
pBCSMH019 and pBCSMH021, respectively, with primers 9 and 10, 
followed by restriction and auto-ligation.  
In order to express Citrine in fusion, at its N-terminus, with an “i-
tag” whose wze nucleotide sequence was modified so that it carried a 
silent mutation we constructed plasmid pBCSJC006. This plasmid was 
obtained by restriction and ligation of the PCR product resulting from 
amplification of plasmid pBCSJC001 using primer pair 31/32. 
For expression of iCitrine-Wze and Citrine-Wze, wze was 
amplified with primers 24 and 25 and cloned into pBCSJC001 and 
pBCSMH002, to produce plasmids pBCSJF001 and pBCSJF002, 
respectively. Plasmids pBCSJF003 and pBCSJF004, which allowed the 
expression of iCFP-Wzd and CFP-Wzd, respectively, were constructed 
through amplification of wzd with primers 42 and 43 and cloning in 
plasmids pBCSMH031 and pBCSMH018, respectively. For expression of 
iCFP-FtsZ and CFP-FtsZ, amplification of ftsZ was carried out with 
primers 26 and 27. The resulting PCR product was cloned into 
pBCSMH018 and pBCSMH031 to produced plasmids pBCSMH035 and 
pBCSMH036, respectively. The nucleotide sequences of the modified 
regions of the constructed plasmids were confirmed by sequencing. 
 
Microscopy 
S. pneumoniae strains were grown until early exponential phase 
(O. D. (600nm) = 0.2 – 0.3) and observed by fluorescence microscopy on 
a thin layer of 1% agarose in PreC medium [14]. Images were obtained 
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using a Zeiss Axio Observer Z1 microscope equipped with a Plan-
Apochromat objective (100×/1.4 Oil Ph3; Zeiss) and a Photometrics 
CoolSNAP HQ2 camera (Roper Scientific). Semrock GFP, CFP, YFP and 
Texas Red filters were used. After acquisition, images were analyzed and 
cropped using Metamorph software (Meta Imaging series 7.5) and Image 
J software [1]. Fluorescence quantification was done using the Metamorph 
software by measuring the integrated fluorescence intensity in a defined 
region of 2 by 2 pixels and subtracting the average background 
fluorescence from every value. The obtained values were then normalized 
to the higher value. Quantification was performed for at least 100 cells of 
each strain. 
 
Protein analysis 
Bacterial cell aliquots of 1ml of culture were harvested at mid-
exponential growth phase. Cells were incubated at 37ºC during 30 minutes 
in deoxicholate (0.25 mg/ml), RNase (10 mg/ml), DNase (10 mg/ml) and 
PMSF (1mM). For fluorescent protein analysis, proteins were incubated 
with solubilization buffer (200 mM Tris-HCl pH 8.8, 20% glycerol, 5 mM 
EDTA pH 8.0, 0.02% bromophenol blue, 4% SDS, 0.05M DDT) [4] at 
37ºC during 5 minutes and separated on SDS-PAGE. Gel images were 
acquired on a FUJI FLA 5100 laser scanner (Fuji Photo Film Co.) with 
635 nm excitation and > 665 nm band pass emission filter for protein 
molecular weight marker detection and 473 nm excitation and > 510 nm 
band pass emission filter for Citrine detection. 
For western-blot analysis, cells extracts were boiled during 5 
minutes before being separated on SDS-PAGE. Proteins were transferred 
into a Hybond PVDF Membrane (Amersham) and probed with Living 
Colors ® Av. Peptide Antibody (Clontech) for the detection of Citrine, 
used at 1:500, followed by 1:100000 of goat anti-rabbit conjugated to 
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horseradish peroxidase. Detection was done with ECL Plus
TM
 Western 
Blotting Detection Reagents (Amersham). 
 
RNA isolation and reverse transcriptase PCR (RT-PCR) 
S. pneumoniae strains were grown in C+Y until early-exponential 
phase for RNA extraction. Prior to harvesting, RNAprotect Bacteria 
Reagent (twice the culture volume, QIAGEN) was added to the culture 
and the mixture was immediately vortexed for 10 sec. The cells were 
harvested, the pellet was frozen in liquid N2 and stored at -80º C 
overnight. The next day, the pellet was resuspended with 200µl of sodium 
deoxycholate 0,25mg/ml during 30 min at 37ºC. RNA was extracted with 
RNeasy Mini kit (QIAGEN) and resuspended in milli-Q water. Total 
RNA was quantified using a Nanodrop Spectrophotometer ND-100. For 
RT-PCR, purified RNA was treated with Turbo DNase (Ambion) and 
screened for absence of contaminating DNA by PCR. 100 ng of DNase-
treated RNA was subjected to reverse transcription using the OneStep RT-
PCR Kit (QIAGEN). To amplify the fluorescent genes, the following 
nucleotides were used: 40/41 for citrine and 18/40 for mCherry. As a 
negative control, RNA isolated from strain BCSMH031 was used. 
 
Quantitative Real-Time PCR 
cDNA was generated from 250 ng of each RNA sample using 
TaqMan RT Reagents (Applied Biosystems, Branchburg, NJ, USA). The 
reaction mixture included 5.5 mM MgCl2, 500 µM dNTPs, 2.5 µM 
random hexamers, 1 × RT Buffer, 0.8 U/µl RNase Inhibitor and 1.25 U/µl 
MultiScribe RT in a final volume of 50 µl. The Reverse Transcription 
conditions were 10 min at 25ºC, 15 min at 42ºC and 5 min at 99ºC. 
Quantification of Citrine and mCherry expression was achieved using the 
ABI7000SDS (Applied Biosystems), SYBR Green chemistry, and the 
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standard curve method for relative quantification. The PCR reagents 
consisted of: 1 × SYBR Green PCR Master Mix (Applied Biosystems), 
400 nM of each primer, and 5 µl of sample cDNA, in a final volume of 25 
µl. The thermocycling profile was: 10 min at 95ºC followed by 40 cycles 
of 15 s at 95ºC and 1 min at 60ºC. qPCR primers for mCherry (34 and 35) 
citrine (36 and 37) and tetracycline (38 and 39) were designed using 
ABI7000SDS – specific software, Primer Express (Applied Biosystems). 
Optical plates included plasmid standard curves for Citrine and 
mCherry, and duplicates of each cDNA sample. “No template” and “no 
RT” controls were also included in every qPCR assays. For each sample, 
the expression of Citrine or mCherry was determined from the respective 
standard curve by conversion of the mean threshold cycle values, and 
normalization was obtained by dividing the quantity of Citrine (or 
mCherry) cDNAs by the quantity of cDNA amplified within the gene 
encoding for the tetracycline resistance protein (used as the endogenous 
control), which is cloned in the same plasmid. The specificity of the 
amplified products was verified by analysis of the dissociation curves 
generated by the ABI 7000 software based on the specific melting 
temperature for each amplicon. The final qPCR results were based on two 
independent experiments. 
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Results and Discussion 
 
Expression of mCherry, Citrine, CFP and sfGFP in S. pneumoniae 
  
S. pneumoniae is a microaerophile organism and therefore can 
only grow in the presence of low levels of oxygen, which may impair the 
correct folding of GFP-like proteins, known to require the presence of 
oxygen [27]. We have expressed fusions of Wze, a protein required for the 
regulation of the synthesis of the capsule polysaccharide [11], to four 
different fluorescent proteins, mCherry [26], Citrine [9], CFP [12] and 
sfGFP [8] (a robustly folded variant of the GFP protein [23]), two of 
which (CFP and sfGFP) had not been previously used in S. pneumoniae. 
The protein fusions Wze-CFP (BCSMH029) and Wze–sfGFP 
(BCSMH030), expressed in the encapsulated strain ATCC6314, allowed 
the visualization of Wze protein at the septum (Figure II-1A), in 
accordance to what we have previously described for Wze-mCherry 
(BCSMH015) and Wze-Citrine (BCSMH016) [10]. This indicates that all 
fluorescent proteins tested were able to fold correctly in the growth 
conditions used. 
In order to test which of the four fluorescent proteins could 
potentially be used together for applications that require co-localization 
studies in S. pneumoniae, we mixed and analyzed various combinations of 
strains expressing the fluorescent proteins (data not shown). Fluorescence 
microscopy analysis of a mixture of three different cultures of the 
unencapsulated laboratory R36A strain expressing Wze-mCherry 
(BCSMH006), Wze-Citrine (BCSMH007) and Wze-CFP (BCSMH035) in 
the cytoplasm (Figure II-1B) showed that the fluorescent signals of these 
three proteins did not overlap. 
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Figure II-1: Fluorescent signals emitted by mCherry, Citrine, CFP and 
sfGFP protein fusions are detectable in live S. pneumoniae bacteria. (A) The 
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septal localization of Wze protein fusions expressed in the encapsulated 
ATCC6314 strain is shown for Wze-mCherry (strain BCSMH015), Wze-Citrine 
(strain BCSMH016), Wze-CFP (strain BCSMH029) and Wze-sfGFP (strain 
BCSMH030). No comparable signal was detected in cells containing an empty 
vector (strain BCSMH052) visualized using appropriate filters for each 
fluorescent protein. (B) Three cultures of unencapsulated R36A strain expressing 
Wze-mCherry (strain BCSMH006, red dots), Wze-Citrine (strain BCSMH007, 
yellow dots) and Wze-CFP (strain BCSMH035, blue dots) were prepared for 
fluorescence microscopy observation as described in the Materials and Methods 
section, mixed on the same slide, and visualized using appropriate filters for each 
fluorescent protein. Fluorescence intensity was plotted, showing that the signals 
from each protein do not overlap. A representative image is shown at the bottom 
of the figure. Exposure times were 5000 msec. Scale bar: 2 µm. 
 
We then constructed new vectors for cell biology studies in S. 
pneumoniae (plasmids pBCSMH001, pBCSMH002, pBCSMH018 and 
pBCSMH020) expressing the four fluorescent proteins, not fused to any 
protein. Surprisingly, all strains expressing solely the untagged fluorescent 
proteins mCherry (BCSMH032), Citrine (BCSMH033), CFP 
(BCSMH034) and sfGFP (BCSMH036) showed extremely low levels of 
fluorescence (Figure II-2). 
 
Optimization of expression of fluorescent proteins in S. pneumoniae  
  
The four fluorescent proteins used in our studies all included, at 
their N-terminal, a linker region, which introduced a spacer between the 
fluorescent protein and the protein of interest, and a GFP-like terminus 
region that had been proposed to stabilize the fluorescent signal [26] 
(Figure II-3). We therefore asked whether this N-terminal linker was 
responsible for the lack of fluorescence in S. pneumoniae. To answer this 
question we constructed a series of plasmids, encoding mCherry or 
Citrine, in which successive fragments of the linker were removed, 
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leaving intact the original promoter region and starting codon (Figure II-
3). 
 
Figure II-2: Fluorescent signals emitted by untagged mCherry, Citrine, CFP 
and sfGFP proteins are not detectable. The intensity of the fluorescence signal 
in unencapsulated bacteria expressing mCherry (strain BCSMH032), Citrine 
(strain BCSMH033), CFP (strain BCSMH034) and sfGFP (strain BCSMH036), is 
plotted as a percentage relative to the signal obtained with expression of the same 
fluorescent protein fused to the C-terminus of Wze (strains BCSMH006, -007, -
033 and -035, respectively). Representative images of each strain are shown at the 
bottom. Scale bar: 2 µm. 
 
Quantification of the fluorescent signal expressed by 
pneumococcal strains encoding truncated mCherry proteins (strains 
BCSMH040 to BCSMH043) showed that removal of the linker caused 
only a small increase in the observed fluorescence (Figure II-4), which  
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was still 80% lower than the signal obtained for strain BCSMH006, 
expressing Wze-mCherry [10]. No increase in the fluorescence signal was 
observed when the linker region was removed from the Citrine protein 
(data not shown) indicating that this region was not impairing 
fluorescence in pneumococcal bacteria. 
 
 
Figure II- 4: The linker region present at the N-terminal of fluorescent 
proteins does not impair expression of fluorescence. The fluorescence signal 
obtained from strains expressing truncated mCherry forms (strains BCSMH040 – 
043) and mCherry alone (strain BCSMH032) is plotted as percentage relative to 
the signal from the strain expressing Wze-mCherry (strain BCSMH006). 
 
 As a second hypothesis, we asked whether there was a specific 
nucleotide sequence present in the coding sequence of Wze that increased 
protein expression in the Wze-Citrine fusion. This was based on the fact 
that the 5´ coding region of the mRNA, immediately after the start codon, 
has been proposed to have an important role in ensuring protein 
translation in bacteria. This effect seems to be more dependent on the 
predicted mRNA secondary structure of this region than on codon usage  
Chapter II 
 
- 70 - 
 
 
Figure II- 5: The first ten amino acids of Wze are required to obtain high 
levels of fluorescence. (Upper panel) Fluorescence (in arbitrary units) emitted by 
Citrine fused to specific aminoacid sequences of Wze, as indicated below the 
graphic, in S. pneumoniae R36A strain. Strain BCSMH031 was used as a 
negative control. Exposure time was 5000 msec. (Bottom panel) Schematic 
representation of each Wze construct. The white boxes represent the Citrine 
protein, while the gray boxes represent different regions of Wze protein: lighter 
grey - aminoacids 1 to 10, light grey - remaining N-terminus region between 
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aminoacids 11 to 50, dark grey - central region between aminoacids 51-176, black 
box - C-terminus region between aminoacids 178-227. Strain names are indicated 
below. 
 
bias or GC content [13]. In order to identify that putative nucleotide 
sequence, pneumococcal bacteria were transformed with plasmids 
encoding different truncated forms of Wze-Citrine fusion (Figure II-5). 
Deletion of the central region (amino acids 51-177, strain BCSJC004) or 
the C-terminal region  (amino acids 178-227, strain BCSJC005) of Wze 
resulted in proteins that were still fluorescent, although a decrease of 
about 40% in the intensity of the fluorescence signal was observed (Figure 
II-5). However, when the first 50 amino acids of the N-terminal region of 
Wze were deleted, in strain BCSJC003, the expression of fluorescence 
was completely lost (Figure II-5). 
In order to determine the minimum size of the N-terminal region 
of Wze required for expression of fluorescence, S. pneumoniae R36A 
strain was transformed with plasmids encoding the first 3, 5, 7, 10 or 50 
aminoacids of Wze linked to the N-terminal of Citrine, and analyzed by 
fluorescence microscopy. Strains BCSJC008 and BCSJC009, expressing 
the Citrine protein fused to the first 3 or 5 amino acids of Wze, 
respectively, showed no significant fluorescence (Figure II-5). Strain 
BCSJC010, which expresses the Citrine protein fused to the first 7 amino 
acids of Wze, showed a decreased fluorescence relative to the strain 
expressing Wze-Citrine. However, strains BCSJC001 and BCSJC002, 
expressing the Citrine protein fused to the first 10 or 50 amino acids of 
Wze, respectively, showed fluorescence levels similar to, or even higher 
than, that obtained for strain BCSMH007, expressing the original Wze-
Citrine fusion (Figure II-5). Expression of Wze aminoacids 11 to 50 fused 
to Citrine did not result in a fluorescent protein (Figure II-5), confirming 
that the first 10 amino acids of Wze were necessary and sufficient for 
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expression of Citrine in S. pneumoniae. We have named this 10 amino 
acid tag, which improved protein expression in pneumococcal bacteria, “i-
tag”. 
The increased fluorescence due to the presence of the i-tag fused 
to Citrine could be the result of higher mRNA or higher protein levels. We 
therefore quantified, by real-time PCR, the levels of mRNA encoding 
untagged Citrine, Wze-Citrine fusion and the various truncated forms of 
this fusion, in exponentially growing bacteria, relatively to the mRNA for 
the tetracycline resistance marker, encoded in the plasmid backbone. 
Figure II-6 shows that the levels of the different mRNAs were not 
sufficiently different to explain the observed variability in fluorescence 
expression. 
  
 
Figure II- 6: mRNA levels are identical in the presence or absence of the “i-
tag”. mRNA encoding Citrine was quantified by Real-time PCR in strains 
expressing specific aminoacid sequences from Wze fused to Citrine, relatively to 
the mRNA for the tetracycline resistance protein which is encoded in the plasmid 
backbone. Strains analyzed were BCSMH031 (transformed with an empty 
vector), BCSMH007 (expressing full Wze-Citrine), BCSMH033 (expressing 
Citrine), BCSJC003 (expressing Wze(51-227)-Citrine), BCSJC004 (expressing 
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Wze(1-50, 178-227)-Citrine), BCSJC005 (expressing Wze(1-177)-Citrine), BCSJC001 
(expressing Wze(1-10)-Citrine), BCSJC007 (expressing Wze(11-50)-Citrine) and 
BCSJC002 (expressing Wze(1-50)-Citrine). 
 
However, analysis of Citrine protein levels in the same strains 
(Figure II-7) showed a direct correlation between strains in which Citrine 
protein could be detected and strains which were fluorescent, namely 
those encoding for Wze-Citrine (strain BCSMH007) and all that included 
the first 10 amino acids of the Wze fused to Citrine (strains BCSJC001, 
BCSJC002, BCSJC005 and BCSJC004). Taken together these results  
 
Figure II- 7: Increased fluorescence resulting from the presence of the “i-
tag” is due to increased protein levels. Cell extracts from strains expressing 
Citrine fused to the C-terminus of the indicated Wze fragments were separated by 
SDS-PAGE and analyzed using a Fluorescent Image Analyzer (Upper panel). 
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Western-blot using an antibody that recognizes the Citrine protein was performed 
(Lower panel), and showed that fluorescence in strains containing the i-tag is due 
to increased protein levels. 
 
show that fusion of the i-tag to Citrine increased fluorescence levels due 
to increased protein levels and not increased mRNA levels. 
 To determine if increased protein levels resulted from higher 
translation rates or increased protein stability, we generated silent 
mutations in the sequence encoding the i-tag, fused to Citrine, and 
analyzed the fluorescence of the resulting constructs. We were able to 
identify mutations that did not alter the amino acid sequence of the tag, 
but resulted in loss of fluorescence, namely the substitution of the UUA 
leucine codon by CUC (Figure II-8). Given that the protein sequence was  
 
 
Figure II- 8: The nucleotide sequence of the i-tag determines the expression 
of fluorescence. (Left panel) Fluorescence (in arbitrary units) emitted by Citrine 
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from the following strains: BCSMH031 (empty plasmid), BCSMH033 
(expressing Citrine), BCSJC001 (expressing Wze(1-10)-Citrine), BCSJC006 
(expressing Wze(1-10)*-Citrine in which the sequence encoding for Leucine was 
changed from TTA to CTC). (Right panel) Sequence encoding aminoacids 3-6 of 
Wze present in Wze(1-10)-Citrine and Wze(1-10)*-Citrine. 
 
not altered, we can rule out the hypothesis that the i-tag acted by 
increasing the stability of the fusion proteins. Therefore, we favor the 
hypothesis that the presence of the nucleotide sequence encoding the i-tag 
results in increased translation rates, possibly by destabilizing the mRNA 
structure of this region and thus facilitating ribosome binding to the 
mRNA molecule. 
 
Construction of plasmids for the expression of fluorescent protein 
fusions in S. pneumoniae 
 
We have redesigned plasmids pBCSMH001, pBCSMH002, 
pBCSMH018 and pBCSMH020, expressing untagged fluorescent proteins  
  
 
Figure II- 9: New plasmids for S. pneumoniae cell biology studies. Map of the 
pBCS plasmids. Fluorescent protein refers to mCherry, Citrine, CFP or sfGFP, 
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encoded by plasmids pBCSMH030, pBCSJC001, pBCSMH031 and 
pBCSMH032, respectively. ApaI and NaeI restriction sites, highlighted with an 
asterisk, are not available in plasmid pBCSMH030. repA, repB, plasmid 
replication genes. tet, tetracycline resistance marker. T, transcription terminator. 
P, promoter. 
 
(Figure II-2) to improve expression of mCherry (pBCSMH030), Citrine 
(pBCSJC001), CFP (pBCSMH031) and sfGFP (pBCSMH032) by 
including the “i-tag” upstream of the fluorescent proteins (Figure II-9). 
Additionally, we have introduced unique restriction sites flanking the 
genes encoding the fluorescent proteins, so that the resulting plasmids can 
be used to express both N- and C-terminal fluorescent fusions of S. 
pneumoniae proteins, under the control of a constitutive consensus S. 
pneumoniae SigA promoter [15]. 
Analysis of strains containing these new plasmids showed that 
expression of i-tagged fluorescent proteins generates cells with 
fluorescence levels comparable to the ones expressing the Wze-fusions 
(Figure II-10). Importantly, the i-tagged fluorescent proteins were 
dispersed throughout the cytoplasm in the encapsulated pneumococcal 
cells  (data not shown) indicating that the i-tag did not interact with Wzd 
or Wze proteins, normally localized at the dividing septum of 
encapsulated strains [10]. 
The developed tools were used to localize different proteins in S. 
pneumoniae, namely FtsZ, a central protein for bacterial division, Wzd, a 
membrane protein, and Wze, a cytoplasmic tyrosine kinase, both of which 
localize at the bacterial division septum when expressed together in 
pneumococcal cells. Figure II-11 shows that fusions of these proteins to 
the C-terminal of CFP or Citrine only produced a fluorescent signal when 
the improved versions, containing the “i-tag”, of the fluorescent proteins 
were used, and not with the normal untagged versions. 
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Figure II- 10: New plasmids for S. pneumoniae cell biology studies produce 
high levels of fluorescence. Comparison of fluorescence emitted by strains 
expressing mCherry, Citrine, CFP and sfGFP alone, their improved i-tag versions 
and their Wze fusions. Data is presented as a percentage relative to the strain with 
highest signal for each fluorescent protein. Strain names are indicated at the 
bottom. 
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Figure II- 11: Applications of the developed tools for localization of S. 
pneumoniae  proteins. (A) Localization of the cell division protein FtsZ as an N-
terminal fusion to CFP (CFP-FtsZ, strain BCSMH050) and to i-tagged CFP, 
(iCFP-FtsZ, strain BCSMH051). (B) Localization of the membrane protein Wzd 
as an N-terminal fusion to CFP (CFP-Wzd, strain BCSJF004) and to improved i-
tagged CFP, (iCFP-Wzd, strain BCSJF003). (C) Localization of the Wze tyrosine 
kinase as an N-terminal fusion to Citrine (Citrine-Wze, strain BCSJF002) and to 
improved i-tag Citrine (iCitrine-Wze, BCSJF001). The i-tagged versions of the 
fluorescent reporters allowed the visualization of each protein at the expected 
sub-cellular region of bacteria, the division septum. Exposure times: 5000 msec. 
Scale bar: 2 m. 
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Final Remarks 
 
We were able to significantly improve the expression of four 
fluorescent proteins, mCherry, Citrine, CFP and sfGFP in the Gram-
positive bacteria S. pneumoniae, by designing a tag that increases 
translation efficiency of heterologous proteins. The set of plasmids 
encoding improved versions of these fluorescent proteins allows the 
expression of both N- and C-terminal fluorescent fusions of 
pneumococcal proteins and should greatly facilitate cell biology studies in 
this important pathogen. 
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Supplementary Information 
 
Table SII-1: Bacterial Strains. 
Name Relevant Characteristics Reference 
ATCC6314 Encapsulated strain, serotype 14. American Type 
Culture 
Collection. 
BCSJC001 R36ApBCSJC001, Tet
r
. This work. 
BCSJC002 R36ApBCSJC002, Tet
r
. This work. 
BCSJC003 R36ApBCSJC003, Tet
r
. This work. 
BCSJC004 R36ApBCSJC004, Tet
r
. This work. 
BCSJC005 R36ApBCSJC005, Tet
r
. This work. 
BCSJC006 R36ApBCSJC006, Tet
r
. This work. 
BCSJC007 R36ApBCSJC007, Tet
r
. This work. 
BCSJC008 R36ApBCSJC008, Tet
r
. This work. 
BCSJC009 R36ApBCSJC009, Tet
r
. This work. 
BCSJC010 R36ApBCSJC010, Tet
r
. This work. 
BCSJF001 R36ApBCSJF001, Tet
r
. This work. 
BCSJF002 R36ApBCSJF002, Tet
r
. This work. 
BCSJF003 R36ApBCSJF003, Tet
r
. This work. 
BCSJF004 R36ApBCSJF004, Tet
r
. This work. 
BCSMC001 ATCC6314cps [1] 
BCSMH006 R36ApBCSMH003, Tet
r
. This work. 
BCSMH007 R36ApBCSMH004, Tet
r
. This work. 
BCSMH015 ATCC6314pBCSMH003, Tet
r
. [10] 
BCSMH016 ATCC6314pBCSMH004, Tet
r
. [10] 
BCSMH029 ATCC6314pBCSMH019, Tet
r
. This work. 
BCSMH030 ATCC6314pBCSMH021, Tet
r
. This work. 
BCSMH031 R36ApBCSLF001, Tet
r
. This work. 
BCSMH032 R36ApBCSMH001, Tet
r
. This work. 
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Table SII-1(Cont.): Bacterial Strains. 
Name Relevant Characteristics Reference 
BCSMH033 R36ApBCSMH002, Tet
r
. This work. 
BCSMH034 R36ApBCSMH018, Tet
r
. This work. 
BCSMH035 R36ApBCSMH019, Tet
r
. This work. 
BCSMH036 R36ApBCSMH020, Tet
r
. This work. 
BCSMH037 R36ApBCSMH021, Tet
r
. This work. 
BCSMH040 R36ApBCSMH024, Tet
r
. This work. 
BCSMH041 R36ApBCSMH025, Tet
r
. This work. 
BCSMH042 R36ApBCSMH026, Tet
r
. This work. 
BCSMH043 R36ApBCSMH027, Tet
r
. This work. 
BCSMH045 R36ApBCSMH030, Tet
r
. This work. 
BCSMH046 R36ApBCSMH031, Tet
r
. This work. 
BCSMH047 R36ApBCSMH032, Tet
r
. This work. 
BCSMH050 R36ApBCSMH035, Tet
r
. This work. 
BCSMH051 R36ApBCSMH036, Tet
r
. This work. 
BCSMH052 BCSMC001pBCSLF001, Tet
r
. This work. 
R36A Non-encapsulated laboratory strain. [2] 
 
 
Table SII-2: Plasmids used in this work. 
Name Relevant Characteristics Reference 
S. pneumoniae 
pBCSJC001 pBCSMH004 derivative, allowing 
expression of Citrine containing the 
first 10 aa of Wze at its N-terminus, 
Tet
r
. 
This work. 
pBCSJC002 pBCSMH004 derivative, allowing 
expression of Citrine containing the 
first 50 aa of Wze at its N-terminus, 
Tet
r
 
This work. 
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Table SII-2 (Cont.): Plasmids used in this work. 
Name Relevant Characteristics Reference 
pBCSJC003 pBCSMH004 derivative, lacking the 
N-terminal 147 nucleotides of wze, 
Tet
r
. 
This work. 
pBCSJC004 pBCSMH004 derivative, lacking the 
central 381 nucleotides of wze, Tet
r
. 
This work. 
pBCSJC005 pBCSMH004 derivative, lacking the 
C-terminal 147 nucleotides of wze, 
Tet
r
. 
This work. 
pBCSJC006 pBCSJC001 derivative, TTA→CTC 
change in codon  4 of Wze, Tet
r
. 
This work. 
pBCSJC007 pBCSJC002 derivative, lacking the 
N-terminal 33 nucleotides of Wze, 
Tet
r
. 
This work. 
pBCSJC008 pBCSJC001 derivative, allowing 
expression of Citrine containing the 
first 3 aa of Wze at its N-terminus, 
Tet
r
. 
This work. 
pBCSJC009 pBCSJC001 derivative, allowing 
expression of Citrine containing the 
first 5 aa of Wze at its N-terminus, 
Tet
r
. 
This work. 
pBCSJC010 pBCSJC001 derivative, allowing 
expression of Citrine containing the 
first 7 aa of Wze at its N-terminus, 
Tet
r
. 
This work. 
pBCSJF001 pBCSJC001 containing iCitrine-wze, 
Tet
r
. 
This work. 
pBCSJF002 pBCSMH002 containing Citrine-wze, 
Tet
r
. 
This work. 
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Table SII-2 (Cont.): Plasmids used in this work. 
Name Relevant Characteristics Reference 
pBCSJF003 pBCSMH031, containing iCFP-wzd, 
Tet
r
. 
This work. 
pBCSJF004 pBCSMH018 containing CFP-wzd, 
Tet
r
. 
This work. 
pBCSLF001 High-copy-number vector, contains 
the -10 constitutive promoter of SigA 
from S. pneumoniae, Tet
r
. 
[10] 
pBCSMH001 pBCSLF001 derivative, allows 
expression of mCherry fusion 
proteins, Tet
r
. 
[10] 
pBCSMH002 pBCSLF001 derivative, allows 
expression of Citrine fusion proteins, 
Tet
r
. 
[10] 
pBCSMH003 pBCSMH001 containing wze-
mCherry, Tet
r
. 
[10] 
pBCSMH004 pBCSMH002 containing wze-Citrine, 
Tet
r
. 
[10] 
pBCSMH018 pBCSLF001 derivative, allows 
expression of CFP fusion proteins, 
Tet
r
. 
This work. 
pBCSMH019 pBCSMH018 containing wze-cfp, 
Tet
r
. 
This work. 
pBCSMH020 pBCSLF001 derivative, allows 
expression of sfGFP fusion proteins, 
Tet
r
. 
This work. 
pBCSMH021 pBCSMH018 containing wze-sfgfp, 
Tet
r
. 
This work. 
pBCSMH024 pBCSMH001 derivative, removal of 
the first ten codons between the ATG 
and the mCherry sequence Tet
r
. 
This work. 
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Table SII-2 (Cont.): Plasmids used in this work. 
Name Relevant Characteristics Reference 
pBCSMH025 pBCSMH001 derivative, removal of 
the first fourteen codons between the 
ATG and the mCherry sequence Tet
r
. 
This work. 
pBCSMH026 pBCSMH001 derivative, removal of 
the first eighteen codons between the 
ATG and the mCherry sequence Tet
r
. 
This work. 
pBCSMH027 pBCSMH001 derivative, removal of 
the twenty two codons between the 
ATG and the mCherry sequence, 
Tet
r
. 
This work. 
pBCSMH030 pBCSMH001 derivative, expression 
of mCherry containing the first 10 aa 
of Wze at its N-terminus, Tet
r
. 
This work. 
pBCSMH031 pBCSMH018 derivative, allowing 
expression of CFP containing the first 
10 aa of Wze at its N-terminus, Tet
r
. 
This work. 
pBCSMH032 pBCSMH020 derivative, allowing 
expression of sfGFP containing the 
first 10 aa of Wze at its N-terminus, 
Tet
r
. 
This work. 
pBCSMH035 pBCSMH018 containing cfp-ftsz, 
Tet
r
. 
This work. 
pBCSMH036 pBCSMH031 containing icfp-ftsz, 
Tet
r
. 
This work. 
E. coli 
pMUTIN-CFP Plasmid containing the CFP coding 
sequence. 
[12] 
pTrc99A-sfGFP Plasmid containing the sfGFP coding 
sequence. 
[8] 
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Table SII-3: Primers used in this work. 
Primer Sequence 5’  3’ Features/ 
Restriction 
sites 
1 GGACTAGTGGGCCCGCCGGCATGGTGAGCAA
GGGCG 
SpeI, ApaI, 
NaeI 
2 GAAGATCTAATCCATGGCATATGAGCGGCCG
CCTTGTACAGCTCGTCC 
BglII 
3 GGATTAGATCTCAGGAATTG BglII 
4 CCCTTGCTCACACTAGTGCC SpeI 
5 CTAGCTAGCATGCCGACATTAGAAATAGCAC NheI 
6 CGGGGTACCTTTTTTACCATAATTTCCATAGG
AAGC 
KpnI 
7 GGACTAGTGGGCCCGCCGGCATGAGTAAAGG
AGAAG 
SpeI 
8 GAAGATCTAATCCATGGCATATGAGCGGCCG
CGTCGACTTTGTATAGTTCATCC 
BglII 
9 GCGGAGCTCTGTTGCTGTTACCAAG SacI 
10 GCGGAGCTCCAGTTTTTTTTGTGCTATTTC SacI 
11 GCGGAGCTCAGTTGTTTTTCCTTCCCCAGG SacI 
12 GGGGTACCCATGCTAGCCTACCTCCTTAAGC KpnI 
13 GGGGTACCAGCTCGGCTGGCTCCGCTGC KpnI 
14 GGGGTACCTCCGCTGCTGGTTCTGGC KpnI 
15 GGGGTACCTCTGGCACTAGTGTGAGCAAGG KpnI 
16 GGGGTACCGTGAGCAAGGGCGAAGAAGATA
AC 
KpnI 
17 GGGGTACCGAAGAAGATAACATGGCTATC KpnI 
18 GGGGTACCATGGCTATCATTAAAGAGTTC KpnI 
19 GCGGAGCTCACTACTTCCGTAAATATAG SacI 
20 GTAGAGCTCCATGCTAGCCTACCTCCTTAAG SacI 
21 GATGAGCTCGGTGAGGCGAATAAACGTGATG SacI 
22 GATGAGCTCTGTTTTTCCTTCCCCAGGG SacI 
23 GATGAGCTCGGTACCAGCTCGGCTG SacI 
24 ATAAGAATGCGGCCGCAATGCCGACATTAGA
AATAG 
NotI 
25 CATGAGATCTTTATTTTTTACCATAATTTCC BglII 
26 CATGCCATGGATGACATTTTCATTTGATAC NcoI 
27 GAAGGCCTTTAACGATTTTTGAAAAATGGAG
G 
StuI 
28 GCGGAGCTCTGTCGGCATGCTAGCCTACCTC
C 
SacI 
29 GCGGAGCTCTTCTAATGTCGGCATGCTAGCC SacI 
30 GCGGAGCTCTGCTATTTCTAATGTCGGCATGC SacI 
31 GCGGCTAGCATGCCGACACTCGAAATAGCAC NheI 
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Table SII-3 (Cont.): Primers used in this work. 
Primer Sequence 5’  3’ Features/ 
Restriction 
sites 
32 GCGGCTAGCCTACCTCCTTAAGCTTATTATAC
C 
NheI 
33 GCGGAGCTCGAGTTCATTAAGAAGGCAG SacI 
34 GCCATTATGACGCTGAAGTGAA  
35 TGCACAGGTTTCTTGGCTTTG  
36 GAGCTGAAGGGCATCGACTT  
37 CTTGTGCCCCAGGATGTTG  
38 AATGGTTGTAGTTGCGCGCTAT  
39 AATGCTTTACCCCTATTTTCCTTTG  
40 CCGGAATTCTTACTTGTACAGCTCGTCCATGC  
41 GGGGTACCATGGTGAGCAAGGGCGAGGAGC  
42 ATTTGCGGCCGCTCATATGATGAAGGAACAA
AACAC 
NotI 
43 CATGCCATGGCTATTTCAACTTACTCAAG NcoI 
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Synthesis of capsular polysaccharide at 
the division septum of Streptococcus 
pneumoniae is dependent on a bacterial 
tyrosine kinase 
 
 
 
The work presented in this chapter was published in: 
Henriques, M. X., Rodrigues, T. Carido, M., Ferreira, L. and Filipe, S. R. 
(2011). “Synthesis of capsular polysaccharide at the division septum of 
Streptococcus pneumoniae is dependent on a bacterial tyrosine kinase.” 
Mol. Microbiol 82(2): 515 -534. 
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Abstract 
 
 One of the main virulence factors of the pathogenic bacterium 
Streptococcus pneumoniae is the capsule, present at the bacterial surface, 
surrounding the entire cell. Virtually all the 90 different capsular 
serotypes of S. pneumoniae, which vary in their chemical composition, 
express two conserved proteins, Wzd and Wze, which regulate the rate of 
the synthesis of capsule.  
 In this work, we show that Wzd, a membrane protein, and 
Wze, a cytoplasmic tyrosine kinase, localize at the bacterial division 
septum, when expressed together in pneumococcal cells, without requiring 
the presence of additional proteins encoded in the capsule operon. The 
interaction between the two proteins and their consequent septal 
localization was dependent on a functional ATP binding domain of Wze. 
 In the absence of either Wzd or Wze, capsule was still 
produced, linked to the cell surface, but it was absent from the division 
septum. We propose that Wzd and Wze are spatial regulators of capsular 
polysaccharide synthesis and, in the presence of ATP, localize at the 
division site, ensuring that capsule is produced in coordination with cell 
wall synthesis, resulting in full encapsulation of the pneumococcal cells. 
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Introduction 
 
 Streptococcus pneumoniae is associated with a variety of 
infections that can range in severity from otitis media to pneumonia or 
meningitis [22]. This Gram-positive bacterium is a common respiratory 
pathogen and a frequent cause of community-acquired pneumonia in 
developed countries. Despite the increased availability of new antibiotics, 
the mortality rate of patients presenting pneumococcal pneumonia and 
concurrent septicemia has remained unchanged, with values higher than 
20%. In developing countries pneumococcal septicemia is a major cause 
of infant mortality, causing 25% of all preventable deaths in children 
under the age of 5 [22].  
 A capsular polysaccharide (capsule or CPS), surrounds 
pneumococcal bacteria, forming a thick layer of 200-400 nm [46]. CPS 
may be linked to bacterial peptidoglycan [45], an heterogeneous polymer, 
that surrounds and protects bacterial cells, made of glycan chains of -(1-
4)-linked N-acetylglucosamine and N-acetylmuramic acid, and 
crosslinked by short peptides [47]. 
 The pneumococcal CPS plays a major role in the colonization 
and persistence of S. pneumoniae in the infected host as non-encapsulated 
mutants of clinical pneumococcal isolates are non-virulent [22]. This is 
probably due to the ability of the CPS to form a shield that prevents 
antibodies and complement components, which bind to deeper cell 
structures such as teichoic-acids and cell-surface proteins, from 
interacting with their receptors on the host phagocytic cells [37, 49]. The 
capsule also seems important to reduce the deposition of complement on 
the bacterial cell surface [1] and the trapping of bacteria in neutrophil 
extracellular traps [48]. 
Synthesis of CPS at the division septum of S. pneumoniae 
 
- 97 - 
 
 Although more than 90 different pneumococcal capsule 
serotypes are known, only a limited number seems to be associated with 
invasive pneumococcal disease [7] and these have been specifically 
targeted by the pneumococcal capsular polysaccharide conjugate vaccines 
recently developed [40]. The vaccination programs in different countries 
seem to have led to a reduction of the total incidence of pneumococcal 
disease caused by the vaccine serotypes [20]. However, an increase of 
pneumococcal disease caused by serotypes that are not covered by the 
different vaccines, has been observed [3], as well as the alteration of the 
serotypes most frequently found in asymptomatic human carriers [16, 21]. 
This worrying trend indicates that vaccines effective against most, if not 
all, serotypes would be of great importance. 
 The capsular biosynthetic loci of 90 different pneumococcal 
serotypes have been recently sequenced [10]. In virtually all serotypes, the 
cps operon includes serotype-specific genes, namely those that encode 
enzymes required for the synthesis of the specific sugar components of 
each capsular polysaccharide, as well as genes that are conserved among 
different serotypes (absent only in serotypes 3 and 37). These proteins are 
involved in the translocation of the capsular polysaccharide repeat unit to 
the outer surface of the plasma membrane (Wzx), in the polymerization of 
the capsule (Wzy), leading to the formation of high-molecular weight 
capsular polysaccharide, or in the regulation of CPS synthesis (Wzg, Wzh, 
Wzd and Wze, the products of the first four genes of the cps operon) [10]. 
In this work, we focused on the role of two of these proteins widely 
conserved in the different S. pneumoniae serotypes: Wzd and Wze. 
 Wze (also known as CpsD) is an autophosphorylating tyrosine 
kinase [35]. Some proteins that belong to the bacterial tyrosine kinase 
family function as co-polymerases in the biosynthesis of capsular and 
extracellular polysaccharides [17-18]. These proteins usually possess a 
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transmembrane domain and an intracellular catalytic domain that, in 
Gram-negative bacteria, form a single polypeptide. On the contrary, in 
Gram-positive bacteria, the two domains occur in the form of two distinct 
polypeptide chains [17-18]. In the case of S. pneumoniae, Wzd (also 
known as CpsC), a membrane protein that belongs to the polysaccharide 
co-polymerase family [36], constitutes the external domain, and Wze 
constitutes the catalytic domain. Because members of the bacterial 
tyrosine kinase family regulate the production and export of bacterial 
polysaccharides which play essential roles in the initial stages of infection 
by pathogenic bacteria, these proteins have raised attention as potential 
novel antibacterial targets [12]. Most important, structural studies have 
shown that these bacterial tyrosine kinases possess unique features with 
no equivalent in eukaryotic kinases [38]. 
 As a bacterial tyrosine kinase, Wze possesses the conserved 
Walker A and B ATP binding motifs and the C-terminal tyrosine rich 
region, whose phosphorylation seems to regulate the rate of the synthesis 
of the capsular polysaccharide [35]. The binding of ATP to Wze is 
necessary for capsular polysaccharide synthesis, as Wze mutants carrying 
an inactive ATP-binding site (G48A, K49A) seem to be unable to produce 
CPS, similarly to a wze null mutant [35]. On the other hand, tyrosine 
phosphorylation of Wze does not seem necessary for capsular 
polysaccharide production. In fact, S. pneumoniae expressing mutant 
forms of Wze, where the C-terminal tyrosines have been replaced by 
phenylalanines, making the protein unable to be phosphorylated, can still 
produce CPS [35]. More recently, an additional role of the phosphorylated 
Wze in the attachment of CPS to the pneumococcal cell wall, required for 
pneumococcal invasive disease, has been proposed [34]. 
 Wzd is essential for the synthesis of CPS as no significant 
amounts of capsule, determined by colony phenotype or reaction with 
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specific polyclonal antiserum, were found in wzd deletion mutants [8, 35]. 
Wzd is thought to be involved in the regulation of the synthesis of the 
bacterial capsule through the promotion of the phosphorylation of the 
cytoplasmic Wze [9]. 
 The current model for capsule synthesis states that Wzd and 
Wze interact in the presence of ATP to promote CPS synthesis. When 
Wzd induces Wze autophosphorylation at its C-terminal tyrosines, a 
reduction of the rate of CPS synthesis occurs, probably due to changes in 
interactions with Wzy (the capsule polymerase). This allows the CPS to 
be linked to the peptidoglycan by an unknown ligase. Finally, 
dephosphorylation of Wze enables the cycle to be repeated [22]. 
 In this chapter we report a previously uncharacterized role of 
Wzd and Wze in the coordination of the synthesis of the CPS with 
pneumococcal cell division, by showing that these two proteins localize at 
the division septum and that this localization is required for the presence 
of CPS at the septum. Pneumococcal Wzd and Wze null mutants were 
able to produce a capsule attached to the cell surface but this 
polysaccharide was absent from the division septum. We therefore 
propose that Wzd/Wze proteins may act as spatial regulators of capsule 
metabolism, ensuring the CPS is produced synchronously with the 
synthesis of peptidoglycan at the division septum. 
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Materials and Methods 
 
Bacterial strains and growth conditions 
 Bacterial strains and plasmids used in this study are listed in 
Tables SIII-1 and SIII-2, respectively, in Supplementary Information. E. 
coli was routinely grown in LB medium at 37ºC unless otherwise 
indicated. When needed, antibiotics were used at the following 
concentrations: ampicillin 100 g/ml, kanamycin 50 g/ml and 
erythromycin 100 g/ml. Isopropyl-β-D-thiogalactopyranoside (IPTG, 
Apollo Scientific Ltd) was used at 0.5 mM and 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-Gal, Apollo Scientific Ltd) at 40 g/ml. 
S. pneumoniae was grown in C + Y liquid medium [26] at 37ºC, without 
aeration,  or in tryptic soy agar (TSA, Difco) plates supplemented with 5% 
sheep blood. Tetracycline (Sigma-Aldrich) and erythromycin (Apollo 
Scientific Ltd) were added to the media when appropriate to make a final 
concentration of 1 and 0.25 g/ml, respectively. For white/blue colony 
selection, X-Gal was used at 120 g/ml. Lactococcus lactis was grown in 
M17 broth (Difco), supplemented with glucose (0.5% w/v), at 30ºC. 
Erythromycin was used at 100 g/ml. 
 
DNA manipulation procedures 
 E. coli competent cells were prepared and transformed as 
described [41]. S. pneumoniae competent cells preparation and 
transformation was executed as previously described [32]. PCR products 
and plasmid DNA were purified with kits Wizard® SV Gel and PCR 
Clean-up System and Wizard® Plus SV Minipreps, respectively 
(Promega). PCR fragments were amplified using Phusion High-Fidelity 
DNA polymerase (Finnzymes). Restriction enzymes were from New 
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England Biolabs. Primers used in this study are listed in Table SIII-3 in 
Supplementary Information. 
 
Construction of null mutants and substitution of capsule wild-type 
genes for fluorescent derivatives 
 In order to delete the entire cps gene cluster from the 
chromosome of S. pneumoniae ATCC6314 strain, plasmid pORI280 was 
used [25]. Fragments of DNA corresponding to the upstream and 
downstream regions of the cps operon were amplified with primers 1 and 
2 and primers 3 and 4, respectively. Primers 2 and 3 have a 23 base pair 
overlapping region. After this first amplification, the two fragments were 
joined by overlapping PCR using primers 1 and 4. The product of this 
reaction was restricted with BamHI and PstI, cloned into pORI280, 
resulting plasmid pBCSMC005, and transformed to E. coli strain EC101. 
The encapsulated ATCC6314 S. pneumoniae strain (serotype 14) was 
transformed with pBCSMC005. The cps null-mutant, strain BCSMC001, 
was obtained by excision of the plasmid as previously described [25]. 
 Construction of wzd and wze null-mutants (strains BCSMH001 
and BCSMH002, respectively) was done in the same way, using primers 5 
to 8 and 9 to 12, respectively. These primer pairs were used to clone the 
upstream and downstream regions of wzd and wze, resulting in plasmids 
pBCSMH012 and pBCSMH013, respectively. In the construction of these 
mutants ~50 bp of the 3’ end of the deleted gene were left intact, to 
guarantee that the expression of the following gene on the operon was not 
disturbed. 
 Plasmid pORI280 was also used to substitute wzd and wze in 
the S. pneumoniae genome by genes encoding the correspondent Citrine 
fluorescent derivatives. For the construction of strain BCSMH003 
(ATCC6314wzd::wzd_citrine), primers 13 and 14 were used to amplify 
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the 3’-part of wzd and the entire citrine coding sequence, using plasmid 
pBCSMH007 as template DNA. Primers 15 and 16 were used to amplify 
the downstream region of wzd, using ATCC6314 chromosomal DNA as 
template. Primers 14 and 15 possess an overlapping region, allowing the 
above fragments to be joined by overlap PCR. The resulting fragment was 
restricted with enzymes BamHI and EcoRI and cloned in pORI280, 
resulting in  pBCSMH010. For the construction of strain BCSMH004 
(ATCC6314wze::wze_citrine), a fragment comprising the 3’-part of wze 
and the entire citrine sequence was amplified with primers 17 and 18 from 
plasmid pBCSMH004. The downstream region of wze was amplified with 
primers 11 and 19, from the chromosomal DNA of strain ATCC6314. 
Primers 11 and 18 contain an overlapping region so that the two fragments 
could be joined by overlap PCR. The resulting fragment was restricted 
with BamHI and EcoRI and cloned in pORI280, giving pBCSMH011. As 
for the construction of the null mutants, a duplicated fragment of ~50 bp 
of the 3’ end of each gene was left on the chromosome, after the citrine 
sequence, so that the expression of the following gene on the operon was 
maintained at normal levels.  
 Plasmids were routinely propagated in E. coli EC101 or 
Lactococcus lactis LL108 and purified before being transformed into S. 
pneumoniae bacteria. 
 
Construction of plasmids for protein expression in S. pneumoniae 
 Plasmid pBCSLF001 was constructed by amplification of 
plasmid pLS578 with primers 20 and 21, and subsequent auto ligation. 
This eliminated the CAT reporter gene, which encodes a chloramphenicol 
acetyltransferase, from pLS578 and added NheI, NcoI and BglII restriction 
sites. 
 The mCherry coding sequence was amplified from plasmid 
pROD17 with primers 22 and 23 and cloned in plasmid pBCSLF001. In 
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this process, KpnI and NotI restriction sites were added upstream and 
downstream of the mCherry sequence, respectively, and plasmid 
pBCSLF002 was obtained. This plasmid was again amplified with primers 
24 and 25, restricted with SpeI and ligated. This procedure mutated two 
guanines nucleotides to adenine, eliminating an internal ribosome binding 
site present on the 5’ end of the mCherry sequence. The resulting plasmid 
was named pBCSMH001. The Citrine gene was amplified from plasmid 
pcDNA3_Citrine with primers 28 and 29 and ligated to the product of 
amplification of pBCSMH001 with primers 26 and 27, producing plasmid 
pBCMH002. The coding sequence for Wze was amplified with primers 30 
and 31 and cloned in pBCSMH001, upstream of the mCherry sequence, 
giving plasmid pBCSMH003. Cloning of the same DNA in pBCSMH002 
produced pBCSMH004. In order to mutate the Walker A ATP binding 
motif of wze, the gene was amplified in two different fragments with 
primer pairs 30 and 32 and 33 and 31. The two fragments were joined by 
overlapping PCR using primers 30 and 31 and the resulting product was 
cloned in pBCSMH001, producing plasmid pBCSMH005. Primers 32 and 
33 encode for the following mutations: G48A; K49A. A second 
mutation of the Walker A ATP motif was done by the same procedure, 
using primers 46 and 47 instead of primers 32 and 33, respectively. The 
resulting plasmid is pBCSMH015, in which Wze carries a K49M mutation. 
Substitution of the four tyrosines (residues 218, 221, 224 and 227) for 
phenylalanines on the C-terminal tyrosine cluster of Wze was achieved 
through a single PCR step with primers 30 and 34. Cloning of this DNA 
fragment in pBCSMH001 produced pBCSMH006. 
 The wzd gene was amplified with primers 35 and 36, and 
cloned on plasmid pBCSMH002 generating the plasmid pBCSMH007. 
 In order to co-express the Wze and Wzd fluorescent 
derivatives in the same cell, plasmid pBCSMH008 was constructed. This 
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was done by amplification of the wzd_citrine sequence from plasmid 
pBCSMH007 with primers 37 and 38, and cloning on pBCSMH003. 
Plasmid pBCSMH009 was also constructed, through amplification of wzd 
with primers 37 and 39, restriction and ligation into pBCSMH003, to 
allow co-expression of Wze-mCherry and untagged Wzd. 
 Plasmids for the constitutive expression of untagged Wzd and 
Wze were also constructed. For this purpose, plasmids pBCSMH007 and 
pBCSMH004 were used as templates in a PCR reaction with primers 26 
and 48 and 26 and 49, respectively. The resulting DNA fragments were 
restricted with BglII and autoligated, giving plasmids pBCSMH016 (Wzd 
expression) and pBCSMH017 (Wze expression). 
 In order to determine the localization of Wzd linked to Wze, 
fragments corresponding to both genes were amplified with primers 35 
and 40 and 41 and 31, respectively, and joined by overlap PCR with 
primers 35 and 31. The resulting fragment that encode for Wzd linked to 
Wze through the linker NH2-AERGSVKTIKG-COOH was cloned into 
pBCSMH002 and originating the plasmid pBCSTR001. The same 
procedure was done for the Wze(WA) mutant, giving plasmid 
pBCSTR002.  
 The nucleotide sequences of the modified regions of the 
constructed plasmids were confirmed by sequencing. 
 
Bacterial Two-Hybrid 
 To test in vitro the interaction between proteins Wzd and Wze, 
a Bacterial Two-Hybrid activity assay was employed. Plasmid 
pBCSMC001, encoding the fusion protein T25-Wzd, was constructed by 
cloning the DNA fragment amplified with primers 42 and 43 from 
ATCC6314 chromosomal DNA into plasmid pKT25. Plasmid 
pBCSMC002, encoding the fusion protein T18-Wze, was constructed by 
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cloning the DNA fragment amplified with primers 44 and 45 from 
ATCC6314 chromosomal DNA into plasmid pUT18C. Cloning of the wze 
mutated forms in plasmid pUT18C was done using primers 44 and 45 and 
plasmids pBCSMH005, pBCSMH015 and pBCSMH006 as templates. 
The resulting plasmids are pBCSMC003 (encoding T18-Wze(WA)), 
pBCSMH014 (encoding T18-Wze(WA2)) and pBCSMC004 (encoding 
T18-Wze(Y)). The nucleotide sequences of the modified regions of the 
constructed plasmids were confirmed by sequencing. 
 Interactions between proteins Wzd and Wze were first tested 
by transformation of BTH101 cells with the constructed bacterial two-
hybrid plasmids. Plates were incubated at 30ºC and screened for 
blue/white colonies, in which blue indicated a positive interaction. Single 
colonies were grown at 30ºC in the presence of 0.5 mM of IPTG and the 
interactions confirmed by -galactosidase activity measurements, as 
described [23]. 
 
Microscopy 
 S. pneumoniae strains were grown until early exponential 
phase and observed by fluorescence microscopy on a thin layer of 1% 
agarose in PreC medium [26]. Membranes were labeled with Nile Red (10 
g/ml, Molecular Probes) and DNA with Hoechst 33342 (0.2 g/ml, 
Molecular Probes). To determine the site of cell wall synthesis, cells were 
labeled with a 1:1 mixture of vancomycin (Sigma) and the fluorescent 
BODIPY FL conjugate of vancomycin (VanFL; Molecular Probes) at a 
final concentration of 0.6 g/ml, during 5 minutes on ice. Images were 
obtained using a Zeiss Axio Observer. Z1 microscope equipped with a 
Photometrics CoolSNAP HQ2 camera (Roper Scientific). After 
acquisition, these images were analyzed, adjusted and cropped using 
Metamorph software (Meta Imaging series 7.5) and Image J software [2].  
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Quellung reactions were performed using 1 ml aliquots of liquid cultures 
(OD600~0.5). Cells were washed 3 × with fresh C + Y medium at 37ºC and 
resuspended in a final volume of 50 l of C + Y medium. A volume of 2 
l of this suspension was mixed with 2 l of CPS14 pneumococcal 
antisera (SSI Diagnostica) and the resulting reaction was observed under 
the microscope. 
 In vivo detection of the capsule present at the surface of S. 
pneumoniae cells was achieved using an antibody specific for the capsular 
polysaccharide of serotype 14 (SSI Diagnostica), purified against the 
nonencapsulated strain BCSMC001, as previously described [50]. Briefly, 
300 ml of a culture of the null-mutant strain at OD ~0.3 was heat-killed 
during 45 min at 56ºC, followed by centrifugation and washing with PBS. 
Cells were suspended in 300 l of Anti-CPS14 diluted 1/100 in PBS and 
incubated o/n at 4ºC with gentle agitation.  On the next day, the sample 
was centrifuged, the supernatant filtered (0.2 m pore, Millipore) and 
stored at 4ºC until further use. Immunofluorescence of live pneumo cells 
was done by incubating, on ice during 5 min, 1 ml aliquots of early 
exponential phase cultures with 50 l of purified antibody. Samples were 
washed 2 × with C + Y at 37ºC, and incubated with 0.4 g/ml of Anti-
rabbit Alexa Fluor 488 (Invitrogen), on ice during 5 min. Cells were 
washed twice with fresh C + Y medium, suspended in 50 l and 2 – 3 l 
loaded on PreC + 1% agarose slides.  
 Fluorescence ratio (FR) calculation was done similarly to a 
previously described method [5, 39]. FR was determined by quantifying 
the fluorescence at the septum of cells initiating division (cells that belong 
to class III as defined in figure III-2) divided by the average of the 
fluorescence at the lateral cell wall of the two future daughter cells. 
Average background fluorescence was subtracted from every value. 
Quantification was performed for at least 100 cells of each strain. 
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Fluorescent protein analysis 
 For the preparation of S. pneumoniae total cell extracts, cells 
were harvested from mid-exponential phase cultures, ressuspended in PBS 
and disrupted in a FastPrep FP120 bead beater (Thermo Electron 
Corporation). The cell breakage program used was 3 cycles of 90 seconds 
at 6.0 rpm, followed by 5 min intervals of incubation on ice. Total cell 
extracts were obtained after centrifugation at 14 000 rpm, during 20 min 
at 4ºC (Eppendorf 5430R), to remove unbroken cells and isoluble 
material. The BCA Protein Assay Kit from Pierce (Thermo Scientific) 
was used to quantify the total amount of protein. 
 For the separation of the membrane and cytoplasmic fractions, 
total cell extracts of uncapsulated bacteria constitutively expressing Wzd-
Citrine (strain BCSMH008) and Wze-Citrine (strain BCSMH007) were 
prepared as described above. These total cell extracts were then 
ultracentrifuged for 20 min at 20 000 rpm (Beckman TL 100). The 
supernatants resulting from this centrifugation were ultracentrifuged 
again, this time at 80 000 rpm during 45 min. The pellet obtained in this 
step contained membrane bound proteins, such as Wzd-Citrine, while the 
supernatant contained Wze-Citrine and other cytoplasmic proteins. 
 Protein samples were incubated with solubilization buffer (200 
mM Tris_HCl pH8.8, 20% glycerol, 5 mM EDTA pH 8.0, 0.02% 
bromophenol blue, 4% SDS, 0.05 M DTT) [14] at 37ºC during 5 minutes 
and separated on SDS-PAGE gels. Gel images were acquired on a Fuji 
FLA 5100 laser scanner (Fuji Photo Film Co.) with 635 nm excitation and 
>665 nm band pass emission filter for protein molecular weight marker 
detection, 532 nm excitation and > 575 nm band pass emission filter for 
mCherry fusions detection and 473 nm excitation and > 510 nm band pass 
emission filter for Citrine fusions detection. 
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Western-Blot 
 Bacterial cell lysates of 1 ml of culture (OD600~ 0.3) were 
harvested and boiled during 3 minutes before being separated on a 10% 
SDS-PAGE gel. Proteins were transferred into a Hybond PVDF 
Membrane (Amersham) and probed with mouse anti-phosphotyrosine 
monoclonal antibody cocktail clone 4G10® Platinum (Millipore) used at 
1:2000, followed by 1:5000 of goat anti-mouse antibody conjugated to 
horseradish peroxidase (Amersham). Detection was done with ECL 
Plus
TM
 Western Blotting Detection Reagents (Amersham). For the 
detection of capsule proteins fluorescent derivatives, the cultures were 
harvested at OD600~0.5. Proteins were transferred and detected as above. 
Probing was done with Living Colors® Av. Peptide Antibody (Clontech) 
used at 1:500, followed by 1:100000 of goat anti-rabbit antibody 
conjugated to horseradish peroxidase. 
 
Dot-blot  
 Cell samples were prepared by harvesting cells at early 
exponential growth-phase (OD600~0.3), and resuspending them in water. 
After adjusting the samples to the same cell density, cells were lysed with 
deoxycholate and boiled for 3 minutes before use. Samples of purified cell 
walls and peptidoglycan were prepared as previously described [43]. 
Briefly, cells were boiled into sodium dodecyl sulfate (SDS, final 
concentration, 4%) for 30 min to inactivate any enzyme that could modify 
the bacteria cell wall. After removal of SDS, cell walls were mechanically 
broken by shaking with an equal volume of acid-washed glass beads with 
a FastPrep FP120 apparatus. Cell walls were digested with Dnase and 
Rnase (for 3h at 37ºC), and trypsin (overnight at 37ºC), which were 
inactivated by boiling in 1% (final concentration) SDS. Cell walls were 
washed twice with water, once with 8 M LiCl and then with 100 mM 
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EDTA. Before lyophilization, broken cell walls (CW) were washed three 
times with water. For purification of peptidoglycan, the cell walls (5 mg) 
were treated with 2 ml of 49% hydrofluoric acid (HF) for 48h at 4°C, 
which is known to cleave phosphodiester bonds and thus remove teichoic 
acids and polysaccharides covalently bound to the bacterial 
peptidoglycan. The peptidoglycan (PGN) was recovered and washed as 
previously described [42]. 
 In order to load in the dot-bot similar amounts of cell walls and 
peptidoglycan, the content of muramic acid was determined in each 
purified sample, by fluorescence HPLC analysis after an hydrolysis 
process, as described [4]. 20 l of peptidoglycan (10 mg/ml) and 50 l of 
cell wall (20 mg/ml) were mixed with 37.25 l of 12 M HCL and 
incubated at 95ºC for 2 hours. The mixture was lyophilized, washed with 
0.5 ml of water, lyophilized again and the final pellet ressuspended in 100 
l of water. 20 l of sample were mixed with 80 l of OPA reagent, 
which was prepared by dissolving 68 mg of o-phtaldialdehyde (Fluka) in 
50 l of 2-mercaptoethanol and 1.4 ml methanol, followed by completion 
of the volume to 10 ml with borate buffer (0.4 M H3BO3, pH 10.4). 
Samples were injected onto Hypersil ODS column C18 (Thermo Electron 
Corporation). The flow rate rate of the mobile phase (0.05 M sodium 
citrate, 0.05 M sodium acetate, methanol and tetrahydrofuran at a ratio of 
90: 8.5: 0.75: 0.75 in vol %) was 1.5 ml/min at 35ºC for 80 min, followed 
by a 20 min gradient from 0 to 80% of a cleaning buffer (water and 
methanol at a ratio of 50: 50 in vol %) and 20 min mobile phase again for 
re-conditioning of the column. Fluorometric emission of the amino sugar 
derivatives was measured at a wavelength of 445 nm with 340 nm as the 
excitation wavelength (Shimadzu RF-10Axl). 
 Samples were loaded into Hybond PVDF (Amersham) 
membranes, pre-equilibrated in PBS and placed on top of PBS-soaked 
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Hybond Blotting Paper. The membranes were allowed to air-dry for 30 
minutes and then blocked during 1 hour in Blocking Buffer (5% non-fat 
dried milk in PBS). Membranes were washed in PBS-T (PBS + 0.05% 
Tween 20) and incubated overnight at 4ºC with primary antibodies Anti-
CPS14, purified as described above, and Anti-CWPS (SSI Diagnostica) 
diluted 1/1000 in PBS-T. The latter serum, Anti-CWPS, was used to 
verify that the samples were retained in the membrane of the dot-blot, as it 
recognizes the phosphorylcholine residues of the Cell Wall 
Polysaccharide, or pneumococcal teichoic acids. After washing with PBS-
T, membranes were incubated during 1 hour at room temperature with 
secondary antibody Anti-Rabbit IgG peroxidase linked diluted 1/100000 
in PBS-T. Membranes were again washed with PBS-T and detected using 
the ECL Plus
TM
 Western Blotting Detection Reagents (Amersham). 
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Results 
 
Membrane-linked Wzd and cytoplasmic Wze are found at the 
division septa of encapsulated Streptococcus pneumoniae bacteria 
 
 The localization of the capsule synthetic machinery in S. 
pneumoniae has not been previously studied. In order to determine the 
localization of Wzd and Wze in the pneumococcal cell we have 
constructed fluorescent derivatives of these proteins in which their C-
terminal end was fused to the fluorescent protein Citrine. Citrine is a 
variant of the Green Fluorescent Protein that fluoresces in the yellow 
range of the light spectrum and that has increased photostability and 
resistance to fluctuations of the environmental pH [19]. Genes encoding 
for Wzd-Citrine and Wze-Citrine proteins were individually introduced 
into the cps operon of the encapsulated ATCC6314 strain, substituting the 
native wzd and wze genes, in strains BCSMH003 and BCSMH004, 
respectively. 
 Wzd-Citrine and Wze-Citrine proteins were found at the 
division septa of pneumococcal bacteria and had similar localization 
patterns at different stages of the cell cycle (Figure III-1), suggesting that 
the recruitment of Wzd and Wze to the division septum occurs in a similar 
manner. 
 To determine the temporal window of the pneumococcal cell 
cycle during which the localization of Wze takes place at the septum, we 
labeled an exponentially growing culture of strain BCSMH004, 
expressing Wze-Citrine, with DAPI, a fluorescent stain that labels DNA, 
and with Nile-Red, a dye that becomes fluorescent when incorporated into 
bacterial membranes. Using these dyes we were able to localize bacterial 
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Figure III-1: Localization of proteins Wzd and Wze in encapsulated 
pneumococcal cells. Fluorescence microscopy images of strains i) BCSMH003 
and ii) BCSMH004, expressing Wzd and Wze Citrine fluorescent derivatives, 
respectively, from their native promoter. Scale bar, 2 µm. 
 
chromosomes and evaluate the stage of membrane invagination during the 
formation of the division septum. We then assigned labeled bacteria to 
five different classes, according to the progression of the cell cycle, from 
newborn bacteria with only one chromosome and no membrane at the 
division septum (class I, Figure III-2) to bacteria that have nearly 
completed division, with fully segregated chromosomes and with a clear 
invagination of the division septum (class V, Figure III-2). The same cells 
were also classified according to the localization of fluorescent Wze-
Citrine protein (classes A to E, Figure III-2). This analysis showed that in 
newborn bacteria, even before the onset of septum invagination (classes I 
and II), Wze is already localized at mid-cell, seen as two spots that 
indicate the formation of a ring (classes A and B). Later on the 
pneumococcal cell cycle, when a membrane septum is being formed and 
chromosome segregation has proceeded (class III), Wze-Citrine is 
observed as a line consistent with septal localization (class C). In a small 
percentage of cells (1.6 %, n=1254), we could observe that fluorescence 
was spread between the old and the new septa (class D). This is consistent 
with a migration of the Wze protein between the old and new septa along 
the membrane. Additionally, in a small percentage of the cells (2.1 %, 
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n=1254), Wze is already found at the mid-cell of the newly born cells 
while still present at the old division septum (class E). 
 
Figure III-2: Classification of encapsulated pneumococcal cells expressing 
Wze-Citrine according to cell division stage. Classification of BCSMH004 
pneumococcal cells (n=1254) according to cell division stage (I – V) and Wze-
Citrine localization (A – E). Representatives of the classes are shown in i). DNA 
was labeled with DAPI and membranes with Nile Red. Scale bar 2 m. 
 
 
 To test for the functionality of Wzd and Wze fluorescent 
derivatives expressed by BCSMH003 and BCSMH004, respectively, we 
performed a Quellung reaction. For that purpose, these strains were 
incubated with rabbit-serum raised against pneumococcal capsular 
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polysaccharide serotype 14, which resulted in a positive reaction of 
agglutination. Agglutination reactions were also observed with the 
parental encapsulated ATCC6314 strain, with the Wzd null mutant 
expressing constitutively untagged Wzd (strain BCSMH025) and with the 
Wze null mutant expressing constitutively untagged Wze (strain 
BCSMH026) (Supplementary Figure SIII-1). This indicated that both 
Wzd-Citrine and Wze-Citrine protein fusions were functional, as Wzd and 
Wze null mutants (strains BCSMH001 and BCSMH002 respectively) 
seemed impaired in their ability to produce capsule as they failed to 
agglutinate (Supplementary Figure SIII-1). 
 We further confirmed that the fluorescent derivatives of Wzd 
and Wze were functional by looking for phosphorylated Wze. It was 
previously shown that Wzd is required for Wze autophosphorylation at its 
C-terminal tyrosines [9]. Therefore, if the Wze fluorescent derivative 
retained its ability to autophosphorylate, and the Wzd fluorescent 
derivative its capacity to induce Wze autophosphorylation, this would 
further indicate the protein fusions were functional. We checked for the 
presence of the phosphorylated Wze fluorescence derivatives in 
unencapsulated strains BCSMH006 and BCSMH011, expressing only 
Wze-mCherry, and in strains BCSMH009 and BCSMH014, expressing 
Wze-mCherry together with Wzd-Citrine, by western-blot using an 
antibody against phosphorylated tyrosines. Wze-mCherry was 
phosphorylated when Wzd-Citrine was also expressed but not in its 
absence (Supplementary Figure SIII-2A), indicating that both fusions 
were functional. We did not detect additional bands that could result from 
phosphorylated untagged Wze, originated from cleavage of the fusion 
proteins. The phosphorylated Wze protein was only observed in the 
encapsulated ATCC6314 control strain (Supplementary Figure SIII-2A). 
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 Importantly for experiments described below, we observed that 
expressing Wzd-Citrine or Wze-Citrine in the encapsulated strains 
BCSMH019 and BCSMH016, respectively, under the control of a 
constitutive promoter, also resulted in a fluorescent signal localized at the 
division septum (see below). Expression of Wze-Citrine fluorescent 
protein from the replicative plasmid pBCSMH004 in strain BCSMH016 
occurred at similar levels as when this protein was produced from the 
coding sequence inserted into the chromosome, under the control of the 
chromosomal cps promoter, in strain BCSMH004 (Supplementary Figure 
SIII-3A). The possibility that Wzd and Wze fluorescent derivatives could 
be being cleaved, which would result in functional and untagged Wzd, 
and Wze proteins was ruled out because BCSMH004 and BCSMH003 
strains produced fluorescent proteins of the expected molecular weight of 
the fusion proteins. This was determined by western blotting with a 
specific antibody against the fluorescent domain of the protein fusions 
(Supplementary Figure SIII-3B). 
 
Co-expression of Wzd and Wze is sufficient for septal localization of 
both proteins 
 
 Having determined that fluorescent derivatives of Wzd and 
Wze localized at the division septum of encapsulated pneumococcal 
bacteria, we then asked whether this localization was dependent on the 
ability of bacteria to produce a capsule. To answer this question, plasmids 
pBCSMH007 and pBCSMH004 were transformed into unencapsulated 
strains R36A (unencapsulated laboratory strain) and BCSMC001 
(unencapsulated strain derived from ATCC6314, in which the entire cps 
operon was deleted). Constitutive expression of either Wzd-Citrine in 
unencapsulated BCSMH008 and BCSMH013 strains or Wze-Citrine in 
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unencapsulated BCSMH007 and BCSMH012 strains, did not result in 
localization of the fluorescent signal at the division septum (Figure III-3): 
Wzd-Citrine was distributed all over the membrane and Wze-Citrine was 
dispersed throughout the entire cytoplasm. 
 
Figure III-3: Localization of Wzd and Wze fluorescent derivatives in 
different pneumococcal cells. Microscopy images of S. pneumoniae strains 
expressing constitutively Wzd-Citrine (strains i) BCSMH008, ii) BCSMH013 and 
iii) BCSMH019) or Wze-Citrine (strains iv) BCSMH007, v) BCSMH012 and vi) 
BCSMH016) are shown in the upper panel. Scale bar 2 m. Quantification of 
septum versus lateral membrane fluorescence (fluorescence ratio, FR) of the same 
strains is also shown. FR values over 2 indicate preferential septal localization, 
whereas FR values equal to or lower than 2 indicate that a protein is dispersed 
over the cell surface. 
 
 We further confirmed the cellular localization of Wzd-Citrine 
and Wze-Citrine by cell fractionation analysis, which showed that Wzd-
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Citrine was found at the membrane while Wze-Citrine was found in the 
cytoplasm (Supplementary Figure SIII-4). These results are in accordance 
with the fact that Wzd carries two hydrophobic regions, responsible for its 
insertion in the membrane, while Wze is predicted to be a cytoplasmic 
protein. 
 In order to confirm that the localizations observed in the 
unencapsulated strains are indeed different from the ones observed in the 
encapsulated strains, we calculated the fluorescence ratio (FR) between 
the intensity of the fluorescent signal at the division septum, of cells that 
had initiated division (class III), and the fluorescent signal measured at the 
lateral cell wall of the same cells. When a fluorescent protein is evenly 
distributed all over the membrane, the intensity of the fluorescence at the 
septum, that contains two membranes, should be approximately twice the 
fluorescence at the lateral wall. On the other hand, when a protein is 
localized at the septum, the fluorescence ratio should be higher than two 
[5, 39]. Determination of the FR in encapsulated strains BCSMH019 and 
BCSMH016 clearly indicated that Wzd and Wze, respectively, were 
localized at the septum (Figure III-3). This is different from the result 
obtained for the unencapsulated strains expressing Wzd (BCSMH008 and 
BCSMH013) and Wze (BCSMH007 and BCSMH012) fluorescent 
derivatives. The FR determined for these strains was consistent with an 
even distribution of the proteins over the cells (Figure III-3). 
 We ruled out the hypothesis that the fluorescent domain of the 
protein fusions was preferably cleaved in the unencapsulated strains, 
which would result in the presence of the fluorescent signal throughout 
the cytoplasm of the cells, because expression of Wzd fluorescent 
derivative in both encapsulated BCSMH019 and in the unencapsulated 
BCSMH008 and BCSMH013 strains produced protein products of similar 
molecular weight and at similar levels (Figure III-4, left panels). Similar 
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results were obtained with expression of Wze fluorescent derivative in 
both encapsulated BCSMH016 and in the unencapsulated BCSMH007 
and BCSMH012 strains (Figure III-4, right panels). Wzd and Wze 
fluorescent derivatives were not cleaved as shown by western blotting 
with a specific antibody that recognizes Citrine protein (Figure III-4, 
lower panels). 
 
Figure III-4: Cell extracts of S. pneumoniae strains expressing Wzd and Wze 
fluorescent derivatives. Analysis of total cell extracts of S. pneumoniae 
separated by SDS-PAGE showing the absence of cleavage of the Wzd and Wze 
fluorescent derivatives. Fluorescence images of the SDS-PAGE gels are shown in 
the upper panels and a Western-Blot analysis, using an antibody that recognizes 
protein Citrine is shown in the lower panels. Unencapsulated strains, R36A and 
BCSMC001 (ATCC6314cps), and the encapsulated ATCC6314 parental strain 
are shown as the controls. Strains BCSMH008, BCSMH013 and BCSMH019, 
which express Wzd-Citrine (indicated by and arrow), are shown on the left. 
Strains BCSMH007, BCSMH012 and BCSMH016, which express Wze-Citrine 
(indicated by and arrow) are shown on the right. The size of the detected bands in 
SDS-PAGE gels and Western-Blot was different as protein extracts were boiled 
prior loading into gels for Western-Blot analysis. 
  
 The observation that fluorescent derivatives of Wzd and Wze 
could localize at the division septum in bacteria capable of producing a 
capsular polysaccharide, but not in unencapsulated strains, suggested that 
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there was an additional protein, encoded by the cps operon, involved in 
recruitment of Wzd and Wze to the septa. Alternatively, a protein 
complex containing Wzd and Wze could be able to find the division 
septum on its own, or by interacting with a topological marker present at 
the pneumococcal division septum. We therefore decided to co-express, in 
unencapsulated pneumococcal bacteria, Wze, fused to the fluorescent 
mCherry protein, and Wzd-Citrine. Expression of Wze-mCherry alone, in 
strains BCSMH006 and BCSMH011, resulted in a dispersed fluorescent 
signal throughout the entire cytoplasm. Expression of Wzd-Citrine alone, 
in strains BCSMH008 and BCSMH013, resulted in dispersal of the 
fluorescent signal all over the membrane (Figure III-5 and Supplementary 
Figure SIII-5), similarly to what was described in Figure III-3. However, 
when Wze-mCherry and Wzd-Citrine were co-expressed in the 
unencapsulated strains BCSMH009 and BCSMH014 both proteins 
localized at the septum (Figure III-5 and Supplementary Figure SIII-5). 
 
 
Figure III-5: Co-localization of Wzd-Citrine and Wze-mCherry in the 
unencapsulated strain R36A. Fluorescent microscopy images of representative 
fields of strains i) BCSMH006 (expressing Wze-mCherry), ii) BCSMH008 
(expressing Wzd-Citrine), iii) BCSMH009 (expressing Wze-mCherry and Wzd) 
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and iv) BCSMH010 (expressing Wze-mCherry and Wzd-Citrine) are shown. 
Scale bar, 2 m. Fluorescent ratios (FR) determined for the Wzd-Citrine 
localization in strains BCSMH008 and BCSMH009 are shown on the right. 
 
 Similar results were obtained when Wze-mCherry was co-
expressed with Wzd in the uncapsulated BCSMH010 strain. We 
confirmed that in all strains there was no cleavage of the fluorescent 
domains of the Wzd and Wze derivatives, and that the proteins were being 
produced at similar levels (Supplementary Figure SIII-6). Furthermore, 
we confirmed that, as expected, untagged mCherry (expressed in the 
unencapsulated BCSLF001 strain and in the encapsulated BCSLF002 
strain) was found dispersed throughout the entire cytoplasm 
(Supplementary Figure SIII-7). 
 These results show that the pair Wzd/Wze is recruited to the 
division septa in the absence of any additional protein encoded by the cps 
operon.  
 
Wzd and Wze interact and this interaction requires the Wze ATP 
binding domain. 
 
 As co-expression of proteins Wzd and Wze is necessary and 
sufficient for their localization at the division septum, it seemed likely that 
these two proteins interacted. In order to test this hypothesis, we used a 
bacterial two-hybrid system [24], based on the expression, in an E. coli 
strain deficient in endogenous adenylate cyclase, of two inactive 
fragments of the catalytic domain of Bordetella pertussis adenylate 
cyclase, T25 and T18, that when fused to interacting polypeptides can 
activate the synthesis of cAMP and consequently restore the ability of the 
E. coli mutant strain to ferment lactose or maltose. This approach showed 
that Wzd was indeed capable of interacting with Wze, as extracts from E. 
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coli cells expressing the proteins T25-Wzd and T18-Wze had a -
galactosidase activity 30 times higher than that resulting from the sole 
expression of the untagged protein fragments T25 and T18 (Figure III-6). 
 
Figure III-6: Requirement of a functional Wze ATP binding domain for its 
interaction with Wzd. Interaction between Wzd and Wze was tested by a 
Bacterial Two-Hybrid assay. The averages and standard deviations of three -
galactosidase activity measurement experiments are shown. Empty vectors: 
expression of untagged T18 and T25 fragments; Positive control: expression of 
T28 and T25 fragments linked to two leucine zipper domains, Wzd+Wze: 
interactions between T25-Wzd and T18-Wze; Wzd+Wze(WA): interaction 
between T25-Wzd and the Walker A ATP binding motif mutant form of T18-
Wze (Wze(WA)); Wzd+Wze(Y): interaction between T25Wzd and T18-Wze 
with a mutated C-terminal tyrosine cluster (Wze(Y)). 
 
 A functional Walker A motif and the enriched Tyr cluster in 
Wze were previously shown to be important for the regulation of the 
synthesis of the capsule in S. pneumoniae [35]. We therefore asked if 
these motifs were also important for the ability of Wze to interact directly 
with Wzd, and consequently for the localization of the pair Wzd/Wze at 
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the division septum. We used again the bacterial two-hybrid system to test 
the interaction between Wzd and Wze(WA), a previously described 
mutated form of Wze in which the Walker A motif is inactivated by the 
mutations G48A and K49A [35]. In this case, the -galactosidase activity 
was similar to the negative control (Figure III-6). Similar results were 
obtained with a mutated form of Wze, named Wze(WA2), in which the 
Walker A motif was inactivated by the mutation K49M (data not shown). 
This mutation results in an inactive P-loop in the Wze homologue of S. 
aureus, CapB, without significant alterations of the protein structure [38].  
On the contrary, when the mutant Wze(Y) protein, with the tyrosines of 
the C-terminus cluster mutated to phenylalanines, was tested in the 
bacterial two-hybrid system, it resulted in -galactosidase activity 16 
times higher than the negative control (Figure III-6). 
 These results show that a functional Walker A motif is 
essential for Wze to interact with Wzd, while the ability of Wze to 
phosphorylate its C-terminal tyrosines is not. 
 
The ATP binding domain of Wze is required for recruitment of the 
pair Wzd/Wze at the division septum 
  
 Since mutations in the conserved Walker A and C-terminal 
tyrosine cluster motifs of Wze had different effects on its interaction with 
Wzd, we tested the effect of those mutations on the localization of Wze. 
In order to do that, we transformed the encapsulated ATCC6314 strain 
with plasmids pBCSMH005 and pBSMH006, encoding the Walker A, 
Wze(WA), and the tyrosine cluster, Wze(Y), mutant forms of Wze, 
respectively, fused to fluorescent protein mCherry, obtaining strains 
BCSMH017 and BCSMH018. 
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 Microscope visualization of the encapsulated BCSMH017 
strain, expressing Wze(WA)-mCherry showed that the protein did not 
localize at the division septa (Figure III-7A). Similar results were obtained 
with encapsulated BCSMH024 strain, expressing Wze(WA2)-mCherry 
(data not shown). On the other hand, expression of Wze(Y)-mCherry in 
the encapsulated BCSMH018 strain, resulted in septal localization (Figure 
III-7A). The three forms of Wze fluorescent derivatives had similar sizes 
and were produced at similar levels (Figure III-7B). 
 
 
Figure III-7: Requirement of a functional Wze ATP binding domain for the 
septal localization of the protein. A) Fluorescent microscopy images of 
encapsulated strains expressing Wze-mCherry fluorescent derivatives from a 
constitutive promoter. i) BCSMH015, wild-type Wze; ii) BCSMH017, Wze 
Walker A ATP binding motif mutant (Wze(WA)); iii) BCSMH018, Wze C-
terminal tyrosine cluster mutant (Wze(Y)). Scale bar, 2 m. B) Analysis of total 
cell extracts of strains in A, separated by SDS-PAGE, showing that all fluorescent 
Wze-mCherry proteins are expressed at the same levels. 
 
 These observations indicated that the ability of Wze to bind 
ATP, but not to autophophorylate its C-terminal tyrosines, is necessary for 
its interaction with Wzd and consequent recruitment to the division septa. 
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 In order to determine if ATP binding was required only for the 
interaction of Wze with Wzd or also for the actual recruitment of the 
Wzd/Wze complex to the division septum, we linked both proteins 
through an 11 aminoacid flexible peptide linker (L11), which should 
overcome the requirement of ATP binding for Wze to interact with Wzd 
and allow us to evaluate its role solely on the localization of the pair of 
proteins. 
 Strain BCSTR001, expressing the chimera protein Wzd-L11-
Wze-Citrine in the background of unencapsulated R36A, showed a 
fluorescent signal localized at the division septum, similarly to what was 
observed in strain BCSMH009, when Wzd-Citrine was co-expressed 
together with Wze-mCherry (Figure III-8). On the contrary, strain 
BCSTR002, unencapsulated R36A strain expressing the protein Wzd-
L11-Wze(WA)-Citrine, which has the inactivated Walker A motif, 
presented a fluorescent signal which was no longer localized at the septum 
(Figure III-8). The results obtained here showed that ATP binding is 
required not only for the ability of Wze to interact with Wzd but also for 
the correct localization of these two proteins at the division septa. 
 The chimera protein Wzd-L11-Wze-Citrine seems functional, 
because when this protein was expressed in strain BCSTR003, lacking 
Wzd, or in strain BCSTR004, lacking Wze it could restore capsule 
production as determined by Quellung reaction (Supplementary Figure 
SIII-1). Furthermore, detection of phosphorylated tyrosines in the 
unencapsulated R36A expressing Wzd-L11-Wze-Citrine (strain 
BCSTR001), in a protein with the correct size for the fusion protein, 
indicated that this was not cleaved and that both Wzd and Wze domains 
were functional (Supplementary Figure SIII-2B), as it has been shown that 
Wze only phosphorylates its C-terminal tyrosines in the presence of Wzd 
[9]. 
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Figure III-8: Localization of the Wzd-L11-Wze chimera fluorescent 
derivatives. Fluorescence microscopy images of representative fields of 
unencapsulated strains i) BCSMH008 (Wzd-Citrine), ii) BCSMH009 (Wzd-
Citrine co-expressed with Wze-mCherry), iii) BCSTR001 (Wzd-L11-Wze-
Citrine) and iv) BCSTR002 (Wzd-L11-Wze(WA)-Citrine). The Wzd-L1-Wze-
Citrine chimera protein can localize at the division septum of pneumococcal cells 
when a functional Wze ATP binding domain is present. Scale bar, 2 m. The 
fluorescence ratios (FR) determined for these strains are shown at the bottom. 
 
Capsular polysaccharide is produced in S. pneumoniae Wzd or Wze 
null mutants, but it is absent from the division septa 
 
 In order to study the effect of lack of Wzd or Wze on CPS 
production we deleted the wzd and wze genes from the chromosome of the 
encapsulated ATCC6314 strain, obtaining the BCSMH001 and 
BCSMH002 strains, respectively. No resistance marker was left in the 
CPS operon to minimize polar effects in downstream genes. The last 50 nt 
of each deleted gene were kept in the chromosome of the mutant strains 
because we found that they were required for the expression of the protein 
encoded by the gene located downstream in the cps operon (data not 
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shown). Both BCSMH001 and BCSMH002 strains seemed to have an 
impaired ability to synthesize the capsular polysaccharide, compared to 
the parental ATCC6314 strain, as assayed by Quellung reaction, in which 
the mutant strains showed a decreased ability to agglutinate in the 
presence of serum against the type 14 capsular polysaccharide (Figure III-
9 and Supplementary Figure SIII-1). 
  
 
Figure III-9: Expression of capsular polysaccharide in the absence of Wzd 
and Wze conserved proteins. A) Brightfield images of the agglutination 
resulting from Quellung reaction. i) ATCC6314, encapsulated parental strain; ii) 
BCSMC001, unencapsulated ATCC6314cps strain; iii) BCSMH001, 
ATCC6314wzd mutant strain; iv) BCSMH002, ATCC6314wze mutant strain. 
Scale bar, 2 m. B) Dot-blot assays performed with whole cells, cell wall (CW) 
and peptidoglycan (PGN) samples from strains as in A. Detection of capsular 
polysaccharide was done with a purified serotype-14 specific serum (AntiCPS14, 
upper panel). As a control, detection of phosphorylcholine with a cell wall 
polysaccharide serum was performed (AntiCWPS, lower panel). 
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 We performed a dot-blot with purified commercially available 
serum, which recognizes capsular polysaccharide 14, to determine if 
capsule was present in wzd and wze null mutant cells, in their purified cell 
walls and in samples of purified peptidoglycan. As seen in figure III-9, we 
found that capsule was being produced at lower levels in the wzd and wze 
null mutant cells than in the wild-type encapsulated ATCC6314 cells and 
it was absent from the unencapsulated BCSMC001 cells. Moreover, the 
capsule was present in samples of purified cell walls from the wzd and 
wze null mutants, similarly to the parental encapsulated strain, and absent 
in samples of the purified peptidoglycan (Figure III-9). These results 
suggest that the capsule was covalently attached to the peptidoglycan in 
both wzd and wze null mutants, identical to what was observed in the 
parental strain, and it was absent when hydrofluoric acid was used to 
remove material linked to peptidoglycan through phosphodiester bounds, 
a step used in the purification of bacterial peptidoglycan. Similar amounts 
of cells walls and peptidoglycan were present in the dot-blot (see methods 
and Figure III-9). 
 In order to determine not only if, but also where, capsule was 
present, we labeled the capsular polysaccharide using again the purified 
rabbit-serum raised against pneumococcal capsular polysaccharide 
serotype 14 and showed by immunofluorescence microscopy that in 
BCSMH001 and BCSMH002, the ATCC6314 wzd and wze null mutants 
strains, respectively, the capsular polysaccharide was absent from the 
division septum (Figure III-10). This is the site where Wzd and Wze 
proteins can localize if co-expressed, and where new cell wall is 
synthesized (see below). However, the capsule was still present in the 
mature cell wall, as judged by the observation of an immunofluorescence 
signal. This is in accordance with what Morona and colleagues have 
reported previously [35].  As expected, the capsule was present over the 
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entire surface of the pneumococci cells in the parental ATCC6314 strain, 
and no signal was detected in BCSMC001, the cps null mutant of 
ATCC6314 (Figure III-10). 
 
 
Figure III-10: Distribution of capsular polysaccharide at the cell surface of 
different pneumococcal cells. Capsular polysaccharide immunofluorescence. i) 
ATCC6314, encapsulated parental strain; ii) BCSMC001, unencapsulated 
ATCC6314cps strain; iii) BCSMH001, ATCC6314wzd mutant strain; iv) 
BCSMH002, ATCC6314wze mutant strain. Capsular polysaccharide is absent 
from the division septum of cells lacking Wzd (BCSMH001) or Wze 
(BCSMH002). Scale bar, 2 m. 
 
  To determine where the new cell wall was being synthesized 
and if it corresponded to the same place where Wze and Wzd localized, 
we labeled encapsulated bacteria BCSMH015, expressing Wze-mCherry, 
with Van-FL, a fluorescent derivative of vancomycin, an antibiotic that 
binds to the recently translocated peptidoglycan precursors that still carry 
an intact D-Ala-D-Ala carboxyl terminus [13]. Fluorescent signals of 
Van-FL and Wze-mCherry co-localized at the division septum (Figure III-
11), indicating that Wze localizes where the new peptidoglycan is being 
synthesized. 
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Figure III-11: Co-localization of Wze-mCherry and new cell wall synthesis. 
Van-FL staining of strain BCSMH015, expressing Wze-mCherry. Strain 
BCSMH005, transformed with the empty vector, is shown for comparison. Scale 
bar, 2 m. 
 
 The observation that Wzd and Wze were required for the 
presence of the capsular polysaccharide at the division septum suggests 
that these proteins are involved in the spatial-temporal regulation of the 
capsule metabolism, ensuring the capsule is present at the division 
septum, where the new cell wall is being synthesized. 
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Discussion 
 
Protein localization studies in S. pneumoniae have been done 
mainly by immunofluorescence, probably due to the fact that these 
bacteria are microaerophiles. Low levels of oxygen could prevent post-
translational oxidation of GFP fusion proteins with the consequent 
absence of fluorescent signal, when expressed in pneumococci. However, 
Eberhardt and colleagues have recently described the localization in live 
cells of fluorescent derivatives of proteins involved in the essential 
pathway of choline metabolism in S. pneumoniae [15]. 
In this work we have studied the localization of the regulators of 
capsule synthesis in S. pneumoniae, Wzd and Wze. We substituted wzd 
and wze in the cps operon by genes encoding the fluorescent derivatives of 
Wzd and Wze. This strategy increases the likelihood that fluorescent 
proteins are produced at the same level as the native unlabeled proteins, 
with minimal alterations in the expression of the other proteins encoded in 
the cps operon. 
Wzd and Wze localized at the septum of live and dividing 
encapsulated pneumococcal cells. Both proteins were recruited to the 
septum early in the cell cycle, as the corresponding fluorescent signal was 
observed at mid-cell in newborn bacteria, before the onset of invagination. 
Surprisingly, we found that when the localization of the 
fluorescent derivatives of Wzd and Wze was determined in 
unencapsulated bacteria both Wzd and Wze proteins were no longer 
localized at the septum, but had a dispersed localization consistent with 
their aminoacid composition: Wzd was found all over the cell membrane, 
while Wze was dispersed throughout the cell cytoplasm. 
The observation that Wzd and Wze localized at the division 
septum only in encapsulated bacteria suggested that one or more proteins, 
Synthesis of CPS at the division septum of S. pneumoniae 
 
- 131 - 
 
encoded in the cps operon, could recruit Wzd and Wze to the division 
septum. An alternative hypothesis was that Wzd and Wze, assembled in a 
protein complex and were able to find the septum on their own, or through 
the interaction with a topological marker present at the pneumococcal 
division septum. The second scenario seems more likely, as we observed 
that co-expression of fluorescent derivatives of both Wzd and Wze in 
unencapsulated strains resulted in a clear septal localization. We have not 
identified the topological marker that determines Wzd/Wze septal 
localization. Interestingly, Wze has homology with proteins from the large 
P-loop NTPase superfamily that include members such as the MinD 
ATPase, a constituent of the MinCDE complex that contributes to the 
determination of the place where the division septum is formed in 
different bacteria [44]. In Gram-positive bacteria, such as Bacillus subtilis, 
MinD can interact with the bacterial membrane and accumulate at cell 
division sites and cell poles [31]. This results in the localization of MinC, 
an inhibitor of the polymerization of FtsZ, at these sites, which ensures 
that bacterial division is temporally and spatially regulated [31]. 
Bacterial two-hybrid assays showed that Wzd and Wze interact 
and that a functional ATP binding domain in Wze is required for their 
interactions. This is in agreement with recent data obtained with Wzd and 
Wze homologues from Streptococcus thermophilus using a yeast two-
hybrid assay [11]. Wze contains a divergent Walker A motif (A/G-X-X-
X-X-G-K-S/T, where X can be any amino acid); and a Walker B ATP 
binding motif (h-h-h-h-D, where h represents a hydrophobic amino acid) 
[30]. Besides these two motifs, Wze also has an additional motif, termed 
Walker A’ (D-X-D), generally found in cell division regulatory proteins 
of the MinD/Mrp family and present in different bacterial tyrosine kinases 
involved with the synthesis of capsular polysaccharides [12]. Morona and 
colleagues have described that a mutation of the Walker A motif, which 
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inactivates the ATP binding ability of the protein, resulted in the 
elimination of capsule synthesis [35]. On the contrary, mutation of the 
tyrosines at the C-terminus of the protein had no apparent effect on 
capsule production. We now found that a functional Walker A motif in 
Wze is also essential for its interaction with Wzd, while the tyrosines at 
the C-terminus of Wze are not. These results suggest that the reason why 
an ATP binding Wze mutant is impaired in its ability to produce capsule, 
may be a consequence of its inability to interact with Wzd and properly 
localize. 
Wze belongs to a bacterial tyrosine kinase protein family which 
includes members reported to act as co-polymerases in the biosynthesis of 
capsular and extracellular polysaccharides [17-18]. In Gram-negative 
bacteria, the tyrosine kinase domain is linked to a transmembrane domain, 
functional homologous to Wzd, forming a single polypeptide. We have 
reproduced the Gram-negative organization of bacterial tyrosine kinases 
in S. pneumoniae by constructing a fluorescent derivative of the chimera 
Wzd-L11-Wze protein, in which Wzd was linked to Wze through an 11-
aminoacid flexible linker. This strain allowed us to test if ATP binding 
activity was required only for Wzd/Wze interactions (as showed in the 
bacterial two-hybrid assays), or also for the septal localization of these 
proteins, as the need of ATP binding for the interaction between Wzd and 
Wze would be by-passed by the physical linkage of the two proteins. The 
fact that expression of Wzd-L11-Wze-Citrine, but not Wzd-L11-
Wze(WA)-Citrine (containing a Walker A mutant form of Wze), in the 
unencapsulated strain R36A  resulted in localization at the division 
septum, showed that the ability of Wze to bind ATP is required not only 
for its interaction with Wzd, but also for the correct localization of the 
proteins. However, at this moment, we cannot rule out the possibility that 
the absence of a functional ATP-binding domain may alter the structure of 
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Wze(WA) in such a way that Wzd and Wze(WA) domains cannot interact 
properly in the Wzd-L11-Wze(WA)-Citrine protein. If this were the case, 
it would also result in the inability of the fusion protein to localize at the 
division septum. 
In order to clarify the role of Wzd and Wze in the production of 
capsular polysaccharide, we constructed mutants of the encapsulated 
strain ATCC6314 where the genes encoding these proteins were deleted. 
The synthesis of the capsule in these wzd and wze null mutants seemed to 
be affected, as seen by their reduced ability to agglutinate when incubated 
with serotype specific serum in a Quellung reaction. These results are in 
accordance with previous reports describing that Wzd or Wze mutants 
were not able to produce capsule, as judged by Quellung reactions and 
ELISA experiments [9, 33, 35]. 
However, we have now determined that wzd and wze mutants still 
produce capsule but in a different manner from the parental ATCC6314 
strain. In the encapsulated parental strain the capsule was distributed all 
around the surface of the cells, as expected. However, in the wzd and wze 
null mutants, capsule was produced at lower levels than those found in the 
encapsulated ATCC6314 parental strain, as determined by quantitative 
detection of capsule bound to cells in a dot-blot assay. More interestingly, 
the capsular polysaccharide was absent from the division septum of the 
wzd and wze null mutant cells, but was still present in the mature cell wall 
as determined by a immunofluorescence microscopy assay using a 
purified serum against serotype 14 capsular polysaccharide. A similar 
observation has been made by Morona and colleagues [35], with deletion 
mutants constructed in an encapsulated serotype 19 S. pneumoniae strain. 
The authors explained this observation as resulting from impaired 
synthesis of capsule, where this polysaccharide was synthesized, exported 
and attached to the cell wall at very low basal rate [35]. 
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In theory, absence of the capsule from the division septum of wzd 
and wze null mutants could result in the inability of these mutants to 
attach capsule to the newly assembled peptidoglycan. In fact, 
phosphorylated Wze has been previously proposed to have a role in the 
attachment of capsule to the cell wall [34]. However, we do not favor this 
hypothesis, as we observed that the capsule produced by the wzd and wze 
null mutants was as tightly associated to peptidoglycan as in the parental 
strain (Figure III-9B). The capsular polysaccharide was removed from the 
peptidoglycan only after incubation with hydrofluoric acid, which is 
known to cleave phosphodiester bonds and thus remove teichoic acids and 
polysaccharides covalently bound to the bacterial peptidoglycan, similarly 
to what has been previously described [45]. It should be emphasized that 
the proposed role for Wzd/Wze in attaching the capsule to the cell wall 
has been made based on the characterization of the amount of capsule 
produced by mutants strains constructed in the background of the 
encapsulated serotype 2 S. pneumoniae D39 strain. As different serotypes 
are known to produce variable amounts of capsule polysaccharide, we 
cannot exclude that the absence of Wzd/Wze may affect differently the 
synthesis of the capsule in different serotypes. 
We propose that Wzd/Wze function as spatial regulators of the 
capsular polysaccharide synthesis, ensuring that it occurs at the proper 
place, the division septum, and at the proper time, possibly to ensure the 
concealment of the newly synthesized cell wall. According to this model, 
wild-type Wzd and Wze interact and migrate to the middle of the dividing 
cells, events that are dependent on a functional ATP binding Walker A 
motif of Wze (Figure III-12). At the septum, the complex Wzd/Wze is 
probably subjected to cycles of phosphorylation/dephosphorylation events 
at the C-terminal tyrosine cluster of Wze, which may affect other 
components of the polysaccharide synthesis and assembly complex  
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Figure III-12: Model for the regulation of capsule synthesis by Wzd and 
Wze. Upon ATP binding to the Walker A motif of Wze, the protein is able to 
interact with Wzd and the complex migrates to the cell septum. At the septum, the 
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complex is subjected to cycling phosphorylation/dephosphorylation events at the 
C-terminal tyrosine cluster of Wze. Two hypothesis are proposed for capsular 
polysaccharide synthesis and export at the division site: A) Wzd/Wze function as 
activators of CPS export at the septum, ensuring that it occurs at the correct place; 
or B) Wzd/Wze function themselves as the exporter at the septum, interacting 
with the synthetic machinery and transferring the CPS repeat unit to the outer 
surface of the plasma membrane at this site. Both hypothesis result in the 
expression of capsule all around the surface of the pneumococcal cells. 
 
through conformational changes as previously proposed from the studies 
of the S. aureus Wzd/Wze homologues, CapA and CapB [38]. 
The formation of capsule at the division septum of the 
pneumococcal cells seems to be regulated by Wzd/Wze proteins. If ATP 
is not able to bind to Wze, or in the absence of Wzd or Wze, capsule is 
absent from the septum, where the new cell wall is synthesized, resulting 
in the presence of capsule at the surface of cells only in regions of mature 
cell wall. This raises the hypothesis that there are two modes to synthesize 
the capsular polysaccharide in pneumococcal bacteria (septal and non-
septal), similarly to what has been proposed for peptidoglycan synthesis 
[51]. The absence of capsule from the septum could then be explained by 
the existence of two capsular polysaccharide synthetic machineries or 
alternatively by the activation of the synthetic machinery at the lateral cell 
wall or at the division septum, the latter dependent on the pair Wzd/Wze. 
Why bacteria require such fine-tuned regulation of the synthesis 
of the capsular polysaccharide is unknown. One possibility is that the 
newly synthesized cell wall, located at the septum, has to be concealed or 
covered by the capsular polysaccharide to avoid bacteria recognition by 
the host complement system, or prevent detection by the host innate 
immune system. The pair Wzd/Wze would therefore assure that the 
capsule polysaccharide is produced or exported where it is most needed: 
the division septum of bacteria. 
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Supplementary Information 
 
 
Table SIII-1: Bacterial strains. 
Name Relevant characteristics Comments/Source/ 
Reference 
E. coli   
     DH5 recA endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 80 
dlacZ M15 
Gibco-BRL 
     EC101 supE thi (lacproAB) (F’ traD36 
proAB lacI
q
 ZM15), repA 
from pWV01 integrated in the 
chromosome 
[28] 
     BTH101 Reporter strain for BTH system, 
F
-
 cya-99, araD139, galE15, 
galK16, rpsL1 (Str
r
), hsdR2, 
mcrA1, mcrB1 
[24] 
Lactococcus lactis 
     LL108 RepA
+
 MG1363, Cm
r
  [29]  
 
S. pneumoniae 
  
     R36A Non encapsulated laboratory 
strain 
[6] 
 
     ATCC6314 Encapsulated strain, serotype 14 American Type Culture 
Collection 
     BCSLF001 R36ApBCSLF002, Tet
r
 R36A expressing 
constitutively mCherry, 
this work  
     BCSLF002 ATCC6314pBCSLF002, Tetr ATCC6314 expressing 
constitutively mCherry, 
this work 
     BCSMC001 
 
ATCC6314cps This work 
     BCSMH001 
      
ATCC6314wzd This work 
     BCSMH002 ATCC6314wze This work 
 
     BCSMH003 ATCC6314wzd::wzd_citrine This work 
     BCSMH004 ATCC6314wze::wze_citrine This work 
 
     BCSMH005 ATCC6314pBCSLF001, Tet
r
 ATCC6314 transformed 
with pBCSLF001, this 
work 
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Table SIII-1 (Cont.): Bacterial strains. 
Name Relevant characteristics Comments/Source/ 
Reference 
     BCSMH006 R36ApBCSMH003, Tet
r
 R36A expressing 
constitutively Wze-
mCherry, this work 
     BCSMH007 R36ApBCSMH004, Tet
r
 R36A expressing 
constitutively Wze-
Citrine, this work 
     BCSMH008 R36ApBCSMH007, Tet
r
 R36A expressing 
constitutively Wzd-
Citrine, this work 
     BCSMH009 R36ApBCSMH008, Tet
r
 R36A expressing 
constitutively Wze-
mCherry and Wzd-
Citrine, this work 
     BCSMH010 R36ApBCSMH009, Tet
r
 R36A expressing 
constitutively Wze-
mCherry and Wzd, this 
work 
     BCSMH011 BCSMC001pBCSMH003, Tet
r
 ATCC6314cps 
expressing constitutively 
Wze-mCherry, this work 
    BCSMH012 BCSMC001pBCSMH004, Tet
r
 ATCC6314cps 
expressing constitutively 
Wze-Citrine, this work 
    BCSMH013 BCSMC001pBCSMH007, Tet
r
 ATCC6314cps 
expressing constitutively 
Wzd-Citrine, this work 
    BCSMH014 BCSMC001pBCSMH008, Tet
r
 ATCC6314cps 
expressing constitutively 
Wze-mCherry and Wzd-
Citrine, this work 
    BCSMH015 ATCC6314pBCSMH003, Tet
r
 ATCC6314 expressing 
constitutively Wze-
mCherry, this work 
    BCSMH016 ATCC6314pBCSMH004, Tet
r
 ATCC6314 expressing 
constitutively Wze-
Citrine, this work 
    BCSMH017 ATCC6314pBCSMH005, Tet
r
 ATCC6314 expressing 
constitutively Wze(WA)-
mCherry, this work 
    BCSMH018 ATCC6314pBCSMH006, Tet
r
 ATCC6314 expressing 
constitutively Wze(Y)-
mCherry, this work 
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Table SIII-1 (Cont.): Bacterial strains. 
Name Relevant characteristics Comments/Source/ 
Reference 
    BCSMH019 ATCC6314pBCSMH007, Tet
r
 ATCC6314 expressing 
constitutively Wzd-
Citrine, this work 
    BCSMH020 R36ApBCSLF001, Tet
r
 R36A transformed with 
pBCSLF001, this work 
    BCSMH021 BCSMC001pBCSLF001, Tet
r
 BCSMC001 transformed 
with pBCSLF001, this 
work 
    BCSMH022 BCSMH001pBCSMH007, Tet
r
 ATCC6314wzd 
expressing constitutively 
Wzd-Citrine, this work 
    BCSMH023 BCSMH002pBCSMH004, Tet
r
 ATCC6314wze 
expressing constitutively 
Wze-Citrine, this work 
    BCSMH024 ATCC6314pBCSMH015, Tet
r
 ATCC6314 expressing 
constitutively 
Wze(WA2)-mCherry, 
this work 
    BCSMH025 BCSMH001pBCSMH016, Tet
r
 ATCC6314wzd 
expressing constitutively 
Wzd, this work 
    BCSMH026 BCSMH002pBCSMH017, Tet
r
 ATCC6314wze 
expressing constitutively 
Wze, this work 
     BCSTR001 R36ApBCSTR001, Tet
r
 R36A expressing 
constitutively Wzd–L11-
Wze-Citrine, this work 
     BCSTR002 R36ApBCSTR002, Tet
r
 R36A expressing 
constitutively Wzd–L11-
Wze(WA)-Citrine, this 
work 
    BCSTR003 BCSMH001pBCSTR001, Tet
r
 ATCC6314wzd 
expressing constitutively 
Wzd-L11-Wze-Citrine, 
this work 
    BCSTR004 BCSMH002pBCSTR001, Tet
r
 ATCC6314wze 
expressing constitutively 
Wzd-L11-Wze-Citrine, 
this work 
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Table SIII-2: Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
 
Replicative plasmids in E. coli 
 
     pRod17 Plasmid containing the mCherry 
coding sequence 
David Sherrat 
 
     
pcDNA3_Citrine 
Plasmid containing the Citrine 
coding sequence 
[19] 
 
 
Plasmids for Bacterial Two Hybrid Assay 
     pKT25 BTH plasmid, N-terminal cyaAT25 
fusion, Kan
r
 
[24] 
     pUT18C BTH plasmid, N-terminal cyaAT18 
fusion, Amp
r
 
[24] 
     pKT25zip BTH control plasmid, Kan
r 
[24] 
     pUT18Czip BTH control plasmid, Amp
r
 [24] 
     pBCSMC001 BTH plasmid containing cyaAT25-
wzd fusion 
This work 
 
     pBCSMC002 BTH plasmid containing cyaAT18-
wze fusion 
This work 
 
     pBCSMC003 BTH plasmid containing cyaAT18-
wze(WA) fusion 
This work 
 
     pBCSMC004 BTH plasmid containing cyaAT18-
wze(Y) fusion 
This work 
 
     pBCSMH014 BTH plasmid containing cyaAT18-
wze(WA2) fusion 
This work 
 
 
Replicative plasmids in S. pneumoniae 
 
     pLS578 Contains the extended -10 
constitutive promoter of SigA from 
S. pneumoniae, Tet
r
 
[27] 
     pBCSLF001 High-copy-number vector, contains 
the -10 constitutive promoter of 
SigA from S. pneumoniae, Tet
r
 
This work 
     pBCSLF002 pBCSLF001 derivative, mCherry 
constitutive expression, Tet
r
 
This work 
     pBCSMH001 pBCSLF002 derivative, allows 
expression of mCherry fusion 
proteins, Tet
r
 
This work 
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Table SIII-2 (Cont.): Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
   
     pBCSMH002 pBCSLF001 derivative, allows 
expression of Citrine fusion 
proteins, Tet
r
 
This work 
     pBCSMH003 pBCSMH001 containing wze-
mCherry, Tet
r
 
This work 
 
     pBCSMH004 pBCSMH002 containing wze-
citrine, Tet
r
 
This work 
 
     pBCSMH005 pBCSMH001 containing wze(WA)-
mCherry, Tet
r
 
This work 
 
     pBCSMH006 pBCSMH001 containing wze(Y)-
mCherry, Tet
r
 
This work 
 
     pBCSMH007 pBCSMH002 containing wzd-
citrine, Tet
r
 
This work 
 
     pBCSMH008 pBCSMH001 containing wze-
mCherry, wzd-citrine, Tet
r
 
This work 
 
     pBCSMH009 pBCSMH001 containing wze-
mCherry, wzd, Tet
r
 
This work 
 
     pBCSMH015 pBCSMH001 containing 
wze(WA2)-mCherry, Tet
r
 
This work 
 
     pBCSMH016 Derivative of pBCSMH007 in 
which citrine was removed, Tet
r
 
This work 
     pBCSMH017 Derivative of pBCSMH004 in 
which citrine was removed, Tet
r
 
This work 
     pBCSTR001 pBCSMH002 containing wzd-L11-
wze-citrine, Tet
r
 
This work 
 
     pBCSTR002 pBCSMH002 containing wzd-L11-
wze(WA)-citrine, Tet
r
 
This work 
 
 
Non replicative plasmids in S. pneumoniae  
 
     pORI280 Em
r
, LacZ
+
, ori
+
 of pWV01 [29] 
     pBCSMC005 pORI280 containing up- and 
downstream regions of cps operon, 
Em
r
, LacZ
+
 
This work 
     pBCSMH010 pORI280 containing the 3’ of wzd, 
the entire citrine sequence, and the 
downstream region of wzd, Em
r
, 
LacZ
+
 
This work 
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Table SIII-2 (Cont.): Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
     pBCSMH011 pORI280 containing the 3’ of wze, 
the entire citrine sequence, and the 
downstream region of wze, Em
r
, 
LacZ
+
 
This work 
     pBCSMH012 pORI280 containing up- and 
downstream regions of wzd, Em
r
, 
LacZ
+
 
This work 
     pBCSMH013 pORI280 containing up- and 
downstream regions of wze, Em
r
, 
LacZ
+
 
This work 
 
 
Table SIII-3: Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
1 CGGGATCCCGGCTGCTTGCGGCCAATCAGG BamHI 
2 AATATCATCACTGTTCTTGAAGGCACCTATAC
CTTGAACATCG 
Region 
overlapping 
primer 3 
3 CCTTCAAGAACAGTGATGATATTGAGATTGT
TAAAATCTTGCG 
Region 
overlapping 
primer 2 
4 GAACTGCAGCCTTTAAAACTTTCTCTCCA PstI 
5 CGCGGATCCGGCGCAGAGATATACTATAC BamHI 
6 CTCCCAAAAGTGTCATCTGCACTAAATTAATT
GATCCATTATAA 
Region 
overlapping 
primer 7 
7 GCAGATGACACTTTTGGGAGTTGTACC Region 
overlapping 
primer 6 
8 CCGGAATTCGTGATAATTACCGCATCAATAA
C 
EcoRI 
9 CGCGGATCCATCAAGACTTGCAGGCAGG BamHI 
10 GCGTAAACTCCATACTTATCAACCGACTATTT
CAACTTACTC 
Region 
overlapping 
primer 11 
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Table SIII-3 (Cont.): Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
11 GGTTGATAAGTATGGAGTTTACGCTTCCTATG
G 
Region 
overlapping 
primer 10 
12 CCGGAATTCCTGCTACCAGTTTCCATGAAAG EcoRI 
13 CGCGGATCCGAAGTCTGGTTTAACCAATC BamHI 
14 CTCCCAAAAGTGTCATCTGCTTACTTGTACAG
CTCGTCCATGCCGAGAGTG 
Region 
overlapping 
primer 15 
15 GGACGAGCTGTACAAGTAAGCAGATGACACT
TTTGGGAGTTGTACC 
Region 
overlapping 
primer 14 
16 CCGGAATTCCCGCATCAATAACAATTCCAAC
AGG 
EcoRI 
17 CGCGGATCCGCAAGGTCGTTTGCGCGTGC BamHI 
18 GCGTAAACTCCATACTTATCAACCTTACTTGT
ACAGCTCGTCCATGCCG 
Region 
overlapping 
primer 11 
19 CCGGAATTCCACTTACTGCTACCAGTTTCC EcoRI 
20 AGCTAGCAACCATGGATTAGATCTCAGAATT
GCAGATAGGC 
NheI, NcoI, 
BglII 
21 AGCTAGCCTACCTCCTTAAGC NheI 
22 AGCTAGCATGATTACGGGTACCAGCTCGGC NheI, KpnI 
23 AACCATGGCCTACACCCGGGTTACATAGAGC
GGCCGCCTTGTACAGCTCGTCCATGC 
NcoI, NotI 
24 GGACTAGTGTGAGCAAGGGCGAAGAAGATA
ACATGGCTATC 
SpeI 
25 GGACTAGTGCCAGAACCAGCAGCGGAGCC SpeI 
26 GGATTAGATCTCAGGAATTG BglII 
27 CCCTTGCTCACACTAGTGCC SpeI 
28 GGACTAGTGGGCCCGCCGGCATGGTGAGCAA
GGGCG 
SpeI, ApaI, 
NaeI 
29 GAAGATCTAATCCATGGCATATGAGCGGCCG
CCTTGTACAGCTCGTCC 
BglII, NotI 
30 CTAGCTAGCATGCCGACATTAGAAATAGCAC NheI 
31 CGGGGTACCTTTTTTACCATAATTTCCATAGG
AAGC 
KpnI 
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Table SIII-3 (Cont.): Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
32 CCCTGGGGAAGCAGCAACAACTACTTCCG Mutation of 
Walker A 
motif (G48A; 
K49A); 
region 
overlapping 
primer 33 
33 CGGAAGTAGTTGTTGCTGCTTCCCCAGGG Mutation of 
Walker A 
motif (G48A; 
K49A); 
region 
overlapping 
primer 32 
34 CGGGGTACCTTTTTTACCAAAATTTCCAAAG
GAAGCGAAAACTCCAAACTTATCAACCG 
Mutation of 
the C-
terminal 
tyrosines of 
Wze; KpnI 
35 CTAGCTAGCATGAAGGAACAAAACACTTTGG NheI 
36 GGGGTACCCTATTTCAACTTACTCAAG KpnI 
37 CATGCCATGGTAAGGAGGTGCTGCGGCCAT
GAAGGAACAAAACAC 
RBS; NcoI 
38 GGAAGATCTCTTGTACAGCTCGTCCATGCC BglII 
39 GAAGATCTCTATTTCAACTTACTCAAG- BglII 
40 TCCTTTAATAGTTTTAACAGATCCTCTCTCCG
CTTTCAAC 
Region 
overlapping 
primer 41 
41 TCTGTTAAAACTATTAAAGGAATGCCGACAT
TAGAAATAGC 
Region 
overlapping 
primer 40 
42 GGGGATCCCGGAGAAAATATGAAGG BamHI 
43 GAATTCCCCTCTCTCCTATTTC EcoRI 
44 GGATCCAATGCCGACATTAGA BamHI 
45 GAATTCCCCTAAGTTATTTTTTACC EcoRI 
46 CCCTGGGGAAGGAATGACAACTACTTCCG Mutation of 
Walker A 
motif 
(K49A); 
region 
overlapping 
primer 53 
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Table SIII-3 (Cont.): Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
47 CGGAAGTAGTTGTCATTCCTTCCCCAGGG Mutation of 
Walker A 
motif 
(K49A); 
region 
overlapping 
primer 52 
48 GGATTAGATCTCGGAGCCAGCCGAGCTGGTA
CCCTATTTCAACTTACTCAAG 
BglII 
49 GGATTAGATCTCGGAGCCAGCCGAGCTGGTA
CCCTATTTTTTACCATAATTTCC 
BglII 
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Supplementary figures 
 
Figure SIII-1: Functionality of the different Wzd and Wze fluorescent 
derivatives. Fluorescent derivatives of Wzd and Wze are functional as they 
complement the production of capsule in Wzd and Wze null mutants. 
Chapter III 
 
 
- 154 - 
 
Representative brightfield images of the agglutination resulting from Quellung 
reactions, with a purified serotype 14 specific serum, are shown: whole fields on 
the right hand side of the figure (scale bar, 10 µm) and zoomed view of chosen 
sections on the left hand side of figure (scale bar, 2 µm). The strains were the 
following: i and i’) BCSMC001 (∆cps); ii and ii’) ATCC6314 (WT); iii and iii’) 
BCSMH001 (∆wzd); iv and iv’) BCSMH002 (∆wze); v and v’) BCSMH003 
(ATCC6314wzd::wzd_citrine); vi and vi’) BCSMH004 
(ATCC6314wze::wze_citrine); vii and vii’) BCSMH022 (∆wzd expressing Wzd-
Citrine constitutively); viii and viii’) BCSMH023 (∆wze expressing Wze-Citrine 
constitutively); ix and ix’) BCSTR003 (∆wzd expressing Wzd-L11-Wze-Citrine 
constitutively); x and x’) BCSTR004 (∆wze expressing Wzd-L11-Wze 
constitutively); xi and xi’) BCSMH025 (∆wzd expressing Wzd constitutively); xii 
and xii’) BCSMH026  (∆wze expressing Wze constitutively). 
 
Figure SIII-2: Detection of tyrosine phosphorylated Wze derivatives. 
Analysis by western-blotting with a primary antibody against phosphorylated 
tyrosines. A) Strains R36A, ATCC6314 (parental encapsulated strain) and 
BCSMC001 (ATCC6314∆cps) expressing constitutively the following proteins: 
1) control, empty plasmid (strains BCSMH020 and BCSMH021; 2) Wze-
mCherry (strains BCSMH006, BCSMH015 and BCSMH011); 3) Wze-mCherry 
and Wzd (strain BCSMH010); 4) Wze-mCherry and Wzd-Citrine (strains 
BCSMH009 and BCSMH014). The bands correspondent to Wze-mCherry and to 
Wze alone are indicated. Wze-mCherry is only detected, as it is phosphorylated, 
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in the presence of Wzd. Non-specific bands, present in all strains, are labeled with 
“*”. B) the Wzd-L11-Wze chimera is phosphorylated. Strains analysed: 
BCSTR001 (R36A expressing constitutively Wzd-L11-Wze) in lane  (1);  
BCSTR002 (R36A expressing constitutively Wzd-L11-Wze(WA) in lane (2). The 
band correspondent to the phosphorylated form of Wzd-L11-Wze is indicated. 
 
 
Figure SIII-3: Analysis of Citrine fluorescent derivatives. A) Fluorescent 
protein analysis by SDS-PAGE. Total cell extracts were loaded in each lane 
showing that the Wze-Citrine fluorescent derivative is expressed at similar levels 
from the constitutive promoter in plasmid pBCSMH004 (lane 1, strain 
BCSMH016) and from its native promoter (lane 2, strain BCSMH004). B) 
Western-blot analysis, with a primary antibody against the Citrine protein, 
showing that Wze-Citrine and Wzd-Citrine are expressed at similar levels from 
their native promoter and do not suffer proteolytic cleavage. Strains BCSMC001 
(ATCC6314cps), ATCC6314 (encapsulates parental strain), BCSMH004 
(ATCC6314wze::wze-citrine) and BCSMH003 (ATCC6314wzd::wzd-citrine) 
were analysed. 
 
 
Figure SIII-4: SDS-PAGE fluorescent protein analysis after cell 
fractionation. Strains analysed: R36A, BCSMH008 (R36A expressing Wzd-
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Citrine constitutively) and BCSMH007 (R36A expressing Wze-Citrine 
constitutively). Total cell extracts ultracentrifuged during 20 minutes at 20 Krpm 
had similar amounts of Wzd-Citrine and Wze-Citrine. However, when these 
samples were ultracentrifuged during 45 minutes at 80 Krpm, the membrane 
Wzd-Citrine protein was pulled down into the pellet fraction, while the 
cytoplasmic Wze-Citrine protein remained in the supernatant. 
 
 
Figure SIII-5: Co-localization of Wzd-Citrine and Wze-mCherry on the 
capsule null mutant strain BCSMC001. Fluorescence microscopy images of 
representative fields are shown. Scale bar 2 m. i) BCSMH011, expressing 
constitutively Wze-mCherry; ii) BCSMH013, expressing constitutively Wzd-
Citrine; iii) BCSMH014, expressing constitutively Wze-mCherry and Wzd-
Citrine. Fluorescence ratios determined for the Wzd-Citrine localization in the 
strains above are shown in the lower panel. 
 
Synthesis of CPS at the division septum of S. pneumoniae 
 
- 157 - 
 
 
Figure SIII-6: SDS-PAGE analysis of total cell extracts of unencapsulated 
strains R36A and BCSMC001 (ATCC6314cps) co-expressing Wzd and Wze 
fluorescent derivatives. R36A strains: BCSMH006, expressing Wze-mCherry; 
BCSMH008, expressing Wzd-Citrine; BCSMH010, expressing Wze-mCherry 
and Wzd; and BCSMH009, expressing Wze-mCherry and Wzd-Citrine. 
BCSMC001 strains: BCSMH011, expressing Wze-mCherry; BCSMH013, 
expressing Wzd-Citrine; and BCSMH014, expressing Wze-mCherry and Wzd-
Citrine. Proteins Wze-mCherry and Wzd-Citrine are indicated by arrows. 
 
 
Figure SIII-7: Fluorescence microscopy images of strains expressing 
mCherry alone. i) strain BCSLF001, R36A transformed with pBCSLF002; ii) 
strain BCSLF002, ATCC6314 transformed with pBCSLF002. Scale bar 2 m. 
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Abstract 
 
 The capsule or capsular polysaccharide (CPS) is a major virulence 
factor of Streptococcus pneumoniae and its production, at the surface of 
the cells at different stages of infection, is tightly regulated. Wze, an 
autophosphorylating tyrosine kinase, and Wzd, a membrane protein 
required for Wze autophosphorylation, are the main regulators of this 
process. Wzd and Wze were shown to regulate the polymerization of the 
CPS and its attachment to the cell wall. More recently, we have proposed 
that Wzd/Wze act as spatial regulators of capsule synthesis and ensure full 
encapsulation of pneumococcal bacteria. However, how the Wzd/Wze 
complex carries out this function remains unknown. 
 In the present work, we performed a Bacterial Two-Hybrid 
screening (BTH) for interactions between components of the Wzd/Wze 
complex and other proteins involved in the assembly and regulation of the 
synthesis of capsule. No interactions were found between Wzd, or Wze, 
and the following proteins: Wzh (a phosphotyrosine phosphatase that 
dephosphorylates Wze), Wzx (the flippase that translocates the CPS 
repeating unit across the membrane) and Wzy (the polymerase that 
assembles the CPS). Interestingly, we found that Wzd interacts with Wzg, 
the CPS-cell wall ligase, in the BTH assay. In accordance, fluorescent 
derivatives of Wzg accumulated at the septum of the pneumococcal cells 
only when Wzg fusions were produced in the presence of functional 
Wzd/Wze. We hypothesize that the Wzd/Wze complex recruits Wzg to 
the septum to ensure the efficient attachment of the CPS to the cell wall at 
that particular site. In this way, the S. pneumoniae cell surface is fully 
encapsulated and protected by the capsular polysaccharide. 
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Introduction 
 
 Streptococcus pneumoniae is an important Gram-positive 
bacterial pathogen, which can colonize asymptomatically the nasopharynx 
of healthy individuals. Having the ability to spread to other sites of the 
human host, it is also capable of causing diseases such as otitis media, 
pneumonia or even meningitis [14]. The expression of capsule or capsular 
polysaccharide (CPS) is central to the ability of pneumococcus to cause 
invasive disease. This structure surrounds the surface of the bacteria, 
acting as a shield that confers protection against the host’s immune 
system. However, a thick capsule may be disadvantageous during the 
colonization stage of infection, by preventing the exposure of bacterial 
molecules required for surface adhesion [14]. Therefore, a tight control of 
the amount of CPS expressed is expected to occur during the infection 
process. 
 To date, more than 90 types of capsular polysaccharide have been 
identified [4]. In the majority of them, the genes that encode proteins 
involved in CPS synthesis and regulation are located at the same region of 
the S. pneumoniae chromosome: the cps operon [3]. The 5’ end of this 
operon is highly conserved between serotypes and is constituted by four 
genes, the products of which are proposed to be involved in CPS synthesis 
regulation [3], as discussed below. The 3’ end of the cps operon is the 
serotype specific region of the locus, comprising genes that encode the 
enzymes necessary for the formation of the specific capsule repeating unit 
of each serotype [3]. This region also includes the genes that encode the 
proteins responsible for the transfer of the CPS repeating units from the 
inner to the outer face of the plasma membrane, Wzx, and for the 
polymerization of the CPS, Wzy. 
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The first gene in the cps operon, wzg, encodes an enzyme whose 
function was discovered only recently. Wzg was initially identified as a 
transcriptional regulator, based on its homology with LytR from Bacillus 
subtilis [9], but more recently Kawai and colleagues have determined that 
Wzg is in fact the long searched CPS-cell wall ligase [16]. 
The other genes of the conserved region of the cps operon, wzh, 
wzd, and wze, encode three proteins that are part of a phosphoregulatory 
system required to control the synthesis of the capsule and its attachment 
to the cell-wall. Wze is an autophosphorylating tyrosine kinase that 
belongs to the Bacterial Tyrosine Kinase family [8]. It possesses the 
conserved motifs characteristic of this protein family: a Walker A ATP 
binding motif and a C-terminal tyrosine cluster [26]. Wzd is a membrane 
protein that is required for the autophosphorylation of Wze [2]. Wzh is a 
phosphotyrosine protein phosphatase that dephosphorylates Wze [24]. 
These three proteins are proposed to regulate the capsule synthesis process 
in the following way [25]: Wze, upon ATP binding to its Walker A motif, 
interacts with Wzd in such a way that CPS synthesis proceeds at its 
maximal level until an unknown signal causes Wze to autophosphorylate 
its C-terminal tyrosines. This probably leads to conformational changes 
that alter the interaction with Wzd and with other members of the CPS 
synthesis machinery, causing a decrease in the CPS synthesis rate. At the 
same time the transfer of the CPS to the CPS-cell wall ligase Wzg is 
favored. When Wzh dephosphorylates Wze, the cycle can be repeated. 
Recently, we have identified a novel role for Wzd and Wze as 
spatial regulators of capsule synthesis [13]. These two proteins were 
found to localize at the septum, in the presence of each other, with no 
additional factor encoded in the cps operon being required for that 
localization. Moreover, in the absence of Wzd or Wze, capsule was 
synthesized and attached to the cell wall, but it was absent from the 
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division septum of the cells, the site where the two proteins localize and 
where cell wall synthesis occurs. Therefore, we proposed that Wzd and 
Wze function as spatial regulators of capsule synthesis, ensuring that it 
occurs at the division septum, possibly to conceal newly synthesized cell 
wall [13]. 
In this work, we wanted to determine how Wzd and Wze can 
spatially regulate the CPS synthesis. We hypothesized that Wzd/Wze 
could recruit other proteins from the CPS synthesis machinery to a septal 
location, or alternatively, that they could activate other members of the 
CPS synthesis machinery at that site. This chapter describes the 
preliminary results obtained in our attempt to test these hypotheses. Using 
a Bacterial Two-Hybrid system, we asked whether proteins Wzd and Wze 
could interact with other proteins of the CPS synthesis machinery. We 
identified a putative interaction between protein Wzd and Wzg, the CPS-
cell wall ligase, which was also found to be capable of interacting with 
itself. Moreover, analysis of the in vivo localization of Wzg revealed that 
it is associated with the membrane and enriched at the septal region. In 
accordance with a possible interaction of Wzd with Wzg, the ability of 
Wzg to localize at the division septum was dependent on the presence of 
Wzd/Wze. 
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Materials and Methods 
 
Bacterial strains and growth conditions 
 Bacterial strains and plasmids used in this study are listed in 
Tables SIV-1 and SIV-2, respectively, in Supplementary Information. E. 
coli was routinely grown in LB medium at 37ºC, unless otherwise 
indicated. When appropriate, ampicillin (100 g/ml), kanamycin (50 
g/ml) and erythromycin (100 g/ml) were added to the growth media. 
Isopropyl--thiogalactopyranoside (IPTG, Apollo Scientific Ltd.) was 
used at 0.5 mM and 5-bromo-4-chloro-3-indolyl--D-galactopyranoside 
(X-Gal, Apollo Scientific Ltd.) at 40 g/ml. 
 S. pneumoniae was grown in C + Y liquid medium [18] at 37ºC, 
without aeration, or in tryptic soy agar (TSA, Difco) plates supplemented 
with 5% sheep blood (Probiológica). When needed, tetracycline (1 g/ml) 
and erythromycin (0.25 g/ml) were added to the growth media. For 
white/blue colony selection, X-Gal was used at 120 g/ml. Lactococcus 
lactis was grown in M17 broth (Difco), supplemented with glucose (0.5% 
w/v), at 30ºC. Erythromycin was used at 100 g/ml. 
 
DNA manipulation procedures 
 E. coli and S. pneumoniae competent cells preparation and 
transformation were executed as previously described [22, 28]. PCR 
products and plasmid DNA were purified with kits Wizard® SV Gel and 
PCR Clean-up System and Wizard ® Plus SV Minipreps, respectively 
(Promega). PCR fragments were amplified with Phusion High-Fidelity 
DNA polymerase (Finnzymes). Restriction enzymes used were acquired 
from New England Biolabs or from Fermentas. The primers used in this 
work are listed in Table SIV-3 in Supplementary Information. 
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Construction of plasmids for Bacterial Two-Hybrid assays 
 In order to test in vitro whether Wzd and Wze could interact with 
other capsule proteins, several plasmids were constructed. All genes were 
amplified using ATCC6314 chromosomal DNA, unless otherwise 
indicated. 
Plasmids pBCSMC005, pBCSMH040 and pBCSMC007, 
encoding fusion proteins T18-Wzd, Wzd-T18 and Wzd-T25, were 
constructed by amplification of wzd with primers 1/2, 3/4 and 5/6, 
respectively, followed by restriction and ligation into plasmids pUT18C, 
pUT18 and pKNT25. 
Amplification of wze with primers 7/8, followed by restriction and 
ligation into pUT18 and pKNT25 produced plasmids pBCSMC006 and 
pBCSMC009, encoding fusions Wze-T18 and Wze-T25, respectively. 
Plasmid pBCSMC008, encoding fusion T25-Wze, was obtained by 
amplification of wze with primers 9/10 and cloning into pKT25. 
Construction of plasmid pBCSMH041, which allows the co-
expression of Wzd with T18-Wze was achieved by amplification of wzd 
with primers 11/12, restriction and ligation into pBCSMC002. The same 
approach was followed for the construction of pBCSMH042, in which 
Wze is co-expressed with Wzd-T18. In this case, wze was amplified with 
primers 13/14 and cloned into pBCSMH040. Plasmids pBCSMH045 and 
pBCSMH046, in which Wzd is co-expressed with T25-Wze and Wze is 
co-expressed with T25-Wzd, respectively, were obtained by amplification 
of wzd with primers 11/12 and wze with primers 8/16, restriction and 
ligation into pBCSMC008 and pBCSMC001. 
Cloning of the fusion protein Wzd-L11-Wze into the Bacterial 
Two-Hybrid plasmids was executed using plasmid pBCSTR001 as DNA 
template for the amplification reaction. For the construction of 
pBCSMH043 and pBCSMH047, encoding fusions T18-Wzd-L11-Wze 
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and T25-Wzd-L11-Wze, respectively, primers 10/15 were used, followed 
by restriction and ligation into pUT18C and pKT25. Construction of 
pBCSMH044 and pBCSMH048, encoding fusions Wzd-L11-Wze-T18 
and Wzd-L11-Wze-T25, respectively, was done using primers 8/15, 
restriction and ligation into pUT18 and pKNT25. 
Plasmids pBCSMH049 and pBCSMH051, encoding T18-Wzg 
and T25-Wzg, was achieved by amplification of wzg with primers 17/18, 
restriction and ligation into pUT18C and pKT25. Amplification of wzg 
with primers 17/19, restriction and ligation into pUT18 and pKNT25 
produced plasmids pBCSMH050 and pBCSMH052, encoding the fusions 
Wzg-T18 and Wzg-T25, respectively. 
The amplification of wchA with primer pairs 20/21 and 20/22, 
followed by restriction and ligation into pUT18C and pUT18, 
respectively, produced plasmids pBCSMH053 and pBCSMH054. These 
encode the fusions T18-WchA and WchA-T18. Construction of plasmids 
encoding the fusions T18-Wzx (pBCSMH055), Wzx-T18 (pBCSMH056), 
T18-Wzy (pBCSMH057) and Wzy-T18 (pBCSMH058) was done by 
amplification of wzx with primer pairs 23/24 and 23/25 and of wzy with 
primer pairs 26/27 and 26/28, respectively, restriction and ligation into 
pUT18C and pUT18. 
Plasmids pBCSMC010 and pBCSMC012, encoding fusions T18-
Wzh and T25-Wzh were done by amplification of wzh with primers 29/30, 
restriction and ligation into pUT18C and pKT25. Amplification of wzh 
with primers 31/32, restriction and ligation into pUT18 and pKNT25 
produced plasmids pBCSMC011 and pBCSMC013, encoding the fusions 
Wzh-T18 and Wzh-T25, respectively. 
The nucleotide sequences of the modified regions of the 
constructed plasmids were confirmed by sequencing. 
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Construction of plasmids for protein expression in S. pneumoniae 
 In order to express fluorescent derivatives of Wzg, plasmid 
pBCSMH039 was constructed by amplification of wzg from the 
ATCC6314 chromosomal DNA with primers 33/34, restriction and 
ligation into pBCSMH031. 
 
Construction of the wzg null mutant 
 In order to construct strains BCSMH057-059, derivatives of the 
encapsulated ATCC6314 strain in which the wzg gene is deleted, plasmid 
pORI280 was used. Fragments of DNA corresponding to the upstream 
and downstream regions of the wzg gene were amplified with primers 
35/36 and 37/38, respectively. Primers 36 and 37 possess an overlapping 
region. After this first amplification, the two fragments were joined by 
overlapping PCR using primers 35 and 38. The resulting fragment was 
restricted with BamHI and EcorI and cloned into pORI280, producing 
plasmid pBCSMH059. This plasmid was transformed into strain 
ATCC6314 and transformants were selected by their ability to grow in the 
presence of erythromycin. Excision of pBCSMH059 was executed as 
previously described [17] and produced strains BCSMH057-059. In the 
construction of these mutants ~50 bp of the 3’ region of the wzg gene 
were left intact, to guarantee that the expression of the downstream gene 
on the operon was not disturbed. 
 Plasmids were routinely propagated in E. coli EC101 or L. lactis 
LL180 and purified before being transformed into S. pneumoniae bacteria. 
 
Bacterial Two-Hybrid assays 
 Interactions were tested by transformation of E. coli strain 
BTH101 with plasmids of interest. Transformants were plated in LA 
media, supplemented with ampicillin, kanamycin, IPTG and X-Gal, at the 
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concentrations indicated above. Plates were incubated at 30ºC and 
screened for blue/white colonies, in which blue indicated a positive 
interaction. 
 
Microscopy 
 S. pneumoniae strains were grown until early exponential phase 
and observed by fluorescence microscopy on a thin layer of 1% agarose in 
PreC medium [18]. Images were acquired in a Zeiss Axio Observer  
microscope, equipped with a Photometrics CoolSNAP HQ2 camera 
(Roper Scientific) and analyzed and cropped using Metamorph (Meta 
Imaging series 7.5) and Image J software [1]. 
 Determination of the Fluorescence ratio (FR) was performed as 
previously described [27]. The intensity of the fluorescent signal by 
quantifying the fluorescence at the septum was divided by the fluorescent 
signal at the poles. Average background fluorescence was subtracted from 
every value. An FR value higher than 2 is indicative of a septal 
localization. Quantification was performed for at least 100 cells of each 
strain. 
 In vivo detection of the capsule produced at the surface of S. 
pneumoniae cells was performed as previously described [13]. 
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Results 
 
Screening for CPS proteins capable of interacting with Wzd/Wze 
 
 Following the finding that Wzd and Wze act as spatial regulators 
of capsule synthesis in S. pneumoniae [13], it was our goal to discover 
how these two proteins were capable of performing that role. Using a 
Bacterial Two-Hybrid assay, we previously detected a positive interaction 
between proteins Wzd and Wze [13]. Therefore, we decided to test 
whether Wzd/Wze could interact with other capsule synthesis proteins 
using the same method. We chose Wzh, Wzg, WchA, Wzx, and Wzy as 
the first targets of our screening and tested them for interactions with 
Wzd, Wze and Wzd co-expressed with Wze. The results obtained are 
summarized in figure IV-1. No interactions were found between Wzd or 
Wze and proteins WchA, Wzx and Wzy. Surprisingly, interactions were 
also not detected between Wze and Wzh, the cognate phosphatase of the 
Wze tyrosine kinase [24]. However, qualitative analysis of the color of the 
colonies transformed with plasmids encoding the fusions Wzd-T18 and 
T25-Wzg revealed that they were blue, albeit less intense than the color 
observed with the positive control (data not shown), suggesting a possible 
interaction between Wzd and Wzg (Figure IV-1). 
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Figure IV-1: Summary of the interactions tested between Wzd and Wze and 
other capsule proteins. Interactions between Wzd and Wze and capsule proteins 
Wzh, Wzg, WchA, Wzx and Wzy were tested using a bacterial two-hybrid 
system. A positive interaction was detected only when Wzd-T18 and T25-Wzg 
were co-expressed (n.d. – not determined). 
 
Wzg, the CPS-cell wall ligase, interacts with Wzd and with itself in a 
BTH assay 
 
 The weak signal observed when Wzd-T18 and T25-Wzg were 
expressed could be explained if Wzg can interact better with the pair 
Wzd/Wze than with Wzd alone. We extended our screening to include 
additional plasmids that allowed the co-expression of Wzd and Wze in 
different combinations and the expression of a chimera protein of Wzd 
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linked to Wze through an 11 aminoacid linker (Figure IV-2). A 
fluorescent derivative of the latter, designated Wzd-L11-Wze, was shown 
to localize at the septum of S. pneumoniae encapsulated and 
unencapsulated cells [13]. 
 
 
Figure IV-2: Wzg may interact with Wzd and with itself. Three colonies of 
each bacterial two-hybrid transformation with plasmids encoding the indicated 
fusions were re-streaked to show the blue/white color. Positive and negative 
controls, constituted by transformation with plasmid pairs pUT18C-zip/pKT25-
zip and pUT18C/pKT25, respectively, are shown at the top. A) Interactions 
between protein Wzg and proteins Wzd, Wze, Wzd and Wze co-expressed in 
different combinations and Wzd-L11-Wze. B) Interactions of Wzg with itself. 
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In this extended screening, we confirmed that the fusion protein 
T25-Wzg may interact with the fusion Wzd-T18, as expression of these 
proteins again produced light blue colonies. The same result was obtained 
when T25-Wzg was expressed with T18-Wzd and with Wzd-T18 in the 
presence of Wze, as well as with T18-Wze in the presence of Wzd (Figure 
IV-2A). No interactions were observed between T18-Wzg and Wzd or 
Wze. Only a weak signal was observed when T18-Wzg was co-expressed 
with T25-Wze in the presence of Wzd, with T25-Wzd in the presence of 
Wze and with T25-Wzd-L11-Wze (Figure IV-2A). Linking T18 or T25 to 
the C-terminus of Wzg seems to abolish its ability to interact with Wzd or 
Wze. Interactions between fusions Wzg-T18 and Wzg-T25 and the 
different Wzd and Wze fusions described above produced only white 
colonies (data not shown). 
Furthermore, we also asked whether Wzg could interact with 
itself. The expression of fusions T18-Wzg and T25-Wzg produced blue 
colonies on X-Gal plates, indicating that the CPS-cell wall ligase Wzg 
may interact with itself (Figure IV-2B). No interactions were detected for 
fusions Wzg-T18 and Wzg-T25. 
 
Wzg septal localization is dependent on the expression of Wzd/Wze 
 
 Following the indication that Wzg may interact with Wzd, we 
decided to determine whether fluorescent derivatives of Wzg would also 
localize to where Wzd is normally found, the division septum of 
encapsulated bacteria. For that purpose, we constructed an N-terminal 
fusion of Wzg to iCFP, an improved version of CFP for in vivo 
localization of proteins in S. pneumoniae, recently developed by us [12]. 
The plasmid expressing iCFP-Wzg was transformed into the wild-type 
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ATCC6314 encapsulated strain (producing strain BCSMH053), into an 
unencapsulated derivative that lacks the cps operon (producing strain 
BCSMH054), into the ATCC6314 wzd null mutant (producing strain 
BCSMH055) and into the ATCC6314 wze null mutant (producing strain 
BCSMH056). The resulting strains were observed by fluorescence 
microscopy (Figure IV-3A). 
 
Figure IV-3: A fluorescent derivative of Wzg localizes to the division septum 
of S. pneumoniae cells, in a Wzd/Wze dependent manner. A) Localization of 
iCFP-Wzg fusion in the S. pneumoniae encapsulated strain (BCSMH053), the 
capsule null mutant strain (BCSMH054), the wzd null mutant strain 
(BCSMH055) and the wze null mutant strain (BCSMH056). Representative 
images are shown. Exposure times: Phase 100 msec, CFP 5000 msec. Scale bar, 2 
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m. B) Fluorescence ratios determined for the strains above: BCSMH053, n= 
117; BCSMH054, n= 108; BCSMH055, n= 105; BCSMH056, n= 112. 
 
The iCFP-Wzg fusion was found to be localized at the membrane 
of the cells (Figure IV-3A), in accordance with the prediction of its three 
transmembrane spanning regions. Interestingly, in the encapsulated strain 
(BCSMH053) there seemed to be an enrichment of the fluorescent signal 
at the septal region of the cells. This enrichment was not observed in the 
unencapsulated strain, or in the wzd and wze null mutants (Figure IV-3A). 
In order to confirm the patterns of localization observed when 
iCFP-Wzg was expressed in the different strains, we determined the 
fluorescence ratio for each strain, as described in the Materials and 
Methods section. FR values higher than 2 indicate that a protein is 
localized at the septum of the cells and not spread throughout the entire 
membrane. This quantification confirmed that indeed the septal region of 
the encapsulated strain was enriched in iCFP-Wzg. This was not observed 
in strains lacking the cps operon, the wzd or the wze genes (Figure IV-3B). 
 
Lack of Wzg results in pneumococcal cells that produce various levels 
of capsule at their surface 
 
We next decided to determine the distribution of the capsular 
polysaccharide at the surface of the pneumococcal cells, in the absence of 
Wzg. For that purpose, we constructed wzg null mutants as previously 
described [13]. Several mutants were obtained in two independent 
experiments. These were analyzed by immunofluorescence microscopy 
using a purified antibody against the serotype 14 capsular polysaccharide. 
Three phenotypes of CPS distribution at the surface of the cells 
were obtained (Figure IV-4). In phenotype 1, represented by strain 
BCSMH057, the capsule was distributed all around the surface of the cells 
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as in the wild-type cells of the encapsulated ATCC6314 strain. However, 
some cells presented a fluorescence signal stronger than the wild-type 
cells, while others presented a weaker signal. In phenotype 2, represented 
by strain BCSMH058, cells were not labeled by the anti-capsular 
antibody, identically to the capsule null mutant BCSMC001 strain. 
Finally, in phenotype 3, represented by strain BCSMH059, cells presented 
a strong fluorescence signal, but this was not homogeneously distributed 
around the entire surface of the cells (Figure IV-4). 
 
 
Figure IV-4: Lack of Wzg results in pneumococcal cells that produce various 
levels of capsule at their surface. Detection of the presence of the capsular 
polysaccharide at the surface of pneumococcal bacteria was carried out by 
immunofluorescence as described in Material and Methods. i) ATCC6314, 
encapsulated parental strain; ii) BCSMC001, unencapsulated ATCC6314cps 
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strain; iii) BCSMH057, ATCC6314wzg strain representative of phenotype 1; iv) 
BCSMH060, strain BCSMH057 expressing constitutively iCFP-Wzg; v) 
BCSMH058, ATCC6314wzg strain representative of phenotype 2; vi) 
BCSMH061, strain BCSMH058 expressing constitutively iCFP-Wzg; vii) 
BCSMH059, ATCC6314wzg strain representative of phenotype 3; viii) 
BCSMH062, strain BCSMH059 expressing constitutively iCFP-Wzg. Scale bar, 
2 m. 
 
 The great majority of the mutants obtained (95%, n= 19) 
presented a CPS distribution correspondent to phenotypes 2 (58%, n= 11) 
or 3 (37%, n= 7). On the other hand, only one mutant displaying the 
phenotype 1 of CPS distribution at the surface of the cells was obtained. 
Despite this low frequency, we believe that the phenotype 1 corresponds 
to the real phenotype caused by the absence of wzg, since this was the 
only phenotype that was complemented upon expression of the protein 
fusion iCFP-Wzg (Figure IV-4): strain BCSMH060, which results from 
transformation of strain BCSMH057 with plasmid pBCSMH039, no 
longer presents cells with different fluorescence intensities when capsular 
polysaccharide is detected by immunofluorescence. On the other hand, 
strains BCSMH061 and 062, expressing iCFP-Wzg constitutively from 
plasmid pBCSMH039, presented the same phenotype as their parental null 
mutant strains, BCSMH058 and 059, respectively. The phenotypes of 
these mutants are probably the result of suppressor mutations in other 
capsule genes. 
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Discussion 
 
 The regulation of capsule synthesis in S. pneumoniae has been the 
subject of several studies. These led to the proposal that Wzd and Wze act 
as the main regulators of this process, through the control of the capsule 
synthesis and cell wall attachment rates. Recently, we have proposed a 
new role for these two proteins as spatial regulators of capsule synthesis, 
which ensure that it occurs at the division septum, possibly to conceal the 
newly synthesized peptidoglycan [13]. Therefore, Wzd and Wze 
guarantee that the S. pneumoniae cell surface is completely surrounded, 
and protected, by the capsular polysaccharide. However, how proteins 
Wzd and Wze perform this role is still not known. Two hypotheses can be 
envisioned: Wzd/Wze may recruit other members of the CPS synthesis 
machinery to the division septum or, alternatively, Wzd/Wze can interact 
and activate other members of the CPS synthesis machinery already 
present at that site. In order to better understand the role of Wzd/Wze, we 
decided to use a Bacterial Two-Hybrid assay and test whether different 
proteins involved in CPS synthesis could interact with Wzd, Wze or Wzd 
co-expressed with Wze. 
 No interactions were detected between Wzd, or Wze, and WchA, 
the first glycosyltransferase in the synthesis of the CPS repeating unit, 
Wzx, the CPS flippase, and Wzy, and the CPS polymerase. Surprisingly, 
also no interactions were detected between Wzh, the cognate phosphatase 
of Wze, and Wze [24]. It is possible that this interaction is transient and 
therefore undetectable with the Bacterial Two-Hybrid system. In fact, a 
weak interaction has been found between the Wzh and Wze homologues 
from Streptococcus thermophilus using a Yeast Two-Hybrid system [5]. 
Alternatively, Wzh, since it dephosphoylates Wze, may only interact with 
the phosphorylated form of the protein. If this is the case, and because 
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Wzd is required for the autophosphorylation of Wze [2], we would expect 
that an interaction would be obtained only when Wzh is co-expressed with 
Wze in the presence of Wzd. However, we failed to observe an interaction 
between the fusions T18-Wzh and Wzh-T18 with the fusion T25-Wzd co-
expressed with Wze. It is possible that co-expression of Wzh with tagged 
Wze in the presence of Wzd or with the tagged Wzd-L11-Wze chimeric 
protein will produce a positive result. A direct fusion of the S. 
thermophilus Wzd and Wze homologues did not interact  with Wzh 
probably due to conformational problems [5]. This may not occur in the 
Wzd-L11-Wze chimera, as this protein seems to be functional [13]. This 
chimera construct has a 11 amino acids linker connecting Wzd and Wze 
that should allow the mobility of both proteins. 
 In this work, we found that the CPS-cell wall ligase Wzg, may 
interact with Wzd in a bacterial two-hybrid assay. E. coli colonies 
expressing both proteins, linked to different fragments of the catalytic 
domain of Bordetella pertussis adenylate cyclase, were light blue. We 
hypothesized that the weak signal could be due to the fact that Wzg 
interacts with the pair Wzd/Wze, and not with Wzd alone. Therefore we 
tested the interactions of Wzg with several combinations of Wzd and Wze 
co-expressed, as well as with the chimera protein Wzd-L11-Wze. 
However, an increase in the intensity of the color of the colonies on 
indicative plates did not occur. The light blue color obtained for the 
colonies expressing the pair of fusions T18-Wzg + T25-Wze, co-
expressed with Wzd, and T25-Wzg + T18-Wze, co-expressed with Wzd, 
may result not from a direct interaction of Wzg with Wze, but from an 
interaction via Wzd, as Wze is known to interact with Wzd [13]. This 
would generate a complex Tagged-Wzg/Wzd/Tagged-Wze where the T18 
and T25 tags could be brought close enough to produce blue colonies. 
Protein Wzg was also found to interact with itself. 
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 Since one of our initial hypotheses was that Wzd/Wze could 
spatially regulate the capsule synthesis by recruiting other capsule 
proteins to the division septum, we decided to determine if the presence of 
Wzd/Wze was required for the correct localization of Wzg. We therefore 
determined the localization of Wzg, fused at its N-terminus end to iCFP. 
As expected due to its three transmembrane domains, Wzg was found to 
be present at the membrane of the pneumococcal cells. Interestingly, the 
Wzg fluorescent derivative was enriched at the septum of the wild-type 
encapsulated cells, as recently described by other authors for the S. 
pneumoniae encapsulated D39 and unencapsulated R6 strains [7]. 
However, we did not observe the septal enrichment of Wzg in the cps 
operon null mutant strain and, more importantly, in the absence of 
proteins Wzd or Wze. Our results are in disagreement with those obtained 
by Eberhardt and colleagues [7], and the reason for this discrepancy 
remains to be determined. 
 In the absence of Wzg, the capsular polysaccharide is produced 
and present all around the surface of the pneumococcal cells. However, 
the levels of CPS seem to differ between cells, as seen by the different 
fluorescent intensity signals observed. This phenotype is identical to the 
one reported for serotype 2 strain D39 [23]. The fact that capsule is still 
produced and attached to peptidoglycan in the absence of Wzg, the CPS-
cell wall ligase is in accordance with previous studies [7]. These showed 
that proteins from the LCP protein family to which Wzg belongs have 
(semi)redundant roles. Therefore, in the absence of Wzg other ligases may 
fulfill its role and attach the capsular polysaccharide to the peptidoglycan. 
 The determination of the function of Wzg in the attachment of the 
capsular polysaccharide to peptidoglycan has been reported very recently 
[16]. Based on the homology of its C-terminal domain with LytR [9], a B. 
subtilis transcriptional regulator [20], it was believed for a long time that 
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Wzg regulated the transcription of the cps operon. In fact, in 
Streptococcus agalactiae, recent evidence that the homologue protein 
CpsIA functions as a transcriptional regulator has been provided [6]. 
Moreover, the latest data regarding the Wzg homologues from 
Streptococcus iniae and S. agalactiae shows that these proteins bind 
specifically to DNA containing the capsule promoter region [10-11]. 
Interestingly, the extracellular domain of Wzg, the one whose structure 
has been solved and which is involved in the attachment of the capsule to 
the cell wall, is not involved in DNA binding [10-11]. DNA binding 
occurs through the less than 30 amino acids of Wzg present in the 
cytoplasm, but the sequential truncation of the S. agalactiae Wzg 
extracellular domain from its C-terminus led to a decrease in the 
specificity of the DNA binding [11]. It seems therefore plausible that Wzg 
has two roles in the regulation of the CPS assembly. It may attach the 
capsular polysaccharide and also control the transcription from the cps 
operon. The binding to DNA, or to the CPS polymer, could be modulated 
by conformational changes in Wzg. It is tempting to speculate that the 
conformational changes proposed to occur during CPS synthesis, and to 
regulate this process through the cycles of phosphorylation and 
dephosphorylation at the C-terminal tyrosines of Wze, are transmitted to 
Wzg by its interaction with Wzd, possibly through their extracellular 
domains. Wzg could be recruited to the division septum by Wzd and 
attach the capsular polysaccharide at that site. A second function would be 
the regulation of the transcriptional levels of the operon mediated by 
structural changes in Wzg that modulate its binding to DNA. These 
hypotheses remain to be tested. 
 In this work we aimed to elucidate how S. pneumoniae capsule 
synthesis is spatially regulated by proteins Wzd and Wze. We found that 
the CPS-cell wall ligase weakly interacts with Wzd. Wzd seems to recruit 
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Wzg to the division septum, since in its absence or when it is delocalized 
from the septum due to the absence of Wze, the septal enrichment of Wzg 
is no longer observed. Therefore, Wzd guarantees the attachment of the 
capsular polysaccharide at the septum by recruiting the Wzg ligase. 
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 Supplementary Information 
Table SIV-1: Bacterial strains. 
Name Relevant characteristics Comments/Source/ 
Reference 
E. coli   
DH5 recA endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 80 
dlacZ M15 
Gibco-BRL 
BTH101 Reporter strain for BTH system, 
F
-
 cya-99, araD139, galE15, 
galK16, rpsL1 (Str
r
), hsdR2, 
mcrA1, mcrB1 
[15] 
EC101 supE thi (lacproAB) (F’ traD36 
proAB lacI
q
 ZM15), repA 
from pWV01 integrated in the 
chromosome 
[19] 
L. lactis 
LL108 RepA
+
 MG1363, Cm
r
 [21] 
S. pneumoniae   
ATCC6314 Encapsulated strain, serotype 14 American Type Culture 
Collection 
BCSMC001 ATCC6314cps [13] 
BCSMH001      ATCC6314wzd [13] 
BCSMH002 ATCC6314wze [13] 
BCSMH053 ATCC6314 transformed with 
pBCSMH039. 
This work. 
BCSMH054 ATCC6314cps transformed 
with pBCSMH039. 
This work. 
BCSMH055 ATCC6314wzd transformed 
with pBCSMH039. 
This work. 
BCSMH056 ATCC6314wze transformed 
with pBCSMH039. 
This work. 
BCSMH057 ATCC6314wzg1 This work. 
BCSMH058 ATCC6314wzg2 This work. 
BCSMH059 ATCC6314wzg3 This work. 
BCSMH060 BCSMH057 transformed with 
pBCSMH039. 
This work. 
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Table SIV-1 (Cont.): Bacterial strains. 
Name Relevant characteristics Comments/Source/ 
Reference 
BCSMH061 BCSMH058 transformed with 
pBCSMH039. 
This work. 
BCSMH062 BCSMH059 transformed with 
pBCSMH039. 
This work. 
 
 
Table SIV-2: Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
 
Plasmids for Bacterial Two Hybrid Assay 
pUT18C BTH plasmid, N-terminal cyaAT18 
fusion, Amp
r
. 
[15] 
pUT18 BTH plasmid, C-terminal cyaAT18 
fusion, Amp
r
. 
[15] 
pKT25 BTH plasmid, N-terminal cyaAT25 
fusion, Kan
r
. 
[15] 
pKNT25 BTH plasmid, C-terminal cyaAT25 
fusion, Kan
r
. 
[15] 
pKT25zip BTH control plasmid, Kan
r
. [15] 
pUT18Czip BTH control plasmid, Amp
r
. [15] 
pBCSMC001 BTH plasmid containing cyaAT25-
wzd fusion. 
[13] 
pBCSMC002 BTH plasmid containing cyaAT18-
wze fusion. 
[13] 
pBCSMC003 BTH plasmid containing cyaAT18-
wze(WA) fusion. 
[13] 
pBCSMC004 BTH plasmid containing cyaAT18-
wze(Y) fusion. 
[13] 
pBCSMH014 BTH plasmid containing cyaAT18-
wze(WA2) fusion. 
[13] 
pBCSMC005 BTH plasmid containing cyaAT18-
wzd fusion. 
This work. 
pBCSMH040 BTH plasmid containing wzd- 
cyaAT18 fusion. 
This work. 
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Table SIV-2 (Cont.): Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
pBCSMC007 BTH plasmid containing wzd- 
cyaAT25 fusion. 
This work. 
pBCSMC006 BTH plasmid containing wze- 
cyaAT18 fusion. 
This work. 
pBCSMC008 BTH plasmid containing cyaAT25-
wze fusion. 
This work. 
pBCSMC009 BTH plasmid containing wze- 
cyaAT25 fusion. 
This work. 
pBCSMH041 BTH plasmid containing cyaAT18-
wze fusion and wzd. 
This work. 
pBCSMH042 BTH plasmid containing wzd- 
cyaAT18 fusion and wze. 
This work. 
pBCSMH043 BTH plasmid containing cyaAT18-
wzd-L11-wze fusion. 
This work. 
pBCSMH044 BTH plasmid containing wzd-L11-
wze- cyaAT18 fusion. 
This work. 
pBCSMH045 BTH plasmid containing cyaAT25-
wze fusion and wzd. 
This work. 
pBCSMH046 BTH plasmid containing cyaAT25-
wzd fusion and wze. 
This work. 
pBCSMH047 BTH plasmid containing cyaAT25-
wzd-L11-wze fusion. 
This work. 
pBCSMH048 BTH plasmid containing wzd-L11-
wze- cyaAT25 fusion. 
This work. 
pBCSMH049 BTH plasmid containing cyaAT18-
wzg fusion. 
This work. 
pBCSMH050 BTH plasmid containing wzg- 
cyaAT18 fusion. 
This work. 
pBCSMH051 BTH plasmid containing cyaAT25-
wzg fusion. 
This work. 
pBCSMH052 BTH plasmid containing wzg- 
cyaAT25 fusion. 
This work. 
pBCSMH053 BTH plasmid containing cyaAT18-
wchAfusion. 
This work. 
pBCSMH054 BTH plasmid containing wchA- 
cyaAT18 fusion. 
This work. 
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Table SIV-2 (Cont.): Plasmids. 
Name Relevant characteristics Comments/Source/ 
Reference 
pBCSMH055 BTH plasmid containing cyaAT18-
wzx fusion. 
This work. 
pBCSMH056 BTH plasmid containing wzx- 
cyaAT18 fusion. 
This work. 
pBCSMH057 BTH plasmid containing cyaAT18-
wzy fusion. 
This work. 
pBCSMH058 BTH plasmid containing wzy- 
cyaAT18 fusion. 
This work. 
pBCSMC010 BTH plasmid containing cyaAT18-
wzh fusion. 
This work. 
pBCSMC011 BTH plasmid containing wzh- 
cyaAT18 fusion. 
This work. 
pBCSMC012 BTH plasmid containing cyaAT25-
wzh fusion. 
This work. 
pBCSMC013 BTH plasmid containing wzh- 
cyaAT25 fusion. 
This work. 
 
Replicative plasmids in S. pneumoniae 
 
pBCSMH031 Allows expression of iCFP fusion 
proteins, Tet
r
. 
[12] 
pBCSMH039 pBCSMH031 containing iCFP-
wzg, Tet
r
. 
This work. 
pBCSTR001 Contains wzd-L11-wze-citrine, Tet
r
. [13] 
 
Non replicative plasmids in S. pneumoniae  
pORI280 Em
r
, LacZ
+
, ori
+
 of pWV01 [21] 
pBCSMH059 pORI280 containing up- and 
downstream regions of wzg, Em
r
, 
LacZ
+
 
This work. 
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Table SIV-3: Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
1 CGGGATCCCGGAGAAAATATGAAGG BamHI 
2 GGAATTCCCCTCTCTCCTATTTC EcoRI 
3 CTAGTCTAGAGATGAAGGAACAAAACACTTT
GG 
XbaI 
4 CGGGGATCCCCTTTCAACTTACTCAAGTTTGG BamHI 
5 CGGGATCCTAAGGAGGAAATATGA BamHI 
6 GGAATTCCATTTCAACTTACTCAAG EcoRI 
7 CGGGGATCCTAGGAGGGAGGAATGCCG BamHI 
8 GGAATTCCATTTTTTACCATAATTTCC EcoRI 
9 CGGGGATCCAATGCCGACATTAGA BamHI 
10 GGAATTCCCCTAAGTTATTTTTTACC EcoRI 
11 CGGAATTCTAAGGAGGTGCTGCGGCCATGA
AGGAACAAAACACTTTGG 
EcoRI, RBS 
12 CGGAATTCCTATTTCAACTTACTCAAGTTTGG EcoRI 
13 CCCAAGCTTTAAGGAGGTGCTGCGGCCATGC
CGACATTAGAAATAGC 
HindIII, 
RBS 
14 GCTCTAGATTATTTTTTACCATAATTTCC XbaI 
15 CTAGTCTAGAGATGAAGGAACAAAACACTTT
GG 
XbaI 
16 CGGGGATCCTAAGGAGGTGCTGCGGCCATG
CCGACATTAGAAATAGC 
BamHI, RBS 
17 CGCGGATCCAATGAGTAGACGTTTTAAAAAA
TCACG 
BamHI 
18 CCGGAATTCTCATCTACCCTCCATCACATCC EcoRI 
19 CCGGAATTCTTTCTACCCTCCATCACATCC EcoRI 
20 AACTGCAGAATGGATAAAAAAGGATTGG PstI 
21 CGCGGATCCTTACTTCGCTCCATTTCTC BamHI 
22 CGCGGATCCTTCTTCGCTCCATTTCTC BamHI 
23 AACTGCAGAATGAGTAATAAAATCAG PstI 
24 CGCGGATCCTTATAATATATTTTCATAACC BamHI 
25 CGCGGATCCTTTAATATATTTTCATAACC BamHI 
26 AACTGCAGAATGAAAATTAGAATAG PstI 
27 CGCGGATCCTCATCCAACTATTTCC BamHI 
28 CGCGGATCCTTTCCAACTATTTCC BamHI 
29 CGGGATCCCGAAATGATAGACATCC BamHI 
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Table SIV-3 (Cont.): Primers used in this work. 
Primer Sequence 5’3’ Features/ 
Restriction 
sites 
30 GGAATTCCCTCCTAAATTAATTGATCC EcoRI 
31 CGGGATCCTGAAGGAGGGTAGATGAAATG BamHI 
32 GGAATTCCAAATTAATTGATCCATTAT EcoRI 
33 ATAAGAATGCGGCCGCAATGAGTAGACGTTT
TAAAAAATCACG 
NotI 
34 GAAGATCTTCATCTACCCTCCATCACATCC BglII 
35 CGCGGATCCGGTAAGAAAAACTTCTG BamHI 
36 CTACTATCATCGATTAACACCTATACCTTGAA
CATCGTAC 
Region 
overlapping 
primer 37 
37 GGTGTTAATCGATGATAGTAGTTTAGCTGTA
GTTAAAGC 
Region 
overlapping 
primer 36 
38 CCGGAATTCGGTTTTGAAACATGATAAC EcoRI 
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The cell wall structure, which surrounds the surface of bacteria, 
constitutes the frontier, and therefore the first contact, between a pathogen 
and the infected host. The capsular polysaccharide, a major component of 
the cell wall that surrounds S. pneumoniae cells, has been extensively 
investigated throughout the years.  
In this thesis, we contributed to the elucidation of the regulation of 
capsular polysaccharide synthesis in S. pneumoniae. We unraveled a new 
role for the proteins Wzd and Wze, which form a complex that localizes at 
the division septum and act as spatial regulators. This ensures CPS is 
expressed around the entire surface of the cells [3]. We shed some light on 
how Wzd/Wze fulfill this function, since our preliminary results indicate 
that Wzg, the CPS-cell wall ligase, is recruited to the septum when Wzd is 
produced in the presence of Wze. Importantly, our results suggest the 
existence of two CPS synthesis machineries, similar to what has been 
proposed for peptidoglycan synthesis [8, 15]. In order to perform our 
studies we have developed novel tools for in vivo protein localization in S. 
pneumoniae. These tools constitute an important help to researchers 
working in the field of pneumococcal cell biology and should be of great 
use in the future. 
Despite the important contributions described in this thesis 
towards the understanding of S. pneumoniae CPS synthesis and 
regulation, many questions still remain and are currently being addressed. 
 
How does the Wzd/Wze complex localize to the septum? 
 
 We have shown that Wzd and Wze, the well accepted main 
regulators of capsule synthesis in S. pneumoniae, interact when the 
Walker A ATP binding motif of Wze is intact. This complex is then able 
to localize to the division septum of the pneumococcal cells, without 
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requiring any other protein encoded in the cps operon. However, the 
factors that determine the septal localization of proteins Wzd and Wze are 
still unknown. 
 The localization of the Wzd/Wze complex to the septal region of 
S. pneumoniae may require its recruitment by another protein, not 
involved in capsule synthesis. This hypothesis implies that proteins Wzd 
and Wze, as a complex, should interact with that unknown protein. Also, 
the recruiting protein should be distributed in the pneumococcal cell with 
an identical pattern as Wzd/Wze, but independent on the ability of the 
bacteria to produce CPS. PBPs are attractive candidates to fulfill this role. 
First, these proteins were shown to localize at the midcell region [7, 12]. 
Second, the S. pneumoniae capsular polysaccharide is covalently attached 
to the peptidoglycan [17], indicating that proteins involved in the 
assembly of the two macromolecules may interact, or probably share a 
similar localization, during a specific window of the bacterial cell cycle. 
Third, we showed that Wzd/Wze co-localized with the signal from 
fluorescent vancomycin labeling, i. e., co-localized with the sites where 
synthesis of peptidoglycan is taking place. In order to enquire whether 
Wzd/Wze can be recruited to the division septum by PBPs the localization 
of Wzd/Wze should be determined in the absence of the PBPs, when 
possible, and/or in conditions that affect their localization, such as 
incubation with specific antibiotics that target different steps of 
peptidoglycan synthesis. Moreover, we could also test their ability to 
interact directly using Bacterial Two-Hybrid and/or pull-down assays. 
Proteins MreC and MreD are also distributed in the pneumococcal 
cell in a very identical pattern as Wzd/Wze [8]. Furthermore, their role in 
peripheral peptidoglycan synthesis makes them also possible candidates 
for the recruitment of the complex. StkP shows the same apparent 
localization pattern as Wzd/Wze [1-2] and interestingly it delocalizes in 
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the presence of antibiotics that affect the latest stages of peptidoglycan 
synthesis [1]. Other proteins, which seem to distribute identically to 
Wzd/Wze, like FtsA, DivIB and FtsL [9, 14], also constitute possible 
candidates for the recruitment of Wzd/Wze and would be interesting to 
test. 
Another hypothesis for the localization of the complex Wzd/Wze 
to the division septum is the recognition of a specific motif present at the 
septal region. Membrane curvature has been recently shown to act as a 
cue for the localization of two proteins, SpoVM and DivIVA, in B. 
subtilis [16]. We have shown that Wzd/Wze localize to the division region 
early in the cell cycle, so the hypothesis of a membrane curvature 
dependent Wzd/Wze localization should not be ruled out. 
Alternatively, the enrichment of certain phospholipids in discrete 
regions of the membrane may be required for the localization of Wzd/Wze 
to the division septum.  In E. coli and B. subtilis, enrichment of 
cardiolipin at the septum and poles has also been identified as a protein 
targeting effector [11]. MinD interacts with the membrane through an 
amphipathic helix that has a preference for anionic phospholipids such as 
cardiolipin [11]. Interestingly, Wze belongs to the same superfamiliy of P-
loop NTPases as MinD, the MinD/Mrp-Etk superfamily [10]. One can 
speculate that an identical mechanism of localization might be at place for 
the localization of Wzd/Wze. To our knowledge, no studies on the 
existence of lipid rich domains in the S. pneumoniae membrane have been 
reported. 
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How does the Wzd/Wze complex control CPS synthesis at 
midcell? 
 
 In this thesis, we have shown that the complex Wzd/Wze is 
required for the expression of capsular polysaccharide all around the 
surface of the S. pneumoniae cells. In the absence of one of the proteins, 
or in conditions in which the complex cannot be formed, such as 
prevention of ATP binding to Wze, we observed that CPS is produced and 
attached to peptidoglycan, but it is absent from the new, septal wall. 
Therefore, we have proposed that proteins Wzd and Wze are spatial 
regulators of capsule synthesis that guarantee that this process occurs at 
the division septum. How do proteins Wzd/Wze perform this regulation is 
an aspect that we are currently trying to elucidate. 
 Two hypotheses can be envisioned for the control of CPS 
expression at midcell by Wzd and Wze: i) the Wzd/Wze complex recruits 
to the septum one or more proteins involved in CPS synthesis; ii) the 
Wzd/Wze complex activates one or more proteins involved in CPS 
synthesis that are already localized at the division septum. In either 
hypotheses, the CPS proteins that, based on their function and the current 
model for CPS synthesis [5, 13], are more likely to be under the regulation 
of Wzd/Wze are Wzx, the capsular polysaccharide flippase; Wzy, the 
capsular polysaccharide polymerase; and Wzg, the capsule-cell wall 
ligase. 
Interestingly, we found that Wzg can interact with Wzd in a 
Bacterial Two-Hybrid assay. More importantly, we observed that Wzg 
could localize at the septum of encapsulated pneumococcal cells. This 
enrichment was not present in the unencapsulated strain or in the absence 
of Wzd or Wze. This suggests that the complex Wzd/Wze can recruit the 
Wzg ligase to the septum and that the lack of capsular polysaccharide at 
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that site in the wzd and wze null mutants might be due to its inefficient 
attachment at that location. These results are still preliminary and pull-
down experiments to confirm the interaction between Wzg and Wzd are 
needed. It would also be interesting to test if the defect in capsule-cell 
wall attachment observed previously in S. pneumoniae expressing Wzd 
single residue mutants [13] is due to a deficient interaction of Wzd with 
Wzg. If this is the case, Wzg should be delocalized when these single 
residue Wzd mutants are expressed, identically to the wzd null mutant. 
Interestingly, the referred mutations are in aminoacids localized in the 
extracellular region of Wzd. Therefore, it is tempting to speculate that 
Wzd and Wzg interact through their extracellular domains. 
Although no interactions have been found between Wzd/Wze and 
proteins Wzx and Wzy using the Bacterial Two-hybrid assay, we cannot 
rule out their existence. More experiments are needed to ascertain if 
besides Wzg other capsule proteins are under the control of Wzd/Wze. 
This will further elucidate the manner in which CPS synthesis proceeds. 
 
Are there two CPS synthesis modes in S. pneumoniae? 
 
  Perhaps one of the most striking results obtained in this thesis is 
the indication that, similarly to the synthesis of peptidoglycan, there are 
two modes to synthesize CPS. The concept of two cell wall synthesis 
machineries, one peripheral and the other one septal, as emerged early in 
ovococcus cell division studies [4] and has recently gained strong support 
[8, 15]. Our capsular polysaccharide immunofluorescence results point to 
an identical phenomenon regarding CPS synthesis. The observed 
distribution of capsule on the surface of the pneumococcal cells that lack 
Wzd or Wze can be explained by the existence of two modes of synthesis, 
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one associated with peripheral cell wall and the other with septal cell wall 
(Figure V-I), which can be discriminated by fluorescence microscopy. 
 
 
 
Figure V-1: Production of capsular polysaccharide associated with the septal 
and peripheral cell wall. Schematic representation of the expected patterns of 
CPS expression at the surface of S. pneumoniae cells when one mode of 
synthesis, septal (A) or peripheral (B), is not-functional. 
 
 Careful analysis of wzd and wze null mutant cells and integration 
with the current model for S. pneumoniae cell wall synthesis allows us to 
propose the type of cell wall with which Wzd/Wze are associated. The 
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association of Wzd/Wze with septal growth should lead to the appearance 
of half-stained cells, as represented in Figure V-IA, and cells stained only 
at the middle region. These were not observed. On the other hand, 
association of Wzd/Wze with peripheral growth would lead to the lack of 
fluorescence signal only at the middle region of the cells (Figure V-IB), 
the pattern observed in the wzd and wze null mutants [3]. Therefore, we 
favor the hypothesis that the complex Wzd/Wze regulates the synthesis of 
CPS, and its attachment to peptidoglycan, at the peripheral cell wall. 
In order to test this model, the expression of capsule at the surface 
of cells in conditions of peripheral or septal growth inhibition should be 
examined. If Wzd and Wze are indeed associated with the production of 
CPS attached to the peripheral cell wall, and not necessary for the 
synthesis of CPS linked to the septal cell wall, then the inhibition of the 
peripheral cell wall growth in the wzd and wze null mutants would lead to 
round cells expressing capsule all around their surface. On the other hand, 
inhibition of septal growth would lead to elongated cells lacking capsular 
polysaccharide at multiple sites. 
Since the proteins known to be specifically involved in the 
different types of growth, peripheral (MreCD, PBP2b) and septal (PBP2x) 
[8, 15] are essential [6, 8], this model cannot be tested through the 
construction of knockout mutants. Instead, inhibition of peripheral and 
septal growth can be achieved through the use of -lactam antibiotics 
from different classes that differentially target the PBPs. One hypothesis 
is the use of piperacillin and cefotaxime, which displayed preferential 
affinities for PBP2b and PBP2x [18], respectively, allowing us to 
distinguish between the peripheral and septal modes of growth. 
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Concluding remarks 
 
 The S. pneumoniae capsular polysaccharide is one of the main 
virulence factors of this major pathogen. It is essential for the bacterium 
during the different stages of interaction with its host and the amount of 
CPS expressed at the surface of the cells in these different environments is 
highly regulated. For these reasons, the S. pneumoniae capsular 
polysaccharide has been the subject of several studies, many with the aim 
of developing new and more efficient strategies against pneumococcal 
infection. In order to achieve this goal, a complete understanding of the 
manner in which CPS synthesis occurs and is regulated is of central 
importance. The results obtained in this thesis have no doubt contributed 
to the elucidation of the capsular synthesis process in S. pneumoniae. 
However, many questions still remain, some raised by the results 
described in this manuscript. The answer to those questions will have 
important implications in the development of new strategies to fight S. 
pneumoniae infections. 
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